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ABSTRACT 
NUTRIENT CHANNELS TO AID THE GROWTH OF ARTICULAR SURFACE-SIZED 
ENGINEERED CARTILAGE CONSTRUCTS 
Alexander Drake Cigan 
 
Osteoarthritis is a joint disease associated with the irreversible breakdown of articular 
cartilage in joints, causing pain, impaired mobility, and reduced quality of life in over 27 million 
Americans and many more worldwide. The tolls by osteoarthritis (OA) on the workforce and 
healthcare system represent significant economic burdens. An attractive strategy for treating OA 
is cartilage tissue engineering (CTE). CTE strategies have been promising at producing cell-
scaffold constructs at small sizes (3-5 mm in largest dimension), but OA often does not present 
symptoms until lesions reach 25 mm in diameter. 
Using bovine chondrocytes seeded in agarose, our lab has produced small CTE constructs 
with native cartilage levels of compressive stiffness and proteoglycan content. As construct 
dimensions are increased, however, the resulting tissue suffers from extreme heterogeneity of 
deposited matrix due to nutrient transport limitations. The ability to successfully scale up 
constructs to clinically relevant sizes is a major goal in CTE research. Another major and largely 
unresolved obstacle is the translation of successes from animal cell models to CTE systems with 
human cells, which is ultimately necessary for clinical treatment of OA. In this dissertation, 
experiments are placed forth which seek to address the nutrient limitations in large cartilage 
constructs and to help bridge the gap from animal cells to human cells for CTE. 
The growth of CTE constructs is limited by the poor availability of nutrients at construct 
centers due to consumption by cells at the construct periphery. The first series of studies in this 
dissertation sought to identify nutrients in culture media that are consumed by cells and are 
critical for matrix production, and to characterize their transport behavior. Among several 
candidate nutrients, glucose proved to be the most indispensable; little to no growth transpired in 
constructs when glucose fell below a critical threshold concentration. A subsequent study 
provided a system-specific glucose consumption rate. These parameters were informative for 
computational models of construct growth, which helped predict transport and growth 
phenomena in constructs and suggest improved culture techniques for later experiments. 
The cultivation of tissue constructs of increasing size presents logistical challenges, as the 
constructs’ requirements for nutrients, growth factors, and even sizes of culture vessels increase. 
The addition of nutrient channels to constructs to improve nutrient transport and tissue growth is 
a promising strategy, but more sophisticated casting and culture techniques are required for 
constructs with channels, particularly as construct size is increased. We first designed casting 
and culture devices for cylindrical 10 mm × 2.3 mm (diameter × height) constructs with 1 mm 
diameter nutrient channels. With information gleaned from computational models predicting 
glucose availability in constructs, we refined our culture system and demonstrated beneficial 
effects of nutrient channels on construct mechanical properties and extracellular matrix contents. 
This was the most successful instance to date of the use of nutrient channels in CTE, and is 
highly promising for channels’ ability to mitigate transport limitations in constructs. 
We next sought to optimize key parameters for culturing channeled constructs. The 
addition of channels is an optimization problem: greater numbers of closer-packed channels 
increase nutrient availability within the construct but simultaneously detract from the construct’s 
initial volume and cell population. Furthermore, we suspected that uneven swelling of 10 mm 
diameter constructs was a side effect of transient treatment with 10 ng/mL TGF-β, a highly 
effective and commonly-employed technique for elevating construct functional properties. By 
increasing channel densities in 10 mm diameter constructs, we identified a channel spacing that 
yielded optimal construct functional properties. In constructs with this channel spacing, reducing 
the TGF-β dosage by tenfold resulted in similar or elevated properties by constructs. These 
experiments supplied us with optimal parameters for further scaling up our constructs to 
clinically-relevant sizes, a practice that can be adapted for any CTE culture system for large 
constructs.  
The ability to treat severe OA by entirely resurfacing diseased joints with CTE would be 
highly desirable, yet this ability remains elusive, as efforts to grow constructs of such size have 
thus far been stymied by nutrient transport limitations. We scaled up our culture system for 10 
mm diameter constructs, employing previously optimized culture conditions and channel 
spacing, and cultured articular surface-sized (40 mm diameter, 2.3 mm thick) constructs. These 
constructs were 100× the size of our small constructs, yet they still attained similar functional 
properties, reaching native cartilage levels of compressive stiffness and proteoglycan content. 
These are the largest CTE constructs to ever achieve such favorable properties. These results 
demonstrate that with nutrient channels, CTE constructs have the potential to replace entire joint 
surfaces that have been compromised by OA. 
Finally, we began to explore the feasibility of translating techniques from our bovine and 
canine model systems into human cells. We harvested adult human chondrocytes from expired 
osteochondral allografts and cast them in small (3 mm diameter) constructs, culturing the 
constructs under various conditions that have been previously successful for animal constructs. 
We observed similarities between human versus bovine and canine constructs, most notably that 
high initial cell seeding density led to marked increases in functional properties, in some cases 
approaching mechanical and biochemical properties of native human cartilage. Human 
constructs also exhibited poor GAG retention and long-term growth relative to animal constructs. 
By establishing successful techniques for human constructs in addition to identifying new 
challenges, we provided an in-depth characterization of human chondrocytes in agarose that is 
promising overall for eventual clinical translation. 
The body of work presented in this dissertation followed a methodical approach to 
scaling up CTE constructs to the sizes of entire joint surfaces, through experimentation with 
nutrient channels in constructs and with the support of predictive computational models. The 
principle behind nutrient channels is fundamental and therefore can be applied to CTE systems 
using other scaffold and cell types. By incrementally increasing the scale of bovine chondrocyte-
laden constructs and by performing initial studies with small human CTE constructs, we have 
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1.1 Hypotheses and specific aims 
The research presented in this dissertation seeks to overcome the nutrient limitations experienced 
by cells in large cartilage tissue-engineered (CTE) constructs by a series of experiments, 
supported by computational modeling, designed to characterize and overcome nutrient 
deficiencies within increasingly large tissues. The primary goal of these collective studies is to 
achieve and demonstrate the ability to increase the scale of CTE constructs, without 
compromising their properties, ultimately up to the size of entire human articular surfaces. To 
accomplish this, the five following specific aims are proposed: 
 
1.1.1 Specific Aim 1: Identify critical nutrients and their rates of cellular 
consumption in constructs 
In the cultivation of CTE constructs, cells are expected to synthesize and deposit extracellular 
matrix (ECM) that is similar in composition to that of native cartilage. To maintain viability and 
synthesize ECM, cells must draw from the culture medium in which they are immersed, which is 
rich in nutrients and building blocks for ECM. Nutrient deficiencies limit the size of engineered 
cartilage constructs, and occur when cells become deprived of one or more “critical” nutrients at 
the centers of large constructs. We define critical nutrients as those which are 1) depleted by 
peripheral cells and 2) critical for synthesis of matrix by cells. These critical nutrients therefore 
form gradients in their concentration, with highest concentrations at the construct surface and 
lowest at the construct center, which will in turn create gradients in matrix synthesis as nutrients 
become depleted. Therefore, in order to scale up constructs successfully, there is a need to 
optimize nutrient supply within the tissue.  
3 
 
In addition to performing tissue engineering experiments, we also possess the capability 
to use finite element models to simulate nutrient transport and consumption and tissue growth in 
constructs. These computational models represent powerful tools for optimizing culture 
conditions virtually, obviating tedious and costly benchtop experiments. In order to predict 
nutrient availabilities in our culture system, the models must first be informed by 
experimentally extracted culture parameters. The two sub-aims of Specific Aim 1 are thus 
need-based: 
Specific Aim 1a: Modulate media concentrations of candidate critical nutrients, 
particularly by reducing them or removing them altogether, and quantify any dose-
dependent effects on construct functional properties. 
Specific Aim 1b: Calculate cellular consumption rates of nutrient(s) identified in SA1a 
by measuring their concentrations in culture media over time. 
  
1.1.2 Specific Aim 2: Design and implement a culture system capable of cultivating 
10 mm constructs and demonstrate beneficial effects of nutrient channels 
Nutrient limitations have been observed in juvenile bovine chondrocyte-agarose constructs as 
small as 4 mm cast with 60 × 10
6
 cells/mL (Bian et al., 2009a). An approach that has 
previously shown promise is the incorporation of nutrient channels in constructs, which 
effectively reduce the path length nutrients must traverse in order to reach the construct center. 
The addition of single 1 mm axial nutrient channels in 4 mm constructs improved their 
mechanical properties, as did the addition of three evenly-spaced channels in 10 mm constructs 
(Bian et al., 2009a). Our more recent experiments failed to demonstrate beneficial effects of 
channels, and resulted in very heterogeneous swelling and matrix deposition (Appendix 2). 
Examining those results, we hypothesize that channels were rendered ineffective by stagnation of 
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media within. We further hypothesize that growth of 10 × 2.34 mm constructs was hindered by 
the fact that for each construct an entire circular face, representing ~ 1/3 of the construct’s total 
surface area, abuts the bottom of the dish in which it is cultured. Thus, we have uncovered a 
need to revisit the culture system for these constructs.  
A major design consideration for any device in this culture system is TGF-β binding. TGF-
β is routinely used in chondrocyte-agarose construct culture, as it has been shown to reproduce 
several native cartilage properties (Byers et al., 2008). However, TGF-β exhibits high binding 
affinity to a broad variety of materials (Albro et al., 2013b), and thus introducing such materials 
into the culture media can reduce or eliminate the effective TGF-β concentration that the 
constructs are exposed to. Therefore, materials used in TGF-β-supplemented cultures must be 
carefully considered. 
As cells consume media nutrients, the media immediately surrounding constructs in static 
culture become nutrient-depleted, and culturing constructs of increasing size in static media 
becomes problematic. By re-orienting constructs such that channels run parallel to the direction 
of media stirring, we aim to encourage media flow through channels and thereby replenish the 
supply of nutrients within them. Before culturing CTE constructs in this novel system, we will 
first employ acellular, channeled agarose gels to validate that the culture system enhances 
convection of solutes to the gels’ centers.  
Experiments run under Specific Aim 1 revealed that glucose is a critical nutrient for 
construct growth, and that when its concentration falls below a threshold value no growth is 
observed (Cigan et al., 2013a; Cigan et al., 2013c; Nims et al., 2014). Experiments run under 
Specific Aim 2b demonstrated beneficial effects of channels on construct mechanical properties, 
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but not on construct matrix deposition. Finite element models (FEBio, www.febio.org) informed 
by experimentally measured glucose consumption rates predicted that glucose availability within 
constructs was enhanced by channels; however, media glucose levels quickly fell below this 
threshold within constructs supplied with conventional media volumes (Nims et al., 2015). 
The second specific aim consists of design-directed and hypothesis-driven sub-aims: 
Hypothesis 2: Enhancing media flow through nutrient channels will improve functional 
properties of constructs. Increasing media supply rates to channeled constructs will 
maintain above-threshold glucose levels and enhance the efficacy of channels. 
Specific Aim 2a: Design and fabricate culture devices to reorient construct channels 
horizontally in culture dishes; simultaneously encourage media convection through 
channels with multiple modes of stirring. Validate convection of media in acellular 
agarose gels. 
Specfic Aim 2b: Using the culture system(s) validated in SA2a, cultivate 10 mm 
constructs, with or without channels, to assess the efficacy of channels in promoting 
homogeneous growth. 
Specific Aim 2c: Increase glucose supply rates to 10 mm constructs by increasing 
glucose concentrations and/or media volumes, and quantify related changes in functional 
properties. 
 
1.1.3 Specific Aim 3: Optimize key parameters of culture system for channeled 
constructs 
With the culture system designed and implemented in Specific Aim 2, we now seek to further 
optimize the system to produce higher-quality engineered cartilage. The incorporation of 3 
evenly-spaced 1 mm nutrient channels in 10 mm constructs improved functional properties 
in a preliminary study (Bian et al., 2009a) and in experiments guided by Specific Aim 2; 
however, this 3-channel configuration was selected semi-arbitrarily. Because we desire to 
optimize outcomes in this culture system, we wish to determine the ideal spacing for nutrient 
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channels in a hypothesis-driven sub-aim. Two simultaneous and competing effects result from 
adding increasing numbers of channels to constructs: 1) improvements in nutrient availability by 
reducing diffusion distances within constructs, and 2) detractions from overall growth potential 
by decreasing initial construct volume and cell number. These competing effects are to be 
mitigated in hypothesis-driven sub-aim Specific Aim 3a.  
During the course of the research contained in this dissertation, new experimental results 
came to light which hold consequences for culturing channeled constructs. TGF-β 
supplementation, which is necessary to reproduce native cartilage properties (Byers et al., 2008), 
was observed to enhance matrix synthesis exclusively in thin boundary layers extending from the 
surfaces of constructs, exacerbating matrix heterogeneity (Albro et al., 2016). Thus we began to 
treat TGF-β as a critical nutrient, similar to glucose in Specific Aim 1, and there became a need 
to optimize supplementation concentrations of TGF-β in channeled constructs. The 
corresponding need-based sub-aim is Specific Aim 3b.  
Hypothesis 3: An optimum channel density exists that balances the competing effects of 
adding nutrient channels and maximizes functional properties of constructs. 
Specific Aim 3a: Cultivate 10 mm constructs with increasing numbers of evenly-
spaced 1 mm channels (0, 3, 12, 19, 27), and identify an optimal channel spacing which 
maximizes construct growth. 
Specific Aim 3b: Cultivate 10 mm constructs with reduced or absent TGF-β 
supplementation, with either no channels or the optimal number of channels determined 





1.1.4 Specific Aim 4: Cultivate articular surface-sized channeled constructs 
The experiments in Specific Aims 2-3 sought to design and optimize a culture system for 10 
mm constructs. At this size, constructs can host various channel configurations while still 
affordably allowing the study of several experimental groups. However, we ultimately aim to 
produce constructs large enough to resurface even the largest human joints (e.g. the knee), and 
therefore we need to scale up successful techniques from Specific Aims 2-3 into a culture 
system capable of cultivating articular surface-sized constructs.  
Our CTE experiments are most often performed with juvenile bovine chondrocytes, as 
they are relatively easy to obtain in desired quantities and readily produce cartilage matrix. This 
animal model is highly idealized, and clinical scenarios for CTE will likely rely on a relatively 
small number of donor cells that first must be expanded in monolayer culture to increase cell 
number. Thus, constructs seeded with passaged chondrocytes represent a more realistic clinical 
scenario, and we desire to ascertain that they can be supported by our culture system. 
Hypothesis 4: Under previously optimized conditions determined in SA1-3, articular 
surface-sized constructs will develop functional properties on par with those of smaller 
constructs. Passaged chondrocytes can produce articular layer-sized constructs with 
functional properties on par with those of constructs cast with primary chondrocytes. 
Specific Aim 4a: Scale up the culture system designed in SA2 to accommodate 40 × 
2.3 mm constructs with the optimum spacing of channels determined in SA3a. In pilot 
studies, culture 40 mm constructs under a variety of conditions to further optimize the 
culture system. 
Specific Aim 4b: Cultivate and characterize 40 mm constructs in a controlled study, 
assessing their properties in comparison to 4 mm and 10 mm constructs. 
Specific Aim 4c: Cast 40 mm constructs with both primary and passaged juvenile 




1.1.5 Specific Aim 5: Translate successful CTE strategies from animal models into an 
engineered human cartilage system 
In addition to the challenges posed by producing clinically relevant-sized engineered cartilage, a 
major parallel obstacle faced by CTE is the successful translation from discoveries made in 
animal model systems into human model systems. Ultimately, engineered cartilage grafts must 
rely on human cell sources in order to successfully treat OA.  
In continuing efforts to strive towards clinical relevance for CTE, we seek to supplement 
our studies on articular surface-sized CTE constructs with a line of experiments that begin to 
characterize adult human chondrocytes as cell sources for CTE. The Musculoskeletal Transplant 
Foundation (www.mtf.org) graciously supplies us with human osteochondral allografts that were 
originally destined for donation but have passed their expiration dates of ~ 28 days post-mortem. 
The practice of transient TGF-β supplementation (for the first two weeks of culture) has 
become indispensable for the cultivation of juvenile bovine chondrocytes in agarose (Byers et 
al., 2008). In experiments using adult canine chondrocytes, however, continuous TGF-β has 
proven to be more beneficial (Ng et al., 2008b). The two treatments will be compared in regards 
to their utilities for human chondrocytes in the hypothesis-driven sub-aims SA5a-b.  
We anticipate that adult human chondrocytes will have lower potential for growth than 
juvenile bovine cells, particularly when harvested from expired allografts. In bovine constructs, 
increasing initial cell seeding densities up to or above 60 × 10
6
 cells/mL has led to concomitant 
increases in matrix synthesis (Bian et al., 2009a; Talukdar et al., 2011), suggesting similar trends 
may be possible for human constructs.  
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Hypothesis 5: By translating successful CTE techniques from our experiments in animal 
model systems into a human chondrocyte model system, we can engineer human cartilage 
with similar functional properties. 
Specific Aim 5a: Cast 3 mm constructs using chondrocytes derived from expired 
human osteochondral allografts, and assess the utility of transient versus sustained TGF-β 
supplementation. 
Specific Aim 5b: Implementing the more successful TGF-β treatment from SA5a, 




Figure 1-1: Overview of experiments performed within this dissertation (blue) and 




As human life expectancies continue to extend, an increasingly elderly population must contend 
with aging-related disease. Osteoarthritis (OA) is characterized by the progressive deterioration 
of articular cartilage and other tissues within the joint. It is a highly prevalent and costly cause of 
disability, afflicting over 27 million people and costing an estimated $185.5 billion in medical 
expenses in the US alone (Kotlarz et al., 2009; Lawrence et al., 2008). Treatment options for OA 
depend on the size and extent of cartilage lesions, and include microfracture, mosaicplasty of 
osteochondral grafts (Hangody et al., 1997), and autologous chondrocyte implantation (Brittberg 
et al., 1996). In the most severe of cases, total joint replacement may be required. To date, there 
is no method which is capable of restoring entire cartilage surfaces in large joints. 
Cell-based therapies constitute an attractive strategy for regenerating functional cartilage 
to treat OA. Cartilage tissue engineering (CTE) is a technique in which donor cells are seeded 
into three-dimensional scaffolds and cultivated in vitro to form neocartilage (Cima et al., 1991; 
Langer and Vacanti, 1993; Paige and Vacanti, 1995). Since its inception, the field of CTE has 
seen numerous advancements, yet several outstanding obstacles prevent it from reaching 
widespread clinical use. Two major, lasting challenges in CTE are 1) the ability to produce tissue 
constructs large enough to be clinically relevant in treating OA, and 2) achieving satisfactory 
properties in engineered cartilage using human cells, which are ultimately required for successful 
implantation of tissue constructs. 
This dissertation sought to address these two obstacles by conducting in vitro 
experiments driven by the five Specific Aims detailed above. The first four Aims are centered 
around the production and cultivation of clinically-relevant-sized cartilage tissue constructs, and 
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the fifth Aim is manifested by a collection of studies attempting to recreate past successes with 
bovine and canine cells in human chondrocyte-laden constructs. 
Chapter 3 of this dissertation addresses Specific Aim 1. Being the earliest work 
performed in a sequence of studies geared towards optimizing growth in large cartilage 
constructs, the focus of this chapter is highly fundamental. For serum-free culture media used in 
cartilage tissue engineering, each ingredient plays its own role in stabilizing cell survival, 
metabolism, and matrix synthesis. We sought to determine whether one media nutrient (or a 
small subset of nutrients) could be identified as being primarily responsible for the 
heterogeneous growth observed in large constructs (Hung et al., 2003) in Experiments 3.1 and 
3.2. After finding a suitable candidate, Experiment 3.3 served to extract rates of nutrient 
consumption and corresponding matrix synthesis by cells. The parameters gleaned from these 
studies provide valuable knowledge that may be used in computational modeling of nutrient 
availability within tissue-engineered constructs and of construct tissue growth. 
Specific Aim 2 is addressed in Chapter 4. As an incremental step towards the growth of 
constructs of clinically relevant scales, we began culturing 10 mm constructs with nutrient 
channels (Bian et al., 2009a). Initial attempts (described in Appendix 2) resulted in extremely 
heterogeneous growth, and revealed a profound need for more advanced culture strategies. In 
this chapter, we set out to uncover methods for systematic casting and effectively culturing these 
constructs (Experiment 4.1), and to implement results from computational models of construct 
growth (Nims et al., 2015) in order to further improve construct growth (Experiment 4.2). The 
abilities to overcome transport-related limitations in culturing centimeter-sized cartilage 
constructs and to demonstrate the efficacy of nutrient channels are important intermediate 
achievements before there is hope of successfully scaling up to articular surface-sized constructs. 
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Specific Aim 3 is addressed in Chapter 5. The purpose of the experiments in this section 
are to further refine our culture system developed for 10 mm constructs with nutrient channels. 
Experiments with articular surface-sized constructs are forecasted to be expensive, requiring 
large numbers of cells and substantial quantities of media and growth factors; therefore, it is 
desirable to optimize facets of this culture system while still at an intermediate scale. The goal of 
these optimization experiments was to economize downstream experiments with larger-scale 
constructs by identifying ideal nutrient channel spacing(s) and growth factor supplementation 
rates. Additionally, such optimization experiments provide a detailed dataset by which 
computational models may be calibrated, allowing them to more accurately predict nutrient 
transport and tissue growth under conditions which interpolate and/or extrapolate experimentally 
tested culture parameters. 
Chapter 6 addresses Specific Aim 4. Herein, armed with techniques honed by 
experiments satisfying the previous Specific Aims, we revisited previous attempts to grow 
cartilage large enough to resurface the human knee joint (Hung et al., 2003). By scaling up our 
culture system optimized for 10 mm constructs, we demonstrate that by implementing nutrient 
channels, constructs can be scaled to sufficient sizes for resurfacing entire joints without 
compromising their functional properties. Though these experiments are performed on bovine 
chondrocytes in agarose, the fundamental concepts underlying nutrient channel utilization are 
broadly applicable, and are promising for the ability to scale up tissue constructs of any cell type 
and scaffold material.  
Parallel to the challenge of scaling up CTE constructs is the obstacle of translating 
techniques from animal model systems into human cell models, which is ultimately necessary for 
clinical translation of CTE techniques. In Chapter 7, Specific Aim 5 is approached. Through a 
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series of experiments using adult human chondrocytes sourced from expired osteochondral 
allografts and encapsulated in agarose scaffolds, we first demonstrated the necessity of sustained 
TGF-β supplementation as opposed to transient supplementation, a characteristic shared by adult 
canine chondrocytes but not by juvenile bovine chondrocytes. The functional properties attained 
by human constructs were similar to those of canine constructs, and in some cases approached 
those of juvenile bovine constructs. These results provide the most comprehensive 
characterization to date of the behavior of healthy adult human chondrocytes in agarose, and give 
us confidence that our animal cell models may ultimately be translated to human cells for 









“And the narrowest hinge in my hand puts to scorn all machinery”  
 –Walt Whitman, 18921  
 
1.3.1 Cartilage structure and function 
The diarthrodial joints of the human body are lined with articular cartilage, a specialized type of 
hyaline, which is responsible for the low-friction articulation of freely-moving joints. Human 
articular cartilage is 0.5 to 8 mm thick, presents a smooth, shiny, white surface, and can be 
characterized as having two distinct phases: the solid phase, consisting primarily of extracellular 
matrix macromolecules, and a liquid phase, i.e. the interstitial fluid (Mow et al., 1980; Mow and 
Ratcliffe, 1997). The two primary constituents of the solid matrix are type II collagen and 
proteoglycans (Mow and Ratcliffe, 1997). Cartilage is a highly hydrated tissue, having a water 
content of 60-85% (Bollet and Nance, 1966; Edwards, 1966; Linn and Sokoloff, 1965; Mankin 
and Thrasher, 1975; Mow et al., 1984). Collagen comprises approximately 10-20% of cartilage’s 
wet weight (Maroudas, 1979; Muir et al., 1970), and proteoglycans comprise approximately 5-
10% (Buckwalter and Rosenberg, 1982; Buckwalter et al., 1994a). In cartilage, type II collagen 
forms a network of fibrils up to 300 nm in diameter (Broom, 1988; Clarke, 1971) interconnected 
via crosslinks. The most abundant form of proteoglycan in cartilage is aggrecan, consisting of a 
core protein and dozens of glycosaminoglycans (GAGs) in the forms of keratan sulfate and 
chondroitin sulfate chains (Buckwalter et al., 1994b; Doege et al., 1991; Hardingham, 1981). 
Aggrecan is said to possess a “bottle brush” structure possessing high concentrations of fixed 
                                                 
1
 Whitman, W. (1900). Leaves of grass, D. McKay. 
15 
 
negative charges due to GAGs. The collagen fibers and GAGs interweave to form a 3D network 
that supports both compressive and tensile loads.  
Cartilage hosts a relatively low cell population compared to other tissues, and of a 
singular cell type, the chondrocyte (Stockwell and Meachim, 1979; Stockwell, 1979). Cell 
densities are high in children (~70 × 10
6
 cells/mL) and decline with age (5-35 × 10
6
 cells/mL in 
adults) (Gilmore and Palfrey, 1988; Stockwell, 1967); in bovine tissue, calves may have ~130 × 
10
6
 cells/mL which declines to 34-47 × 10
6
 cells/mL in mature steer (Rosenthal et al., 1941). 
Adult cartilage is unusual among 3D tissues in that it contains no nerves, blood vessels, or 
lymphatics (Stockwell, 1979).  
The articular cartilage’s primary function is to provide a smooth and durable surface for 
joint articulation. In order to satisfy the highly mechanical demands imposed by locomotion and 
physical activity, cartilage exhibits remarkable mechanical properties. The type II collagen 
possesses high tensile strength, with a tensile elastic modulus ranging between 2-7 GPa (Silver et 
al., 2002). The high fixed negative charge density of GAG attracts positive counterions, 
increasing the osmotic pressure of the tissue, and in turn drawing in more water in a phenomenon 
known as the Donnan effect (Donnan, 1924; Lai et al., 1991). The high charge density gives 
GAGs a propensity to swell apart; this swelling is resisted by the tensile integrity of the collagen 
fibril network (Kempson et al., 1976; Zhu et al., 1993). Compressive loads applied to GAGs are 
resisted in part by electrostatic repulsion. The mechanical characteristics of cartilage are also in 
no small part attributed to the interstitial fluid. Water is incompressible, and thus the water must 
exude from the tissue before it may be compressed. Due to the small pore size within cartilage 
ECM, this exudation occurs slowly, and the interstitial fluid supports the majority of the initial 
compressive load (Soltz and Ateshian, 1998; Soltz and Ateshian, 2000b). Over time, the tissue 
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relaxes as the water within is reallocated, and at equilibrium the load is supported solely by the 
solid matrix (Soltz and Ateshian, 1998). 
Being a multiphasic material with a viscous component, cartilage is often mechanically 
characterized by its properties at equilibrium. By applying compressive strain and allowing 
sufficient time to pass for interstitial water to depressurize and exude from the tissue, the 
equilibrium stress yields an aggregate or compressive Young’s modulus of the solid matrix, 
assuming the matrix approximates a linearly elastic material (Armstrong et al., 1984; Mow et al., 
1980). The aggregate modulus of cartilage at equilibrium has been demonstrated to correlate 
with the wet weight fraction of proteoglycans (Mow et al., 1990). Compressive aggregate moduli 
of articular cartilages may range from 250-1000 kPa (Athanasiou et al., 1991; Krishnan et al., 
2003). The tensile properties of cartilage are much higher than its compressive properties, with 
tensile Young’s moduli having been reported to range between roughly 1 MPa and 30 MPa 
(Akizuki et al., 1986; Roth and Mow, 1980; Setton et al., 1994; Woo et al., 1976). This tension-
compression nonlinearity (Huang et al., 2005; Soltz et al., 2000; Soltz and Ateshian, 2000a) 
bolsters cartilage’s ability to support high initial compressive loads by permitting a high degree 
of interstitial fluid pressurization. 
 
1.3.2 Osteoarthritis 
The most prevalent ailment afflicting the joints of the body is osteoarthritis (OA). OA can 
develop throughout aging or as a downstream result of joint injury. A disease of the entire joint, 
OA is characterized by the disruption of multiple tissues including bone, cartilage, and synovium 
(Buckwalter and Mankin, 1997a). In part due to the lack of innervation to joints, little pain is 
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associated with early OA, and only once substantial tissue degradation has occurred does the 
disease manifest itself symptomatically. Often, defects in the articular cartilage can span the full 
cartilage thickness to the point at which exposed subchondral bones begin to grind against one 
another; these defects may exceed 5 cm
2
 in area (Moisio et al., 2009b), occupying significant 
portions of the joint surface. 
 Several common treatment methods exist for mitigating damage caused to cartilage by 
OA. For relatively small, full-thickness defects, microfracture may be performed by drilling into 
the subchondral bone to allow bone marrow and its intrinsic stem cells to repair the focal 
cartilage defect (Steadman, 2001). Osteochondral plugs can be used to fill defects either from a 
non-load-bearing articular surface of the patient (autologous) or from cadaveric tissue 
(allogeneic) (Pritzker et al., 1977), though the former may lead to donor site morbidity. Cell-
based therapies do exist, primarily in the form of autologous chondrocyte implantation (ACI). 
ACI involves harvesting non-load-bearing cartilage from the patient and expanding the number 
of chondrocytes in culture, for eventual implantation back into the patient’s cartilage defect 
(Brittberg et al., 1994; Brittberg et al., 1996). These various techniques have their respective 
advantages and disadvantages, but none are appropriate for treating cases of severe OA in which 
broad swaths of the articular surface have eroded away. Under such circumstances the only 
treatment option is a partial or total joint replacement, in which the diseased surfaces are 
removed, a portion of the underlying bone is resected and bored into, and inert biomaterials are 
fitted to form an artificial joint (Bartel et al., 1986; Long and Rack, 1998; Nicholson and Wieder, 
1956). The latter procedure is highly invasive, destructive, and may require revision surgeries, 
particularly in younger patients who are expected to outlive the implant’s lifetime. To date, there 




1.3.3 Cartilage functional tissue engineering 
A promising approach to restoring damaged articular cartilage is by cartilage tissue engineering 
(CTE). The most common paradigm for CTE is to begin with human chondrocytes or stem cells, 
embed them within a polymer scaffold, and subject them to suitable culture conditions such that 
the cell-scaffold construct develops cartilage-like properties. Culture conditions include a culture 
medium, a vessel or bioreactor, and any number of cues intended to stimulate chondrogenesis by 
cells. Such cues may be biochemical, as in growth factor supplementation or co-culture (Byers et 
al., 2008), or mechanical, as in dynamic loading or fluid flow (Cartmell et al., 2003; Li et al., 
2001; Mauck et al., 2000; Sah et al., 1989). Ultimately, the goal is de novo cartilage which can 
effectively be implanted into a patient in order to replace deteriorated tissue. 
The objective of CTE researchers is to mimic the native cartilage tissue as identically as 
possible. In addition to producing a tissue that bears morphological resemblance to cartilage, it is 
crucial to take under consideration the mechanical integrity of native cartilage and the 
mechanical environment in which it resides. The strategy of producing de novo tissue that can 
withstand the biomechanical and biochemical environment of the host tissue has been termed 
“functional tissue engineering,” and generally relies on quantitative measures such as Young’s 





1.3.3.1 Agarose as a scaffold material 
Cartilage tissue engineering practices either involve the utilization of a three-dimensional 
scaffold in which to house cells, or may alternatively implement a scaffoldless design 
(Eleswarapu and Athanasiou, 2013; Hu and Athanasiou, 2006; Responte et al., 2012). Scaffolds 
are generally comprised of synthetic or natural polymers and may include woven meshes, spun 
fibers, decellularized ECM, hydrogels, or a host of other materials. As scaffold fabrication 
techniques continue to advance, an increasingly diverse array of materials with various 
properties has become available.  
For the studies presented in this dissertation, agarose is exclusively used as a scaffold 
material due to its well-established, favorable performance in prior CTE studies. Hydrogels are 
an attractive scaffold choice for CTE since cells can be mixed in homogeneously with molten 
gel, as opposed to prefabricated scaffolds which must undergo a seeding stage (Freed et al., 
1994) which may be subject to resulting heterogeneous cell distribution as scaffold size 
increases. Agarose is particularly inert and discourages cellular adhesion, which simulates a 
suspension culture in early stages before sufficient ECM has been deposited by cells (Benya and 
Shaffer, 1982). Agarose is known to stabilize the chondrocyte phenotype in vitro (Benya and 
Shaffer, 1982; Buschmann et al., 1992; Mauck et al., 2000). Furthermore, proteoglycans 
produced by chondrocytes in agarose have been shown to be most similar to those of native 
cartilage as compared to proteoglycans produced in fibrin, alginate, and polyglycolic acid (PGA) 
scaffolds (Mouw et al., 2005). Agarose has been suspected to be non-biodegradable in the body; 
however, there is evidence that it is phagocytized by cells and degrades thusly (Varoni et al., 
2012). In an in vitro setting, treatment of constructs with the enzyme agarase once sufficient 
matrix has been produced can remove the majority of the original scaffold material and improve 
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functional properties (Ng et al., 2009b). Chondrocyte-seeded agarose constructs have also 
performed well in an in vivo canine model wherein the constructs exhibited excellent integration 
with the host tissue (Ng et al., 2010), as well as in phase II clinical trials for autologous 
chondrocyte implantation (Selmi et al., 2008). A phase III clinical trial evaluating their efficacy 
is currently underway in France (ClinicalTrials.Gov, 2007). 
 
1.3.3.2 Chondrocytes as cell sources 
Due to the unique ECM found in cartilage, cells implemented in CTE studies must be capable of 
producing a cartilage-like matrix of type II collagen and proteoglycans in order to generate 
cartilage similar to the host tissue. Thus, researchers have selected either chondrocytes or 
mesenchymal stem cells (MSCs), which are capable of being coaxed to follow chondrogenic 
lineage (Johnstone et al., 1998; Johnstone and Yoo, 1999; Nöth et al., 2007). MSCs have the 
advantage of being readily isolated from various tissues in the adult human body, such as bone 
marrow or adipose tissue, obviating the potential threat of donor site morbidity within the joint. 
Indeed, MSCs have shown great promise for the cultivation of engineered cartilage (Awad et al., 
2004; Bhumiratana et al., 2014; Ghone and Grayson, 2012; Mesallati et al., 2015; Sampat et al., 
2011). As a trade-off, chondrogenically-induced MSCs can exhibit undesirable characteristics 
such as a tissue phenotype more similar to fibrocartilage than hyaline cartilage (Steck et al., 
2005; Wakitani et al., 2004) and a predilection for dedifferentiation and/or cell hypertrophy 
(Ichinose et al., 2005; Winter et al., 2003). 
The alternative to stem cells is the utilization of chondrocytes, cartilage’s native cell type. 
Innately possessing chondrogenic phenotype, the implantation of these cells has already seen 
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clinical avail in the form of ACI (Bentley et al., 2003; Peterson et al., 2000). It has been shown 
that in agarose, chondrocytes respond well to growth factor stimulation to boost functional 
properties (Byers et al., 2008). Chondrocyte-agarose constructs exhibit synthesized collagens 
which are predominantly type II (Ng et al., 2009b). Furthermore, results from the plethora of 
CTE studies in the literature that have been performed with animal chondrocytes are likely to 
have more relevance to human chondrocytes than to MSCs. Additionally, as techniques to guide 
MSC commitment to chondrogenic lineage improve (Yodmuang et al., 2015), strategies that are 
successful with chondrocytes may potentially have translational relevance for MSC-laden 
constructs. Thus, chondrocytes embody a highly useful model system for CTE studies, with high 
potential for clinical translation. 
 
1.3.3.3 Chondrogenic media 
An essential component of tissue engineering strategies, and more broadly cell culture, is the 
nourishing of cells via a culture medium. This medium is not only responsible for maintaining 
hydration, pH and osmotic balance for cells, but also for supplying nutrients and building blocks 
for cell viability, proliferation, and synthesis of ECM. A variety of base culture media exist, and 
these are often further customized with cell- or system-specific additives. 
Experiments in cell culture for decades have implemented serum-based media in order to 
support cell proliferation and viability, as serum intrinsically possesses many of the nutrients 
required by cells to thrive. By this same token, serum contains a wide array of nutrients and 
factors which are not fully characterized or understood. Furthermore, the compositions of sera 
depend on factors such as geographical location and season of the year and there is substantial 
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batch-to-batch variation which mars the consistency of cultures using sera. Serum-free media 
therefore present attractive alternatives to serum-containing media. A relatively small number of 
nutrients may be added to Dulbecco’s Modified Eagle Medium (DMEM) in order to sustain cell 
viability and proliferation, as in the case of ITS (insulin-transferrin-selenium) media (Bottenstein 
and Sato, 1979), which has been shown to support growth of chondrocytes seeded within agarose 
(Kelly et al., 2008; Kisiday et al., 2005).  
 An additional benefit of ITS media is their compatibility with TGF-β supplementation for 
chondrocyte-agarose constructs. When cultured in ITS media, these constructs reach native 
levels of EY and GAG when TGF-β is supplemented at 10 ng/mL and is discontinued after the 
first two weeks of culture; this effect is diminished in FBS-based media (Byers et al., 2008; Lima 
et al., 2007). 
 
1.3.3.4 Obstacles in cartilage tissue engineering 
When the field of tissue engineering first emerged, articular cartilage was identified as an early 
target tissue based on its lack of vasculature and its relatively low population by a single cell 
type (Cima et al., 1991). Over 25 years later, the problem of cartilage tissue engineering (CTE) 
has yet to be resolved, due to a handful of persistent obstacles preventing the in vitro growth of 
adequate replacement cartilage. When cultivated in vitro, cells in CTE systems may reproduce 
native levels of GAG (Byers et al., 2008; Cigan et al., 2013a; Kelly et al., 2006) or collagen (Hu 
and Athanasiou, 2006), but are generally not both. Cartilage’s complex depth-dependent 
architecture (Buckwalter and Mankin, 1997b; Muir et al., 1970) is difficult to recapitulate. The 
low-friction surface properties of native cartilage are exceptional, and engineered tissues haven’t 
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yet the capability to mimic them (Bhumiratana et al., 2014; Peng et al., 2014). Once a graft has 
matured, maintaining its integration with the host tissue upon implantation presents a formidable 
challenge (Gratz et al., 2006; Nover et al., 2016). Another significant obstacle is the inability 
thus far to produce large enough engineered cartilage tissue to resurface arthritic joints (Hung et 
al., 2003; Moisio et al., 2009b). While it is recognized that all of these obstacles should 
ultimately be addressed in order to produce replacement cartilage of the highest possible quality, 
the latter will comprise the major focus of this dissertation. 
The vast majority of CTE studies focus on cultivating tissue constructs ≤ 5 mm in their 
largest dimension. However, OA typically does not manifest symptomatically until cartilage 
lesions reach ~ 25 mm in diameter (Moisio et al., 2009b), and therefore CTE constructs below 
this size threshold are ultimately not clinically relevant for treatment of OA. Prior studies 
attempting to grow CTE constructs on this scale have been met with extreme nutrient limitations 
(Hung et al., 2003; Hung et al., 2004). 
 
1.3.3.5 Nutrient transport in articular cartilage 
Adult articular cartilage is a thin tissue, with one surface abutting the impermeable subchondral 
bone, and the other facing outward into the synovial joint. Thus, adult cartilage only obtains 
nutrients and clear metabolites via the synovial fluid. Its lack of vasculature is justified by the 
relatively low cell population, and by the low metabolic demands of chondrocytes (Stockwell, 
1967). Indeed, unlike cells in blood-perfused tissues, chondrocytes primarily produce their 
energy via anaerobic pathways such as glycolysis as opposed to oxidative respiration (Stockwell 
and Meachim, 1979). Nutrients enter the cartilage by passive diffusion across the articular 
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surface, and by convection via a solute pumping mechanism when the cartilage is loaded 
dynamically (Albro et al., 2008; Chahine et al., 2009; Huang and Gu, 2007; Mauck et al., 2003a). 
This influx of nutrients into the cartilage is countered by cellular metabolism, establishing a 
gradient of nutrients in which concentrations are highest at the articular surface and diminish 
throughout the cartilage’s depth (Mobasheri et al., 2002).  
While cartilage is in its developing stages it is perforated by a network of canals (Levene, 
1964; Stockwell, 1971) which nourish the growing tissue (Wilsman and Van Sickle, 1972; 
Yamaguchi et al., 1990). These canals eventually fill in during skeletal maturation, becoming 
uniform with the surrounding cartilage (Haines, 1974), though they have been observed in 
humans as old as 16 years of age (Gruber et al., 1990).  
 
1.3.3.6 Nutrient transport in engineered cartilage 
When attempting to recreate cartilage in vitro in a relatively short amount of time, CTE 
researchers require cells to rapidly synthesize large amounts of cartilage ECM. An intuitive 
strategy to boost matrix synthesis is to enlist more cells by increasing the initial seeding density 
of the construct, with the expectation that this will be accompanied by a more or less 
proportional increase in matrix synthesis. This strategy has resulted in greater bulk functional 
properties of constructs (Bian et al., 2009a; Mauck et al., 2002; Talukdar et al., 2011), however, 
the heightened levels of cellular consumption tend to steepen gradients of nutrients, and 
concomitantly, of synthesized matrix within constructs (Albro et al., 2016; Bian et al., 2009a; 
Talukdar et al., 2011; Zhou et al., 2008). Simultaneous to the problem of steepening nutrient 
gradients is the presence of opposing gradients of metabolites, such as lactate, which can 
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accumulate within constructs and alter features of the cellular microenvironment such as 
interstitial fluid pH (Heywood et al., 2006b; Zhou et al., 2008). These transport limitations are 
further emphasized by increasing construct dimensions. 
A number of strategies have been implemented to mitigate the effects of nutrient 
gradients and transport limitations in engineered tissues. By perfusing media either around 
constructs (surface perfusion) or through them (direct perfusion), convection of nutrients 
increases their availability in constructs while simultaneously flushing out metabolites (Cartmell 
et al., 2003; Grayson et al., 2010; Maidhof et al., 2010; Marsano et al., 2008), with the potential 
downside of clearing out beneficial autocrine factors before they have opportunities to act on 
cells. By dynamically loading constructs during culture, solutes can be pumped into the tissue to 
increase their availability within (Albro et al., 2008; Chahine et al., 2009; Lima et al., 2007; 
Mauck et al., 2002). Alternatively, the inclusion of nutrient channels in constructs, a biomimicry 
of the cartilage canals which exist during native cartilage development, can shorten transport 
distances necessary for nutrients to traverse in order to reach the construct interior. This practice 
has shown hopeful results in chondrocyte-agarose constructs (Bian et al., 2009a; Buckley et al., 
2009; Mesallati et al., 2011). It is highly likely that for the production of large, clinically relevant 











This section details methodologies and materials that were commonly used in the 
experiments presented herein. For the sake of succinctness in later chapters, it may be assumed 
that all experiments utilized these methods as described in this section unless otherwise stated. 
 








Bovine articular cartilage was harvested from 2-month-old calf carpometacarpal joints (Figure 
2-1). The cartilage fragments were digested in high-glucose DMEM supplemented with 5% FBS 
and 1000 U/mL Type IV collagenase for 6-8 hours at 37°C to release chondrocytes, then passed 











chondrogenic media and mixed with equal parts 4% (w/v) low gelling temperature agarose in 
phosphate buffered saline to yield a 2% agarose solution with a target seeding density of 
chondrocytes. The solution was poured between glass slides or into other custom molds and 
allowed at least 15 minutes to set, and a biopsy punch was employed to form cylindrical 2.3 mm-
thick constructs with diameters of 3 mm, 4 mm, or 10 mm. Constructs were cultured in a 
humid incubator at 37°C, 5% CO2 in ITS media. The media consisted of high-glucose DMEM 
containing 100 nM dexamethasone, 100 µg/mL sodium pyruvate, 50 µg/mL L-proline, 1% ITS+ 
Premix (final media concentrations: 6.25 µg/mL human recombinant insulin, 6.25 ng/mL 
selenous acid, 6.25 µg/mL human holo transferrin, 1.25 mg/mL bovine serum albumin and 5.35 
µg/mL linoleic acid), 1% PS/AM antibiotic-antimycotic and 173 µM ascorbic acid 2-phosphate. 
Media were changed three times weekly. 
 
2.2 Mechanical characterization 
Constructs were tested under unconfined compression between impermeable platens in a PBS 
bath using a custom device (Figure 2-2). The device featured a linear variable differential 
transformer (LVDT; Macro Sensors model PR812-200), a high torque stepper motor (Anaheim 
Automation model 23Y004D-LW8), a digital step drive (Geckodrive Motor Controls model 
G213V), and a 250 g or 10 lb load cell (Honeywell). For each sample, a creep tare load was first 
applied to ensure full surface contact, and subsequently a stress-relaxation test was conducted 
which comprised of a ramp displacement to 10% strain at a ramp speed between 0.3 and 1 µm/s. 
The strain was held until equilibrium was reached (~1,800 s for 3-4 mm constructs, ~11,000 s 
for 10mm constructs). Finally, a dynamic test was performed at equilibrium (10 ± 1% strain, 
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0.01 Hz, 5 cycles). A custom MATLAB script was used to extract equilibrium load, equilibrium 
displacement, and dynamic stiffness. The compressive Young’s modulus EY and the dynamic 
modulus G* were calculated from these values together with the construct geometry. 
 
 
Figure 2-2: Custom unconfined compression testing apparatus, featuring (A) 
stepper motor, (B) LVDT, (C) load cell, and (D) sample chamber. 
 
2.3 Biochemical characterization 
Mechanically tested samples were lyophilized and digested in proteinase K solution (0.5 mg/mL 







pepstatin A) overnight at 56°C (Hollander et al., 1994; Kelly et al., 2006). Sulfated 
glycosaminoglycan content was determined by 1,9-dimethylmethylene blue dye-binding assay 
(Farndale et al., 1986). PicoGreen dsDNA quantitation assay was used to determine DNA 
content using lambda bacteriophage DNA as a standard and assuming 7.7 pg DNA/cell 
(McGowan et al., 2002). Collagen content was assessed by assaying orthohydroxyproline (OHP) 
as previously described (Kelly et al., 2006); briefly, proteinase K digests were mixed with equal 
parts 12 N HCl, sealed in glass ampules, hydrolyzed at 110°C for 16 hours, then dried and 
resuspended in a salt buffer. The OHP content of the hydrolysis product was assessed via 
chloramine T and dimethylaminobenzaldehyde assay and a 1:7.6 OHP-to-collagen mass ratio 
was assumed (Hollander et al., 1994);  in similar chondrocyte-agarose constructs it has been 
shown that collagen measured by this method is predominantly type II (Ng et al., 2009b). 
Contents of collagen and GAG were normalized to either sample wet weights (%/ww) or to 
initial (day 0) construct volume (%/D0ww), while DNA contents were expressed in either total 
mass per construct or in cell density (cells/mL). 
 
2.4 Custom mold design and fabrication 
In a previous study examining the effects of three nutrient channels in 10mm constructs, the 
channels were produced by hand with a biopsy punch (Bian et al., 2009a). For the experiments 
conducted herein, for which more precise control of channel placement was desired, custom 







Figure 2-3: (A) Diagram of custom mold used to cast channeled constructs. (B) 




To produce constructs with precise arrangements of three or twelve channels, a half-mold 
was fabricated (Figure 2-3). A 6.35 mm-thick PTFE (polytetrafluoroethylene) sheet was milled 
to size (76 mm × 102 mm), and a CNC mill was used to drill an array of 0.94 mm holes with 
2.165 mm center-to-center distance in a triangular packing configuration. Stainless steel pins 
(1 mm × 10 mm) were press-fitted into the holes. By suppressing certain pins, several channel 
arrangements could be produced. For constructs with three channels (CH3), equilateral triangles 
of pins spaced 4.33 mm center-to-center were deployed to produce three 1 mm channels per 






the distance from the circle’s center to the margin of the nearest channel (2 mm) matched the 
distance from the circle’s edge to the channel margin. By deploying additional pins, constructs 
with twelve channels (CH12) with 2.165 center-to-center distance could be cast. Finally, by 
suppressing all pins in a region of the half-mold, 10 mm constructs with no channels (CH0) 
could be produced, much as though a mold comprised of parallel glass plates had been used. The 
PTFE half-mold was separated from a glass slide by a 2.34 mm-thick silicone rubber spacer. 
 
2.5 Culture rack design and fabrication 
Custom culture racks were fabricated to suspend 10 mm × 2.3 mm constructs, exposing nearly 
all surface area to media as well as orienting channels in the direction of media stirring (4.1). The 
racks were comprised of PTFE and PTFE-coated steel, as these materials have low binding 
affinity for TGF-β, as assessed in a preliminary test. 
For suspension of 10 mm constructs, trapezoidal pieces of PTFE (30 mm base, 8 mm 
height) were fashioned from a 6.35 mm-thick sheet with a laser-cutter, and a drill press was used 
to place twelve 0.99 mm holes in two rows. Twelve PTFE-coated stainless steel wires (1.00 
mm, 43 mm length, McMaster-Carr) were used to connect pairs of PTFE pieces. The spacing of 
wires allowed constructs to rest loosely upright in specialty deep culture dishes without impeding 
media flow through the horizontally oriented nutrient channels (Figure 2-4). Detailed diagrams 





Figure 2-4: Diagram of 10 mm CH3 constructs resting in a custom culture rack 
within a specialty deep Petri dish. 
 
2.6 Histological analysis 
Samples were immersed in an acid-formalin-ethanol solution at 4°C for 24-48 hours (Kelly et al., 
2006). The fixed samples were then dehydrated with increasing concentrations of ethanol, 
cleared with Citri-solv, infiltrated with paraffin wax, and embedded in a paraffin block. A sledge 
microtome was used to cut 5-7 µm sections, which were subsequently stained for GAG (0.1% or 




Chapter 3  
 
Identification of size-limiting nutrients 





3.1 Insulin, ascorbate, and glucose have a much greater 
influence than transferrin and selenous acid on the in vitro 
growth of engineered cartilage in chondrogenic media2 3 
 
3.1.1 Abstract 
The primary goal of this study was to characterize the response of chondrocyte-seeded agarose 
constructs to varying concentrations of several key nutrients in chondrogenic media, within the 
overall context of optimizing the key nutrients and the placement of nutrient channels for 
successful growth of cartilage tissue constructs large enough to be clinically relevant in the 
treatment of osteoarthritis (OA). To this end, chondrocyte-agarose constructs (4 mm × 2.34 
mm, 30  10
6
 cells/mL) were subjected to varying supplementation levels of insulin (0× to 30× 
relative to standard supplementation), transferrin (0× to 30×), selenous acid (0× to 10×), 
ascorbate (0× to 30×) and glucose (0× to 3×). The quality of resulting engineered tissue 
constructs was evaluated by their compressive modulus (E-Y), tensile modulus (E+Y), hydraulic 
permeability (k), and content of sulfated glycosaminoglycans (GAG) and collagen (COL); DNA 
content was also quantified. Three control groups from two separate castings of constructs (1× 
concentrations of all media constituents) were used. After 42 days of culture, values in each of 
these controls were, respectively: E-Y = 518 ± 78, 401 ± 113, 236 ± 67 kPa; E+Y = 1420 ± 430, 
                                                 
2
 This study was published as: Cigan, A. D. Nims, R. J. Albro, M. B. Esau, J. D. Dreyer, M. P. Vunjak-Novakovic, 
G. Hung, C. T. Ateshian, G. A., 2013a. Insulin, ascorbate, and glucose have a much greater influence than 
transferrin and selenous acid on the in vitro growth of engineered cartilage in chondrogenic media. Tissue Eng Part 
A 19, 1941-1948. 
3
 This study was partially published as: Cigan, A. D. Nims, R. J. Albro, M. B. Breves, S. L. Hung, C. T. Ateshian, 
G. A. (2012). Insulin and ascorbate have a much greater influence than transferrin and selenous acid on the growth 




1140 ± 490, 1240 ± 280 kPa; k = 2.3 ± 0.8  10
-3
, 5.4 ± 7.0  10
-3





GAG = 7.8 ± 0.3, 6.3 ± 0.4, 4.1 ± 0.5 %/ww; COL = 1.3±0.2, 1.1 ± 0.3, 1.4 ± 0.4 %/ww; and 
DNA = 11.5 ± 2.2, 12.1 ± 0.6, 5.2 ± 2.8 µg/disk. The presence of insulin and ascorbate was 
essential, but their concentrations may drop as low as 0.3× without detrimental effects on any of 
the measured properties; excessive supplementation of ascorbate (up to 30×) was detrimental to 
E-Y, and 30× insulin was detrimental to both E+Y and E-Y. The presence of glucose was similarly 
essential and matrix elaboration was significantly dependent on its concentration (p < 10
-6
), with 
loss of functional properties, composition and cellularity observed at ≤ 0.3×; excessive glucose 
supplementation (up to 3×) showed no detrimental effects. In contrast, transferrin and selenous 
acid had no influence on matrix elaboration. These findings suggest that adequate distributions of 
insulin, ascorbate and glucose, but not necessarily of transferrin and selenous acid, must be 
ensured within large engineered cartilage constructs in order to produce a viable substitute for 
joint tissue lost due to OA. 
 
3.1.2 Introduction 
Osteoarthritis (OA) is a pathological condition characterized by the breakdown of articular 
cartilage, resulting in pain, inflammation and impaired joint mobility. Although currently no 
treatments for OA exist which restore the native joint surface, cartilage tissue engineering is a 
promising approach for replenishing lost native tissue with de novo tissue produced by culturing 
cells under controlled conditions within a suitable 3D scaffold. The culture of chondrocyte-
seeded agarose constructs containing 30  10
6
 cells/mL in chemically-defined media under 
transient supplementation of human recombinant TGF-3 has been shown to reproduce native 
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levels of compressive Young’s modulus (E-Y) and sulfated glycosaminoglycan (GAG) content 
(Byers et al., 2008; Lima et al., 2007). This cell-seeding density is on the same order of 
magnitude as the native cell density in adult bovine articular cartilage (50-150   10
6
 cells/mL) 
(Jadin et al., 2005). 
 A major challenge in cartilage tissue engineering is the ability to make sufficiently large 
constructs for adequate repair of cartilage defects. Current strategies employ smaller constructs 
(~20 mm
2
), however, OA generally does not become symptomatic until defects reach ≥ 5 cm
2
 
and therefore small constructs may not ultimately be clinically relevant for treatment of OA 
(Cohen et al., 2003; Moisio et al., 2009b). As construct size increases, inhomogeneous tissue 
properties tend to develop as consumption by cells on the periphery results in poor nutrient 
availability towards the construct center (Bian et al., 2009a; Hung et al., 2003; Hung et al., 2004; 
Kelly et al., 2009). Various techniques have been developed to overcome transport limitations 
such as direct perfusion (Cartmell et al., 2003; Maidhof et al., 2010; Marsano et al., 2008), 
dynamic loading (Albro et al., 2008; Chahine et al., 2009; Mauck et al., 2003a), and the 
introduction of nutrient channels (Bian et al., 2009a; Buckley et al., 2009). A major goal of our 
research is to implement computational models to optimize placement of channels for successful 
growth of large constructs. This technique necessitates an understanding of which nutrients are 
critical for tissue growth.  
 Agarose gels are often employed in cartilage tissue engineering applications as agarose is 
known to stabilize the chondrocyte phenotype in vitro (Benya and Shaffer, 1982; Buschmann et 
al., 1992; Mauck et al., 2000). Furthermore, proteoglycans produced by chondrocytes in agarose 
have been shown to be most similar to those of native cartilage as compared to proteoglycans 
produced in fibrin, alginate, and PGA scaffolds (Mouw et al., 2005). Chondrocyte-seeded 
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agarose constructs have also performed well in an in vivo canine model wherein the constructs 
exhibited excellent integration with the host tissue (Kelly et al., 2009), as well as in phase II 
clinical trials for autologous chondrocyte implantation (Selmi et al., 2008). A phase III clinical 
trial evaluating their efficacy is currently underway in France (ClinicalTrials.Gov, 2007). 
 As an alternative to serum-based media, which contain a complex profile of nutrients and 
growth factors that may vary batch-to-batch, many tissue engineering experiments employ a 
chemically defined medium, consisting of insulin-transferrin-selenium (ITS) additives. Insulin is 
required for cellular metabolism of glucose and is thus necessary for cell culture (Gey and 
Thalhimer, 1924). Transferrin is an essential protein which is known to transport iron into cells, 
where the iron plays a role in the hydroxylation of proline during collagen synthesis (Bjare, 
1992; Hutton Jr. et al., 1966), and selenium is an essential trace element which boosts the activity 
of glutathione peroxidases in shielding cells from oxidative stress (Helmy et al., 2000). ITS-
supplemented media have been shown to viably support and promote matrix deposition within 
chondrocyte-seeded agarose constructs (Kelly et al., 2008; Kisiday et al., 2005). The effects of 
relative concentrations of insulin, transferrin and selenium on cell proliferation have been 
investigated in 2D monolayer culture of rat neuroblastoma cells (Bottenstein and Sato, 1979) and 
HeLa cells, but the specific effects of ITS concentrations on the functional properties of 
engineered cartilage have not been characterized. 
 Ascorbate is a requisite cofactor in the production of collagen II by chondrocytes (Jeffrey 
and Martin, 1966) and has also been observed to influence GAG production (Priddy et al., 2001), 
and thus is an essential media supplement for cartilage tissue engineering. Ascorbate levels have 
been modulated over narrow ranges in short-term pellet culture (Ibold et al., 2009) and 
comparisons have been made between chondrocyte-seeded agarose constructs that have been 
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cultured in the presence or absence of ascorbate (Bounelis and Daniel, 1983; Priddy et al., 2001), 
yet the effects of its concentration over a broad range on tissue-engineered constructs remain to 
be uncovered. 
 Due to the avascular nature of mature cartilage and its resulting low oxygen tension, 
chondrocytes rely primarily upon glycolysis and lactic acid fermentation to generate ATP. 
Furthermore, glucose is used by chondrocytes to form building blocks in the synthesis of GAG 
(Stockwell, 1979). The chondrocytes require adequate glucose concentrations (Heywood et al., 
2006b; Otte, 1991). Both chondrocyte density and metabolic consumption shape the gradient of 
glucose concentration throughout the depth of articular cartilage (Mobasheri et al., 2002), and 
computational models predict that glucose gradients are also present in engineered cartilage 
(Sengers et al., 2005; Zhou et al., 2008). Therefore, it is important to also investigate the 
influences of various levels of glucose in our current culture system. 
 In this study, we characterized the response of chondrocyte-seeded agarose constructs to 
varying concentrations of several key nutrients in chondrogenic media (CM), to determine the 
relative importance of CM supplements in the growth of engineered cartilage. This aim was 
achieved by subjecting chondrocyte-agarose constructs to varying supplementation levels of the 
three ITS constituents as well as ascorbate and glucose. The quality of the resulting engineered 
tissue constructs was evaluated by their mechanical properties and their content of the major 





3.1.3 Materials and methods 
Media were prepared in which the concentrations of each of the nutrients of interest were 
individually modulated over a broad range for six weeks of cultivation time. Constructs were 
assessed for mechanical and transport properties (hydraulic permeability, k; equilibrium 
compressive Young’s modulus, E-Y; and equilibrium tensile Young’s modulus, E+Y) and 
subsequently evaluated for GAG and collagen contents as well as their cellularities (DNA 
contents). 
 
3.1.3.1 Cell harvest and culture 
Bovine articular cartilage was sourced from 18 calf joints, mixed male and female (Section 2.1). 
An agarose gel was produced with a seeding density of 30 × 10
6
 cells/mL (Section 2.1). A biopsy 
punch was employed to form cylindrical constructs (4 mm × 2.34 mm). Constructs were 
cultured in various media (Section 3.1.3.2) for 42 days. 
 
3.1.3.2 Media compositions 
All media were based upon standard chondrogenic media (CM, aka ITS media; Section 2.1). The 
concentrations of the five investigated CM constituents were individually varied relative to the 
1× standard: insulin (INS; 0×, 0.3×, 3×, 10×, 30×), transferrin (TR; 0×, 0.3×, 3×, 10×, 30×), 
selenous acid (SA; 0×, 0.1×, 10×), ascorbic acid 2-phosphate (AAP; 0×, 0.3×, 3×, 10×, 30×), and 
glucose (GLU; 0×, 0.3×, 3×) (Figure 3-1). AAP groups and their 1× control were prepared from 
the standard CM containing 1% ITS+ Premix. For GLU groups and their 1× control, glucose was 
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added to standard CM that had instead been prepared with glucose-free DMEM. INS, TR and SA 
groups shared a 1× ITS control prepared using the individual constituents of the ITS+ Premix at 
their standard concentrations. All media were supplemented with 10 ng/mL TGF-β3 for the first 
two weeks of culture (Byers et al., 2008). Samples were taken from all groups at day 0, day 21 
and day 42 (n = 5 per group). 
 
 
Figure 3-1: Preparation of constructs, experimental groups and media types used. 
INS = insulin, TR = transferrin, SA = selenous acid, AAP = ascorbic acid 
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3.1.3.3 Mechanical characterization 
Constructs were tested as described in Section 2.2, with a creep tare load of 0.005 N for 200 s, 
ramp speed of 1 µm/s, 1800 s relaxation time. Stress-relaxation data were curve-fitted as 
previously described (Huang et al., 2012). Briefly, finite element models were constructed 
(FEBio (Maas et al., 2012a)) that incorporated the geometry of the specimens, and the 
engineered cartilage was modeled as a biphasic material containing intrinsically incompressible 
fluid and solid phases (Mow et al., 1980); the composite porous solid phase consisted of a 
compressible neo-Hookean solid ground matrix (Bonet and Wood, 1997) reinforced by a 
continuous, random distribution of fibril bundles sustaining tension only, with a linear stress-
strain response; the hydraulic permeability was assumed constant (Ateshian et al., 2009; Huang 
et al., 2012). A least-squares parameter optimization routine in FEBio (Maas et al., 2012a) was 
used to curve-fit the stress-relaxation data and extract the specimen k, E-Y, and ξ (fibril tensile 
modulus) values. These values were substituted into a finite element analysis of equilibrium 
uniaxial tension to produce E+Y. 
 
3.1.3.4 Statistics 
Statistical significance was assessed using one-way ANOVA with Tukey’s HSD post-hoc tests, 
with α = 0.05. E-Y, E+Y, ξ, k, GAG, collagen and DNA content served as dependent variables 
while culture time or media treatment served as the independent variable. Data are reported as 





3.1.4.1 Mechanical characterization 
Curve-fits were generally faithful to the experimental data (Figure 3-2), producing near-unity 
coefficients of determination (R
2
 = 0.968 ± 0.050, Table 3-1). After 42 days in culture, the 1× 




/Ns, E-Y = 518 ± 78 kPa, and E+Y = 1420 ± 430 




/Ns, E-Y = 401 




/Ns, E-Y = 
236 ± 67 kPa, and E+Y = 1240 ± 280 kPa. Complete removal of insulin or ascorbate, or reduction 
of glucose resulted in significantly higher k (Table 3-1) and significantly reduced E-Y (Figure 
3-3) and E+Y (Table 3-1) as compared to their respective controls (p < 0.005); in fact, 0× INS, 0× 
AAP, 0× GLU, and 0.3× GLU possessed mechanical properties similar to day 0 values (k ~0.10 
mm
4
/Ns, E-Y ~9 kPa, E+Y ~80 kPa). The high doses 30× INS and 30× AAP also exhibited 
significantly lower E-Y than controls (p < 0.005), and 30× INS yielded lower E+Y (p < 0.05). 
Conversely, modulations in TR or SA dosages had no significant effect on E-Y or E+Y (p > 0.07) 
and only 0.3× TR exhibited a heightened k (p < 0.05). Similar day 42 trends were observed at 
day 21, with the exception of several TR and SA groups that showed reduced E-Y versus 1× 






Figure 3-2: Representative curve fits for constructs with high E-Y (1× ITS) and 
with low E-Y (30× AAP) during stress-relaxation test of ramp to 10% strain, 




















30X AAP (model fit)
1X ITS (experimental)
1X ITS (model fit)
R2 = 0.992 




Table 3-1: Hydraulic permeabilities (k), fibril tensile moduli (ξ), equilibrium 
tensile young’s moduli (E+Y), and coefficients of determination of curve fits (R
2
) 
of day-42 constructs. Statistically indistinct groups for each nutrient treatment 
have been condensed; p-values indicate statistical significance versus 
corresponding 1× control or condensed group. NS, no significance; INS, insulin; 






Figure 3-3: Compressive Young’s moduli (E-Y) of constructs at day 42. Asterisks 
(*) denote p < 0.05 versus corresponding 1× control; daggers (†) denote p < 0.05 
versus corresponding 0× group; hash marks (#) denote other statistical differences 
(p < 0.05). INS, insulin; TR, transferrin; SA, selenous acid; GLU, glucose. 
 
 
3.1.4.2 Glycosaminoglycan content 
GAG contents ultimately reached 7.78 ± 0.26 and 6.28 ± 0.44 %/ww in 1× ITS and 1× AAP 
controls, respectively (Figure 3-4). Within the treatment groups of ITS and AAP, only 3× AAP 
exhibited a significantly elevated GAG content of 9.54 ± 1.60 %/ww versus control (p < 0.05). 































fourfold in the absence of ascorbate and twentyfold in that of insulin. Elaboration of GAG 
appeared to be insensitive to changes in concentrations of transferrin (p = 0.25) or selenous acid 
(p = 0.56), as well as to non-zero variations of insulin (p > 0.5). The 1× GLU control’s content 
reached 4.07 ± 0.49 %/ww; groups 0× GLU and 0.3× GLU were significantly lower (p < 0.0005) 
and 3× GLU was significantly higher (p < 0.01). Data from the day 21 time point revealed the 
same trends, with the exception of the 3× AAP group which had not yet significantly exceeded 









Figure 3-4: GAG contents of constructs at day 42. Asterisks (*) denote p < 0.05 
versus corresponding 1× control; daggers (†) denote p < 0.05 versus 
corresponding 0× group; hash marks (#) denote other statistical differences (p < 
0.05). GAG, sulfated glycosaminoglycan. 
 
 
3.1.4.3 Collagen content 
Collagen levels reached 1.27 ± 0.22 %, 1.06 ± 0.33 %, and 1.40 ± 0.39 % by wet weight in the 
1× ITS control, 1× AAP control, and 1× GLU control, respectively (Figure 3-5). Significant 































(p < 0.0005), or in the case of reduced glucose (0.3× GLU, p < 0.0005). In all of these groups the 
measured collagen contents were extremely low (< 0.2 %/ww). Similar behavior was observed in 
day 21 collagen contents that became more pronounced over time (data not shown). At this 
earlier time, the absence of selenous acid appeared to have detrimental effects on collagen 
production versus 1× control (p < 0.005), but by the end of the study the concentrations of 
selenous acid and transferrin had no effect on collagen (p = 0.26 and p = 0.085, respectively). 
 
Figure 3-5: Collagen contents of constructs at day 42. Asterisks (*) denote p < 
0.05 versus corresponding 1× control; daggers (†) denote p < 0.05 versus 
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3.1.4.4 DNA content 
After 42 days in culture, DNA content in all INS, TR, SA and AAP groups had increased 
roughly fourfold from day 0 levels (2.90 ± 0.34 µg/disk for INS, TR, SA and AAP groups; 4.85 
± 0.35 µg/disk for GLU groups) except the GLU groups and those lacking ascorbate or insulin. 
The control DNA contents were 12.06 ± 0.56 µg/disk and 11.53 ± 2.22 µg/disk for 1× AAP and 
1× ITS controls, respectively (Figure 3-6); both 0× INS and 0× AAP were significantly lower (p 
< 0.005). The 1× GLU control ultimately reached 5.19 ± 2.77 µg/disk. ANOVA detected a 
significant influence of glucose concentration on DNA content at day 42 (p = 0.03), though the 
Tukey’s HSD post-hoc analysis did not detect these specific differences. The overall DNA trends 
confirmed the results at day 21, though at that earlier time the lower DNA contents in groups 0× 
INS and 0× AAP were not yet appreciable and the 30× AAP group had temporarily exceeded the 






Figure 3-6: DNA contents of constructs at day 42. Asterisks (*) denote p < 0.05 
versus corresponding 1× control; daggers (†) denote p < 0.05 versus 





At the conclusion of the six-week culture period, ITS and AAP controls possessed Young’s 
moduli approximately equal to native values from similar bovine sources (~550 kPa) (Soltz and 
Ateshian, 1998) and GAG contents on par with that of native cartilage (~4 %/ww) (Basalo et al., 
2004); the GLU control exhibited native values of GAG and ~1/2 of native E-Y. Native levels of 




/Ns) (Soltz and Ateshian, 
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1998), and E+Y (~15-20  10
3
 kPa) (Ateshian et al., 2009; Park and Ateshian, 2006) were not 
reached by any groups. The absence of insulin, glucose or ascorbate in the culture media 
corresponded to the lack of mechanical stiffening and accretion of matrix products within the 
constructs (Figure 3-3, Figure 3-4, Figure 3-5; Table 3-1). Considering the roles of glucose 
(anaerobic ATP production), insulin (cellular uptake of glucose), and ascorbate (collagen 
synthesis), it is not surprising to see the resulting poor functional properties. However, such a 
dramatic a drop across the board in mechanical and biochemical properties places a strong 
emphasis upon the importance of transport and distribution of insulin, glucose and ascorbate 
within the construct. These data suggest that it is vital to maintain sufficient concentrations of 
these nutrients throughout the tissue volume if there is to be matrix production at the center as 
well as the periphery. 
 Whereas engineered cartilage constructs of the type and size implemented in this study 
typically produce a more homogenous matrix (Bian et al., 2009a; Hung et al., 2004; Lima et al., 
2007), large heterogeneities of elaborated matrix are often observed in cultures of larger 
constructs (Bian et al., 2009a; Hung et al., 2003). The observations in the current study give rise 
to consideration as to whether deficiencies of these critical nutrients could be responsible for this 
behavior. Based upon the lack of significant differences between 0.3× and controls for insulin 
and ascorbate (Figure 3-3, Figure 3-4, Figure 3-5, Figure 3-6; Table 3-1), it is possible that dose 
dependencies could exist at lower concentrations than those implemented herein, and that 
elucidating these dose dependencies could merit further study. When glucose was reduced to 
0.3× of the 25 mM concentration present in high-glucose DMEM—slightly higher than the 
standard glucose supplementation of 5.52 mM—dramatic reductions in tissue mechanical 
integrity (Figure 3-3, Table 3-1) and matrix deposition (Figure 3-4, Figure 3-5) were observed. 
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This reinforces the utilization of high-glucose media in place of standard DMEM in cartilage 
tissue engineering studies, and also suggests that diminishing glucose concentrations within 
constructs may impair tissue growth.  
 The media used during the culture phase of this study were based upon a CM formulation 
including ITS as a substitute for serum. It should be noted that although an FBS-containing 
media formulation was used during the 24 h cartilage digestion step of the cell isolation 
procedure, it is unlikely that this initial exposure to serum before construct casting could have 
confounded the results of the study. ITS media contains what are believed to be essential 
supplements for proliferation of many cell types in long-term culture (Bottenstein and Sato, 
1979). While our results corroborate the importance of insulin in culture, no detrimental effects 
were observed after 42 days in the absence of either transferrin or selenous acid (Figure 3-3, 
Figure 3-4, Figure 3-5, Figure 3-6; Table 3-1). This would suggest that the role of transferrin is 
not vital for chondrocyte survival or matrix synthesis, and perhaps that uptake of non-transferrin-
bound iron, which has been observed in various other cell types (Anderson and Vulpe, 2009; 
Latunde-Dada and Simpson, 2010), also occurs in chondrocytes. Similarly, selenous acid was 
found to be unnecessary for developing constructs, suggesting that either oxidative stress is not a 
threat in this culture system or that the cells are able to compensate for it. Furthermore, cytotoxic 
effects that have previously resulted from exposure to high selenium concentrations (Bottenstein 
and Sato, 1979) were not observed. These results are valuable for resolving transport limitations 
in cartilage tissue engineering systems as they suggest that concentrations of neither transferrin 
nor selenous acid need be considered as a limiting factor in tissue growth. Though their absence 
does not seem to elicit detrimental effects by day 42, it would be prudent to continue the usage of 
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both these constituents in future studies, since day 21 results show some delays in matrix 
elaboration in the absence of these constituents. 
 The glucose groups, which along with their control were cast separately from ITS and 
ascorbate treatment groups, exhibited lower E-Y (Figure 3-3), GAG contents (Figure 3-4) and 
DNA contents (Figure 3-6) than the ITS and ascorbate groups. While the cause of these 
differences is not entirely clear, it is likely the result of variability intrinsic to the harvest and 
casting processes. We have observed that constructs from different casts may develop disparate 
properties, such as E-Y and DNA, despite sharing similar casting conditions. Because the aim of 
this study was to modulate each constituent separately, comparisons were only made relative to 
the corresponding control for any given group. 
 While modulating glucose concentration affects media osmolarity, and osmotic 
environment changes have been shown to have an impact on chondrocyte metabolism (Oswald et 
al., 2011; Xu et al., 2010), the osmolarity change elicited in this study by reducing glucose was 
low compared to osmolarities previously studied, and therefore the resulting changes in tissue 
properties are likely attributed to the concentration of glucose. Due to their lower media 
concentrations, altering the concentrations of insulin, transferrin, selenous acid or ascorbate does 
not elicit substantial changes in media osmolarity. 
 The chondrocytes used were isolated from bovine calf cartilage. Due to their availability 
for harvesting in large numbers and their ability to readily produce cartilage matrix, these cells 
constitute an ideal model system and are most practical for large-scale studies such as this (~250 
constructs). For clinical tissue engineering applications where the cell source may be diseased 
adult human chondrocytes or stem cells, it may be necessary to verify whether the influences of 
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the critical nutrients persist at similar concentrations. For example, diseased cells may exhibit 
lower metabolic requirements, while the converse may be true for stem cells. 
 With the exception of the highest dosage of selenium (10×), no treatments were found to 
increase DNA content of the constructs; lack of insulin or ascorbate yielded significantly less 
DNA. Though it was not corroborated by post-hoc analysis, a significant effect of glucose 
concentration on DNA was revealed by ANOVA and therefore glucose levels should be a 
consideration in related studies in which a specific level of cell proliferation is desired. All other 
groups increased similarly throughout the culture duration, suggesting that the proliferation of 
chondrocytes within this culture system is nearly independent from concentration variations of 
ITS and ascorbate, so long as the insulin and ascorbate levels remain above 0.3×. It should be 
noted that while the DNA assay provides an estimate of the total cell number, it does not 
examine the state of the cells. It has been suspected by our group that chondrocytes in agarose 
will allocate their energy toward either proliferation or matrix synthesis, with a preference 
toward one or the other at a given point in time. Some promising preliminary work has shown 
that synchronizing chondrocyte cell cycle prior to 3D culture can promote matrix growth. 
However, in the present study, glucose did have significant effects toward increasing GAG, 
collagen, and DNA contents. Since increasing glucose supply also increases the potential for 
ATP production via glycolytic pathways, it is possible that the energy budget of the 
chondrocytes increases concomitantly. For the purposes of this study, in which the most desired 
attributes of the constructs were their mechanical properties and matrix compositions, a greater 
emphasis was placed on effects seen in construct mechanical and biochemical properties than for 
effects on DNA content. Further experiments would be required in order to characterize specific 
cellular behavior such as cell fate processes. 
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 The findings of this study have allowed us to identify several nutrients in CM that could 
potentially be limiting for the growth of engineered cartilage:  The presence of insulin and 
ascorbate is essential, but their concentrations may drop as low as 0.3× without detrimental 
effects; in contrast, excessive supplementation of insulin or ascorbate can be detrimental. The 
matrix elaboration was significantly dependent on glucose concentration, with loss of functional 
properties observed at 0.3× or less; however, excessive glucose supplementation (up to 3×) 
shows no detrimental effects. In contrast, transferrin and selenous acid appear to have no long-
term influence on matrix elaboration in this culture system. Future work can now focus on 
transport and consumption of these critical nutrients within constructs and to what extent their 
availabilities influence construct inhomogeneity, especially as construct dimensions increase. 
This information will in turn help to strengthen finite element model predictions of transport and 
tissue growth, an invaluable tool in developing strategies for growing cartilage constructs of 
clinically relevant size. 
 
3.1.6 Acknowledgments 
Research reported in this publication was supported by the National Institute of Arthritis and 
Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Numbers 
R01AR060361, R01AR046568, and T32AR059038. The content is solely the responsibility of 
the authors and does not necessarily represent the official views of the National Institutes of 
Health. I also would like to acknowledge the hard work of undergraduate students John D. Esau, 




3.2 Identification of a glucose concentration threshold critical 
for tissue growth in engineered cartilage4 5 
 
3.2.1 Introduction 
Tissue engineering of cartilage is a promising approach for treatment of osteoarthritis. Culture of 
~4 mm chondrocyte-agarose constructs with TGF- has been shown to reproduce native 
glycosaminoglycan (GAG) levels and Young’s modulus (EY) (Byers et al., 2008). However, 
producing engineered cartilage constructs sufficiently large to be clinically relevant in treating 
cartilage defects remains a major obstacle in the field. As construct size increases, 
inhomogeneous tissue properties tend to develop as consumption by cells on the periphery 
results in poor nutrient availability towards the construct center (Bian et al., 2009a). A major 
goal of our research involves using computational models to predict tissue growth in large 
engineered constructs and optimize the placing of nutrient channels. As such, it is necessary to 
identify nutrients whose depletion has deleterious results to construct growth. Previous studies 
have shown that glucose plays a key role in anaerobic metabolism by chondrocytes (Otte, 1991), 
and that its metabolism is sensitive to media nutrient concentrations (Obradovic et al., 1999; 
Sengers et al., 2005). Therefore, this study simulates reduced-glucose conditions experienced 
inside constructs to elucidate the precise dependence of construct growth on declining glucose 
supplementation concentration. 
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3.2.2.1 Harvest and culture 
Bovine articular chondrocytes were harvested and seeded at 30  10
6 
cells/mL in 2% agarose to 
form cylindrical constructs (4 mm  2.34 mm) (2.1). Constructs were cultured for 42 days 
using 500 µL/construct chondrogenic media as previously formulated (3.1.3.2), except that 
glucose-free DMEM was used and glucose added to produce media containing either 0.17×, 
0.50×, 0.67×, 0.83×, or 1× the level of high-glucose DMEM (4.5 g/L, ~25 mM). All groups 
received 10 ng/mL TGF-3 until day 14 (Byers et al., 2008); media were changed 3 weekly. 
Constructs were taken from all groups at days 21 and 42 (n = 4-5 per group). 
 
3.2.2.2 Mechanical and biochemical evaluation  
Constructs were assessed for EY, GAG and collagen contents, and DNA as described above (2.2, 
2.3). 
 
3.2.2.3 Glucose quantitation 
Media samples were assayed for glucose concentration by Amplex Red glucose assay. All 
constructs for each glucose treatment were cultured in common dishes; measurements represent 
averages for their treatment groups. Consumption rates were tabulated as mmol glucose/day, 





Statistical significance was assessed using one-way ANOVA (α = 0.05), with glucose 
concentrations as the independent factor and EY, GAG, DNA, and collagen served as dependent 





After six weeks in culture the 1× control had reached 450 ± 159 kPa (mean ± SD) and groups 
0.83×, 0.67×, and 0.5× were statistically on par (Figure 3-7A). Significantly lower EY was 
exhibited by 0.17× (p < 0.05) as compared to all four higher glucose concentrations. This same 
trend was also present at day 21 but was less pronounced. 
 
3.2.3.2 Biochemistry 
By day 42 the GAG levels in the 1×, 0.83×, 0.67× and 0.5× groups had exceeded 4.5 %/ww and 
were not significantly different from one another (Figure 3-7B). The 0.17× constructs showed 
reduced GAG contents as compared to higher-glucose groups at both time points (p <0.0005).  
At day 42, the four higher-glucose groups collectively contained 10.83 ± 0.94 µg/disk 
DNA; 0.17× contained 7.08 ± 1.47 µg/disk, significantly less (p < 0.005). Day 21 DNA values 
exhibited no significant trends (p > 0.29). 
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Groups 0.5× and 1× ultimately reached ~1.25%/ww collagen, with groups 0.67× and 0.83× ~1.7 
%/ww. The 0.17× group was lowest, being significantly lower than all other groups after three 
weeks (p < 0.05) and lower than groups 0.67× and 0.83× after six (p < 0.05) (Figure 3-7C).  
Glucose levels between media changes fell consistently for all groups throughout the 
culture period, with the lower-supplementation groups consuming nearly all their glucose (Figure 
3-8). Consumption rates (slopes of cumulative consumption curves) were well-fitted by linear 
regressions (R
2 




Figure 3-7: EY (A), GAG content (B), and collagen content (C) of constructs in 
varying glucose concentrations at day 42. Significance is denoted by * (p < 0.05) 






















































Figure 3-8: Media glucose levels at times of media change (top) and glucose 
consumption rates by constructs (bottom). Concentrations represent average 
values for 5-10 constructs and are expressed in mmol glucose normalized to day 0 






























































D42 DNA (ug/disk) 
Glu. Cons. Rate 
(mmol/day•mL) 
1)  0.17X 7.08 ± 1.47
2,3,4,5
 0.019 
2)  0.5X 11.05 ± 0.50
1
 0.059 
3)  0.67X 9.86 ± 0.48
1
 0.101 
4)  0.83X 10.95 ± 0.54
1
 0.086 




Table 3-2: Construct DNA contents and glucose consumption rates. Superscripts 




This study examined the effects of variations in glucose concentrations on matrix synthesis in a 
chondrocyte-agarose tissue engineering system. Most strikingly, the data indicate that in high-
glucose DMEM the glucose can drop to half its original value with no detrimental effects to the 
constructs (Figure 3-7); however, as glucose levels drop further there is a marked decrease in 
functional properties. It is evident from the consumption data (Figure 3-8) that glucose does not 
get depleted in 1×, 0.83×, and 0.67× groups. At 0.5× however, it appears that all of the glucose 
present in the media is nearly used up over time in culture, but that amount is sufficient to 
maintain equally good composition and functional properties as the higher concentrations. 
Therefore, any amount lower than 0.5× is evidently insufficient, as is apparent in the 0.17× 
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group. Thus, in this culture system of chondrocyte-agarose constructs seeded at 30  10
6 
cells/mL and provided 500 µL media/construct, glucose concentrations within constructs must be 
maintained over 12.5 mM to ensure satisfactory tissue growth. This threshold, along with the 
obtained glucose consumption rates, both provide valuable parameters for computational 
modeling of growth of engineered cartilage constructs, particularly as construct size and 
thickness are increased to be clinically relevant for treatment of osteoarthritis. 
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Following the successful identification of glucose as a critical nutrient for growth of CTE 
constructs (3.1) and the discovery of a glucose threshold below which tissue growth ceases (3.2), 
an outstanding parameter required for computational modeling of glucose availability is the rate 
of glucose consumption by cells in this culture system. Thus, an experiment was designed and 
performed to calculate glucose metabolism by CTE constructs.  
Constructs were cast at a relatively low initial cell seeding density in order to discourage 
the formation of steep glucose concentration gradients within constructs. In the absence of such 
steep gradients, we assume the cellular consumption of glucose to be approximately 
homogeneous throughout the construct volume.  
 
3.3.2 Methods 
Constructs were cast in 2% agarose, 4 × 2.3 mm in size (2.1), with 10
7
 cells/mL, and cultured 
in ITS media (3.1.3.2) for 49 days. Constructs were supplemented with 10 ng/mL TGF-β for the 
first 14 days (Byers et al., 2008). During the first media change cycle of alternating weeks (D0-
D3, week 1; D14-D17, week 3; D28-D31, week 5; D42-45, week 7), a 72-hour time course was 
run. Constructs were supplied with 0.5 mL each, and were cultured in n = 3 dishes with at least 5 
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constructs per culture dish. An initial (t = 0 h) sample of fresh media was taken, and 0.5 mL 
samples of spent media were aspirated from each of the three dishes at 4 h, 8 h, 24 h, 48 h, and at 
72 h. At each time point, one construct from each dish was transferred to a new dish in order to 
maintain a media-to-construct ratio of 0.5 mL/construct in the test dishes.  
At the conclusion of 7 weeks, the fresh and spent media samples were assayed for 
glucose concentration as described above (3.2.2.3). Statistical effects were examined by two-way 
ANOVA, with time points and specific week of measurements as independent factors, on the 
residual media glucose concentrations (α = 0.05). Glucose consumption rates were calculated as 
the slope of the line representing change in media glucose concentration versus time.  
 
 
Figure 3-9: Depletion of media glucose concentration by CTE constructs over the 























Hours after Media Change 
Week 1 Week 3




Constructs actively consumed glucose over the course of each 72-hour period, in similar fashion 
from the beginning of culture (week 1) throughout the termination of culture (week 7; Figure 
3-9). Constructs appeared to consume more glucose during weeks 3 and 5 (after TGF-β release) 
than during weeks 1 and 7; however, two-way ANOVA revealed a significant effect of sampling 
time points (p < 0.0001), but not of week-to-week effects (p = 0.10). The net averaged glucose 
consumption rate from all samples during weeks 1-7 was 1.24 ± 0.35 × 10
-13
 mol/(cell · h).  
3.3.4 Discussion 
In this experiment, we systematically characterized the glucose consumption behavior of 
chondrocytes in agarose in our culture system. Due to the low cell seeding density implemented, 
nutrient gradients are minimized and we assumed that consumption of glucose occurs 
homogeneously throughout the constructs. The level of glucose consumption measured bears 
resemblance to previously measured consumption rates by bovine chondrocytes in 3D culture 
and in monolayer (Marcus and Srivastava, 1973; Obradovic et al., 1999). In a subsequent study 
in this thesis culturing 10 mm × 2.3 mm constructs seeded with ~100 × 10
6
 cells/mL (4.2), 
average glucose consumption rates were lower than the present study, measured to be 8.6 ± 2.3 × 
10
-14
 mol/(cell · h) compared to 1.24 ± 0.35 × 10
-13
 mol/(cell · h), likely due to lower 
consumption rates at the construct center where glucose has been depleted. In future 
computational modeling of glucose availability in tissue engineered cartilage constructs of 
increasing size and cell seeding densities, this measured consumption rate of glucose in our 
system will prove to be indispensable.   
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Chapter 4  
 
Design and implementation of a culture 
system for cultivating centimeter-sized 





4.1 Nutrient channels and stirring enhanced the composition 
and stiffness of large cartilage constructs7 
 
4.1.1 Abstract 
A significant challenge in cartilage tissue engineering is to successfully culture functional tissues 
that are sufficiently large to treat osteoarthritic joints. Transport limitations due to nutrient 
consumption by peripheral cells produce heterogeneous constructs with matrix-deficient centers. 
Incorporation of nutrient channels into large constructs is a promising technique for alleviating 
transport limitations, in conjunction with simple yet effective methods for enhancing media flow 
through channels. Cultivation of cylindrical channeled constructs flat in culture dishes, with or 
without orbital shaking, produced asymmetric constructs with poor tissue properties. We 
therefore explored a method for exposing the entire construct surface to the culture media, while 
promoting flow through the channels. To this end, chondrocyte-seeded agarose constructs (10 
mm, 2.34 mm thick), with zero or three nutrient channels (1 mm), were suspended on their 
sides in custom culture racks and subjected to three media stirring modes for 56 days: uniaxial 
rocking, orbital shaking, or static control. Orbital shaking led to the highest construct EY, 
glycosaminoglycan (GAG), and collagen contents, whereas rocking had detrimental effects on 
GAG and collagen versus static control. Nutrient channels increased EY as well as GAG 
homogeneity, and the beneficial effects of channels were most marked in orbitally shaken 
samples. Under these conditions, the constructs developed symmetrically and reached or 
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exceeded native levels of EY (~400 kPa) and GAG (~9 %/ww). These results suggest that the 
cultivation of channeled constructs in culture racks with orbital shaking is a promising method 
for engineering mechanically competent large cartilage constructs. 
 
4.1.2 Introduction 
OA is a debilitating disease characterized by damage to the articular cartilage layers lining 
diarthrodial joints. In advanced cases, lesions span the full thickness of cartilage, leading to 
bone-on-bone contact during joint articulation. With its relatively low cell density and avascular 
nature, adult cartilage lacks the ability to regenerate when injured, leading to irreversible 
degeneration. Currently, there is no treatment available to fully restore durable articular surfaces.  
 A potential approach to the treatment of OA is by culturing cells within a scaffold under 
suitable conditions in vitro in order to produce viable replacement cartilage (Johnstone et al., 
2013; Langer and Vacanti, 1993; Vacanti and Langer, 1999). Culture of chondrocytes within 
agarose scaffolds is a well-established technique which stabilizes chondrocyte phenotype and 
encourages the elaboration of sulfated glycosaminoglycans (GAG) which are similar to those 
found in native cartilage (Benya and Shaffer, 1982; Buschmann et al., 1992; Mauck et al., 2000; 
Mouw et al., 2005; O'Conor et al., 2014; Rahfoth et al., 1998). These chondrocyte-agarose 
constructs have had some success in reaching native values of compressive Young’s modulus 
(EY) and GAG content when their dimensions are small (~4 mm) (Bian et al., 2009a; Byers et 
al., 2008; Cigan et al., 2013a; Nims et al., 2014); however, constructs of this size may not be 
sufficiently relevant clinically, as OA symptoms often manifest themselves when cartilage 
defects become larger, e.g., 25 mm (Curl et al., 1997; Moisio et al., 2009b). Previous attempts 
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to engineer cartilage constructs of this size have been met with transport limitations; the 
consumption of nutrients by cells at the construct periphery deprives its center of these nutrients, 
establishing concentration gradients throughout the depth of the construct. Depletion of glucose 
beneath a threshold level within constructs results in little to no local matrix elaboration by 
chondrocytes (Cigan et al., 2013a; Nims et al., 2014) and dissolved oxygen plays a prominent 
role in chondrocyte metabolism and forms gradients within tissue engineered cartilage 
(Obradovic et al., 1999; Zhou et al., 2008). Furthermore, interplay between glucose, oxygen, and 
other nutrients elicit a broad range of metabolic behaviors that will vary with nutrient 
concentrations throughout the depth of the tissue (Heywood et al., 2006a; Heywood et al., 2006b; 
Sengers et al., 2005; Zhou et al., 2008). Thus as construct scale is increased, the general result is 
a heterogeneous construct with a soft, matrix-deficient center, with poor functional properties, 
that would be unsuitable for implantation (Hung et al., 2003; Hung et al., 2004).  
 A number of techniques have been implemented in attempts to improve nutrient transport 
in large engineered cartilage constructs, such as incorporation of nutrient channels to reduce the 
necessary path length along which nutrients must travel to reach the construct center (Bian et al., 
2009a; Buckley et al., 2009), stirring or perfusion of culture media to prevent stagnation around 
the construct (Davisson et al., 2002; Vunjak-Novakovic et al., 1999), and dynamic loading to 
pump solutes into the tissue (Albro et al., 2008; Chahine et al., 2009; Mauck et al., 2003a; 
Mauck et al., 2003b; Mesallati et al., 2011). In statically cultured 10 mm chondrocyte-agarose 
constructs, the incorporation of nutrient channels has yielded higher EY, approaching native 
values (Bian et al., 2009a); in 6 mm constructs, microchannels combined with rotational 
culture improved GAG distribution, though GAG content and EY fell short of native levels 
(Buckley et al., 2009). In chondrocyte-seeded 10 mm PGA scaffolds cultured flat in Petri 
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dishes, orbital shaking at ~0.8 Hz increased collagen but not GAG content versus static control, 





Figure 4-1: Abnormal swelling of 10 mm constructs cultured flat in Petri dishes 
for 56 days with orbital shaking; (A) perspectives of whole specimens, and (B-C) 
profiles of bisected specimens with or without channels (channel positions 
denoted by dotted lines, regions of excessive swelling denoted by arrows). 
 
 
In our studies, 10 mm chondrocyte-agarose constructs cultured flat in Petri dishes with 
0.8 Hz orbital shaking swelled asymmetrically due to extreme heterogeneity of GAG deposition, 
rendering unconfined compression testing infeasible (Figure 4-1). Peripheral regions in some 
specimens reached twice the thickness of the central region, and many samples experienced 
warping due to the occlusion of fresh media to the downward-facing sides of the constructs. In 




channeled constructs, the direction of media flow produced by orbital shaking was perpendicular 
to the nutrient channels, and channels were not found to alleviate matrix heterogeneities nor did 
they increase matrix content. 
 Therefore, we sought to overcome the matrix heterogeneities observed in large constructs 
by manipulating the culture system to maximize the benefits of nutrient channels. Specifically, it 
was hypothesized that introducing media stirring and nutrient channels aligned with the direction 
of media flow could produce large, symmetric, and homogeneous constructs with functional 
properties consistent with those of our previous studies on smaller constructs (Bian et al., 2009a; 
Cigan et al., 2013a; Kelly et al., 2009; Kelly et al., 2006; Kelly et al., 2008; Lima et al., 2007; Ng 
et al., 2009b; Nims et al., 2014). To this end, we recently developed a simple and novel 
technique to reorient large constructs and maximize their surface area available for nutrient 
transport in culture dishes, and media stirring was introduced to the culture system to improve 
nutrient channel efficacy (Cigan et al., 2013b). Constructs were evaluated both quantitatively for 
their mechanical properties and content of the major matrix constituents GAG and collagen, and 
qualitatively by histological staining for distribution of these matrix components. 
 
4.1.3 Methods 
4.1.3.1 Harvest and cell isolation 
Chondrocytes were harvested and isolated as described previously (2.1). Briefly, slices of 
articular cartilage were sterilely harvested from juvenile bovine calf wrists and subsequently 
digested with collagenase; the cartilage digest was then filtered through a 70 µm mesh to remove 




4.1.3.2 Construct preparation 
Isolated chondrocytes were suspended in chondrogenic media (CM) (3.1.3.2) at a concentration 
of 120 × 10
6
 cells/mL and combined 1:1 with molten 4% w/v type VII-A agarose to produce a 
2% agarose gel with a nominal cell density of 60 × 10
6
 cells/mL. The gel was cast into either the 
PTFE-glass mold (to produce channeled constructs) or a glass-glass mold (to produce constructs 
without channels) and incubated 20 minutes at room temperature to solidify. The molds were 
opened and a 10 mm biopsy punch was utilized to create 2.34 mm-thick constructs with either 
three channels (CH3) or no channels (CH0). 
 
4.1.3.3 Construct culture 
The constructs were suspended in culture racks (2.4) submerged in CM within deep Petri dishes 
(63 mm × 22 mm). Dishes were either stirred throughout the culture duration on an orbital 
shaker at 0.8 Hz or on a rocker at 0.4 Hz, or were cultured statically. Videos of the stirring 
modes may be found in the Supplementary Materials of Cigan et al. (Cigan et al., 2014b). The 
dishes were oriented on the rocker such that the direction of flow was normal to the flat faces of 





Figure 4-2. Distribution of bolus of 10 kDa fluorescein-dextran to PBS bath of 
agarose gels suspended within culture racks, subjected to (A) 0.4 Hz rocking, (B) 
0.8 Hz orbital shaking, (C) static condition, after 2 h. 
 
 
 In a preliminary study, acellular channeled 8% agarose gels in culture racks were 
subjected to boluses of 10 kDa fluorescein-conjugated dextran and imaged after 2 h by 
fluorescent microscopy (Figure 4-2); both 0.8 Hz orbital shaking and 0.4 Hz rocking improved 
the distribution of dextran to the regions surrounding channels, as compared to static controls. 
 All constructs were supplemented with 10 ng/mL human recombinant TGF-β3 for the 
first 14 days of culture (Byers et al., 2008), a volume of 6 mL of CM for each construct was 
implemented, and media were changed thrice weekly. Spent media samples were taken from 
each group at each media change. 
 
1mm 
A B C 
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4.1.3.4 Mechanical testing 
At days 0, 35, and 56, constructs from each group (n = 5) were removed from culture. The 
diameters and thicknesses of constructs were measured, and the samples were subsequently 
tested for EY as described above (2.2; 0.23 N, 400 s creep tare and time; 10% strain, 0.58 µm/s 
ramp speed, 11 × 10
3
 s relaxation time). The relaxation time was scaled proportionally with 





4.1.3.5 Biochemical composition 
Samples were assayed for GAG, collagen, and cellularity as described above (2.3). Aliquots of 
spent media, taken at the time of each media change, were also assayed for GAG content. 
Cumulative masses of media GAG over the culture period were calculated and normalized to the 
day-0 volume of the constructs (mg/mL). Additionally, GAG retention fractions were computed 
based on Equation 1. 
      
                  
                                 
      Equation 1 
 
4.1.3.6 Histology and immunohistochemistry 
Histology was performed as described above (2.6) on construct half-cylinders. Prior to 
embedding, half-cylinders were bisected, forming quarter-cylinders, and embedded for both 
sagittal and transverse sectioning (7 µm sections). For GAG staining, 1% Safranin O was used. 
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Polarized light microscopy was used to examine collagen morphology and orientation in 
Picrosirius Red-stained samples. To further clarify collagen distribution and type, a subset of 
sectioned samples were processed for collagen-specific immunohistochemistry (types I and II), 
which was performed as described previously (employing primary antibodies derived from rabbit 
in place of mouse)(Mauck et al., 2003b).  
 
4.1.3.7 Statistics 
A two-way ANOVA (α = 0.05) was employed (STATISTICA) to determine significance, using 
presence of channels and mode of stirring as independent factors and EY, GAG, collagen, and 
DNA as dependent variables. Once significance was established, Tukey’s HSD post-hoc tests 
were run to examine differences between experimental groups. Because multiple constructs were 
cultured within each dish, values for media GAG represent averages for their corresponding 
groups without standard deviations; thus, statistical comparisons among groups for media GAG 
were not performed.  
 
4.1.4 Results 
The constructs were evaluated qualitatively by inspection and by histological staining, and 
quantitatively for mechanical stiffness and biochemical content. Because similar trends between 
stirring and channel groups existed at days 35 and 56 and overall functional properties were 




4.1.4.1 Construct appearance 
Constructs grew symmetrically and little to no regional variations in opacity or appearance were 
discernible within individual constructs. Samples that had been rocked during culture were the 
most translucent, and those that were orbitally shaken were most opaque (Figure 4-3). Some 
channels had decreased from their original diameters, and some had become partially or 





Figure 4-3: Construct morphology, freshly cast (Day 0) and after 56 days in 
culture under various stirring conditions. 
 
 























4.1.4.2 Histology and immunohistochemistry 
Safranin O staining for GAG was visibly darker in orbitally shaken constructs as compared to 
static controls, whereas constructs from the rocker exhibited lighter staining (Figure 4-4A). Thin 
regions immediately encompassing the channel edges exhibited lighter staining, though generally 
beyond this region darker staining was seen in the interior of channeled constructs as compared 
to no-channel controls. Some channels were partially or fully filled with matrix. When stained 
for collagen, variations between samples were less apparent (Figure 4-4B); however, channeled 
constructs tended to exhibit darker staining throughout their depths (as seen in sagittal sections). 
Generally, throughout their depths the channeled, orbitally shaken samples stained darker than 
all other groups. A fibrous collagen ring was observed around the peripheries of orbitally shaken 
constructs, particularly those with channels (Figure 4-5A). Polarized light revealed the presence 
of thick collagen bundles in this region (Figure 4-5B). Collagen-specific immunohistochemistry 
detected primarily type II collagen at the periphery and at the construct interior (Figure 4-5C). 
Type I collagen staining was also found in the periphery and at the center, to a lesser extent, but 







Figure 4-4: Effects of culture conditions on the amounts and distributions of 
cartilaginous tissue components: stains for (A) GAG by Safranin O and (B) 
collagen by Picrosirius Red in sample quarter-cylinders after 56 days of culture 
(both sagittal and transverse sections). Arrows indicate filled-in channel margins. 
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Figure 4-5: Portion of orbitally-shaken, 3-channeled construct sagittal section 
visualized with (A) Picrosirius Red histological staining, (B) polarized light 
microscopy of Picrosirius Red stain, (C) overlaid collagen-specific 
immunohistochemistry of sample sections, colorized such that purple indicates 
collagen type I and green indicates collagen type II (dashed line marks sample 





All groups increased in cell density over the course of the culture period (Day 0 ρ: 85 × 10
6
 
cells/mL; p < 0.0001). Mode of stirring and presence of channels influenced cell density (p < 
0.01 and p < 0.05, respectively; Figure 4-6A). Orbital shaking resulted in the highest 
cellularities, at ~143 × 10
6
 cells/mL (p < 0.05). Channels elicited a slight, yet significant overall 
decrease in cell density (p < 0.05).  
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Figure 4-6: (A) Cell density, (B) GAG, (C) Collagen, and (D) EY after 56 days. 
(*) indicates p < 0.05 for the effect of stirring condition, (#) indicates p < 0.05 for 


























































































4.1.4.4 Biochemical composition 
Stirring condition had a highly significant influence on GAG (p < 0.0001, Figure 4-6B). Orbital 
shaking yielded approximately 9%/ww GAG, significantly higher than other stirring conditions 
(p < 0.0005). Rocked constructs had less GAG than static controls (p < 0.0005). A similar trend 
was found for collagen (Figure 4-6C), in which orbital shaking yielded the most collagen 
(~2%/ww; p < 0.0005) and rocking yielded the least (p < 0.0005). Channels had no significant 
influence on total GAG or collagen content per construct. 
 The highest cumulative media GAG was found in the orbitally shaken, channeled group 
(42.1 mg/mL); all other groups had similar levels (~30 mg/mL, data not shown). Retention of 
GAG within constructs was highest in orbitally shaken constructs (~78% with or without 
channels) and lowest in rocked groups (38% with channels, 53% without channels); static 
controls had ~67% retention. 
 
4.1.4.5 Mechanical properties  
At day 56, EY (Figure 4-6D) varied from near-day-0 values at the lowest (rocked groups) to 
nearly 400 kPa in the highest group (CH3, orbited). Stirring type had a significant effect (p < 
0.0001), as did presence of channels (p < 0.05). Orbited constructs were significantly stiffer than 
their static and rocked counterparts (p < 0.0005), as were channeled constructs over their no-





This study demonstrated that it is possible to engineer high-quality cartilage constructs on the 
scale of 10 mm, by refining our culture system with channeled scaffolds and stirring during the 
cultivation. By suspending constructs on their sides in culture racks, the surface area was 
increased for nutrient diffusion, enhancing nutrient availability within the tissue and effectively 
ameliorating the uneven swelling and warping observed in preliminary studies (Figure 4-1 versus 
Figure 4-3). The alignment of channels in the direction of media flow resulted in stiffer 
constructs as compared to no-channel controls (Figure 4-6D). With the incorporation of nutrient 
channels and introduction of orbital shaking, constructs attained values of EY comparable to 
native values (~400 kPa) and GAG levels (~9%/ww, Figure 4-6B) exceeding native values 
(~4%/ww) (Basalo et al., 2004); to the best of our knowledge, these are the highest GAG levels 
to be observed in agarose-chondrocyte constructs of this size to date. Collagen reached levels 
typically observed in our smaller constructs (2%/ww, Figure 4-6C) though these levels remain 
below native values (~10%) for immature bovine cartilage (Basalo et al., 2004). 
 Orbital shaking of constructs was found to significantly increase EY, GAG, collagen, and 
construct cellularity (Figure 4-6A-D); staining for GAG was also intensified, as was staining for 
collagen in the presence of nutrient channels. Stains also revealed a fibrous ring comprised of 
thick collagen fibers encompassing constructs that were subjected to orbital shaking (Figure 
4-5A-B), which is consistent with effects seen in spinner flask culture (Vunjak-Novakovic et al., 
1999). Immunohistochemistry detected collagens type I and II in this ring, though type II was 
more abundant (Figure 4-5C). Quantitatively, ELISAs have previously shown that constructs of 
this type (juvenile bovine chondrocyte-agarose) produce predominantly type II collagen (Ng et 
al., 2009b). Orbitally shaken constructs also exhibited the highest GAG retention rates. 
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Conversely, uniaxial rocking resulted in significantly decreased matrix concentrations (Figure 
4-6B-C) as compared to statically cultured constructs, an observation consistent with histological 
staining in constructs’ peripheral regions (Figure 4-4). Rocked specimens did not stiffen 
throughout the culture period, and they experienced the lowest retention of GAG. This disparity 
occurred despite both stirring methods demonstrating similar potential for improving solute 
transport in acellular, channeled agarose gels in a preliminary study (Figure 4-2). These data 
suggest that the media flow induced by rocking at this frequency (0.4 Hz) either adversely 
affected matrix production by cells, washed matrix macromolecules out into the media before 
they became entrapped by the scaffold, or elicited some combination thereof. 
 The disparities between the rocking and orbital shaking observed in this study strongly 
suggest that ample validation must be performed for any tissue engineering system that 
incorporates media stirring. The detrimental effects of rocking on these constructs were 
unanticipated and the underlying cause was not fully elucidated from the available measurements 
and observations. However, from a tissue engineering perspective, in-depth investigation of 
those causes is not a high priority, as the primary goal of this study was to improve our culture 
system, which was amply achieved with orbital shaking (Figure 4-6) in custom racks that expose 
virtually all the construct surface area to media (Figure 2-4). This superior stirring method may 
thus be employed in future studies with larger constructs.  
 At the conclusion of the 56-day culture period, many of the channels remained 
unoccluded and had not been entirely filled by neocartilage, an observation consistent with a 
previous study which employed 1 mm channels (Bian et al., 2009a). This has the benefit of 
improving nutrient transport throughout culture, yet channel filling would be desirable when 
cultivating tissue for implantation. Furthermore, in constructs with supraphysiological levels of 
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GAG (i.e. those with orbital shaking), channels led to slight warping of constructs (Figure 4-4). 
Since such warping was not exhibited at day 35 (data not shown), it is likely that shorter culture 
durations or techniques to retard or halt GAG production could mitigate this effect. In light of 
these observations, experiments seeking to fine-tune parameters such as channel diameter and 
culture duration may eventually be required to ensure timely channel filling and isotropic tissue 
growth. 
 The constructs in this study were subjected to their respective stirring conditions for the 
entirety of the culture period, and temporal effects of these stirring conditions were not explored. 
A number of culture techniques have been shown to possess temporal effects on the properties of 
engineered cartilage, such as transient TGF-β supplementation (Byers et al., 2008), delayed 
dynamic compressive loading (Lima et al., 2007), transient hypoxia (Yodmuang et al., 2013), 
and transient perfusion (Davisson et al., 2002). In light of these findings, the effects of transient 
or delayed media stirring in this culture system could prove to be a worthwhile investigation. 
Furthermore, the frequencies of orbital shaking and uniaxial rocking were not modulated in this 
study, and relationships between stirring frequency and construct properties were not established. 
It is possible that an optimum frequency exists for orbital shaking which could produce even 
higher-quality tissue, or that certain frequencies could reconcile the detrimental effects of 
uniaxial rocking; these notions could also merit further study.  
 Due to the beneficial effects of nutrient channels on functional properties of constructs in 
culture racks with orbital shaking, we believe that this culture system holds promise for further 
investigations with large channeled constructs. Future studies will employ finite element 
modeling of nutrient consumption and matrix synthesis (Ateshian et al., 2014; Maas et al., 
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2012b) to anticipate the optimal placement of nutrient channels within large constructs, for the 
purpose of producing tissue that will be more clinically effective for treatment of OA. 
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4.2 Elevated matrix production in large engineered cartilage 
constructs is significantly facilitated by nutrient channels and 
sufficient media8 9 
 
4.2.1 Introduction 
A number of techniques have improved functional properties of large constructs: the 
incorporation of nutrient channels in constructs 6 mm or larger has previously increased EY or 
dynamic modulus, but not GAG or collagen production (Bian et al., 2009a; Buckley et al., 2009; 
Cigan et al., 2014b), and suspending constructs and introducing orbital shaking to encourage 
media convection through channels has produced high-quality large constructs (Cigan et al., 
2014b). Recently, finite element modeling of transport and growth within large constructs has 
suggested that common culture conditions lead to premature consumption of available glucose, 
such that nutrient channels intended to increase glucose availability deeper within the constructs 
would be effective only when coupled with higher volumes of culture media (Nims et al., 2013). 
The current study integrates these previous strategies and model predictions, with the overall 
objectives of refining this culture system and producing large constructs with superior functional 
properties, by experimentally evaluating the efficacies of multiple configurations of nutrient 
channels under increasing media volumes. 
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4.2.2.1 Harvest and culture 
Bovine articular chondrocytes were seeded at 60 × 10
6
 cells/mL in 2% agarose to form 
cylindrical constructs (10 mm × 2.34 mm). A custom PTFE/steel casting mold (Figure 2-3) 
was used to produce constructs with 0, 3, or 12 1 mm channels (CH0, CH3, or CH12, 
respectively) in a triangular packing arrangement with mutual spacing of 4.330 mm (CH3) or 
2.165 mm (CH12). Constructs were suspended on their lateral surfaces by custom PTFE/PTFE-
coated steel wire racks (Figure 2-4, Figure 4-7) and cultured with orbital shaking (0.8 Hz) in 
various volumes of chemically defined ITS media per construct (5mL, 10mL, 15mL). Media 
were changed three times weekly. Samples were taken from all groups at day 56 (n = 5 per 






Figure 4-7: Photograph of 10 mm constructs resting in their custom culture rack 
in specialty deep Petri dish. Dish lid has been removed for visualization purposes. 
 
 
4.2.2.2 Mechanical and biochemical properties 
Constructs were tested under unconfined compression stress-relaxation to 10% strain. EY was 
calculated from the equilibrium stress-strain response (2.2). Masses of GAG, collagen, and DNA 
were measured as above (2.3), and were normalized to either reference (D0) construct wet 
weight (%/D0ww) or to D56 wet weight (%/D56ww).  
 
4.2.2.3 Histological analysis 





Statistical significance was assessed using two-way ANOVA (α = 0.05) using presence of 
channels (CH), media volume (MV), and their interaction (CH × MV) as independent variables, 
with Tukey’s HSD post-hoc tests. 
 
4.2.3 Results 
4.2.3.1 Mechanical properties 
CH and MV had no effects on EY (p > 0.13); EY for all constructs was 304 ± 97 kPa (Figure 4-8). 
Swelling ratio (SR) was strongly influenced by CH (p < 0.0001), and also by MV (p < 0.05), and 
CH × MV (p < 0.0005; Figure 4-8). SR was near unity in CH0, and increased with number of 
channels (p < 0.05) to ~2.75 in CH12 constructs (Figure 4-9). 10mL constructs swelled to a 






Figure 4-8: EY (left) and swelling ratios (right) of 10 mm constructs with 0-12 
channels and 5-15 mL media per construct. (*) denotes p < 0.05 between channel 
configurations for a given media volume, (+) denotes p < 0.05 between media 
volumes for a given channel configuration. 
 
Figure 4-9: CH12 and CH0 constructs at day 0 (top), and sample CH12 construct 
receiving 15 mL media side-by-side with a CH0 construct receiving 5 mL media, 










































Figure 4-10: Day 0 wet weight-normalized GAG (left) and collagen contents 
(right) of 10 mm constructs with 0-12 channels and 5-15 mL media per 
construct. (*) denotes p < 0.05 between channel configurations for a given media 
volume, (+) denotes p < 0.05 between media volumes for a given channel 
configuration. 
 
Figure 4-11: Day 56 wet weight-normalized GAG (left) and collagen contents 

































































































Figure 4-12: Day 0 wet weight-normalized cellularity of 10 mm constructs with 
0-12 channels and 5-15 mL media per construct. (*) denotes p < 0.05 between 
channel configurations for a given media volume. 
 
4.2.3.2 Biochemical properties 
GAG content by D0 wet weight was significantly affected by CH (p < 0.0001), MV (p < 0.005), 
and CH × MV (p < 0.0001; Figure 4-10). Greater numbers of channels increased GAG (p < 
0.0005); this effect was most pronounced in 15mL MV, in which CH12 constructs contained 
2.8× the GAG of CH0. CH0 constructs with 15 mL MV had significantly less GAG than at 10 
mL MV (p < 0.05). 10mL MV led to more GAG than 5mL (p < 0.005). By D56 wet weight, all 
groups similarly reached 7.1 ± 0.7 %/D56ww GAG (p > 0.12; Figure 4-11).  
Collagen content by D0 wet weight was influenced by CH (p < 0.0001), MV (p < 0.05), 
and CH × MV (p < 0.001), and increased with number of channels (p < 0.05; Figure 4-10). More 

























observed in collagen contents when normalized by D56 weight (1.6 ± 0.3 %/D56ww, p > 0.35; 
Figure 4-11).  
All groups increased in cellularity from D0 levels (84.9 ± 6.3 × 10
6
 cells/mL). A 
significant trend was observed between CH and cell number (p < 0.0001), and the addition of 
either 3 or 12 channels increased cell number (p < 0.005; Figure 4-12). MV did not affect 
cellularity (p = 0.24), though the effect of CH × MV was significant (p < 0.05). 
 
4.2.3.3 Histological analysis 
A detailed histological analysis can be found in Nims et al. (Nims et al., 2015). 
 
4.2.4 Discussion 
The incorporation of nutrient channels encouraged cell proliferation and increased matrix content 
in large constructs (Figure 4-10, Figure 4-12). A greater number of closer-packed channels 
yielded even more matrix content, and this trend was better delineated by higher volumes of 
media (15 mL/construct). This trend may likely be attributed to the ability of channels to increase 
glucose availability and glucose consumption by cells within construct centers. Conversely, low 
media volume (5 mL) hindered the channels’ effectiveness at improving tissue growth. High 
media volumes (15 mL) resulted in significantly less %/D0ww GAG in CH0 constructs 
compared to 10 mL; while this finding is counterintuitive, it may be explained by beneficial 
autocrine factors produced by the cells being washed out by stirring and diluted in a larger 
volume of media. Regardless of the precise mechanism for this observation, other attempts to 
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culture CH0 constructs have been unsuccessful (Bian et al., 2009a)(Chapter 5), and therefore the 
growth of unchanneled large constructs is not promising in any volume of media. 
 An alternate possible approach to improving glucose supply is to increase the frequency 
of media changes. The volumes of media chosen were based partially upon computational 
models run which predicted improved glucose supply at larger media volumes (Nims et al., 
2015). An additional consideration is the set of constraints imposed by the culture system 
designed in 4.1. In this system, specialty deep Petri dishes are used which can comfortably hold a 
culture rack, constructs, and approximately 25-30 mL media (to immerse constructs without 
overtopping the dish). Thus, 5 mL groups were cultured with five constructs in 25 mL, 10 mL 
groups were cultured with three constructs in 30 mL, and 15 mL groups were cultured with two 
constructs in 30 mL per dish. More frequent media changes are technically feasible, and would 
involve a smaller media volume per construct on a daily or near-daily basis. However, in 
addition to the logistical challenge of changing media daily for 56 days for this study and all 
subsequent ones, it is unclear what the effect of frequent media changes would be on TGF-β 
treatment, as this could cause more pronounced matrix heterogeneity due to the nonlinear effects 
of TGF-β binding to ECM and the agarose scaffold (Albro et al., 2016). 
Greater number of channels led to greater construct swelling (Figure 4-9), as the agarose 
was unable to resist Donnan pressure resulting from such high GAG accumulation. This swelling 
diluted all D56 weight-normalized GAG and collagen to similar levels for all groups (7.1 
%/D56ww GAG and 1.6 %/D56ww collagen; Figure 4-11), and the constructs were 
mechanically indistinct. Even so, the constructs exhibited mechanical and biochemical properties 
comparable to those of smaller constructs from previous studies (Cigan et al., 2013a; Kelly et al., 
2006). To our knowledge this is the highest GAG content observed in constructs of this size, 
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although collagen levels were still low compared to native cartilage (~10 %/ww) (Basalo et al., 
2004). Restriction of construct swelling in future studies could potentially yield higher weight 
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Chapter 5  
 
Optimization of culture system for 





5.1 Optimizing nutrient channel spacing and revisiting TGF-β 
in large engineered cartilage constructs10 
 
5.1.1 Abstract 
Cartilage tissue engineering is a promising approach to treat osteoarthritis. However, current 
techniques produce tissues too small for clinical relevance. Increasingly close-packed channels 
have helped overcome nutrient transport limitations in centimeter-sized chondrocyte-agarose 
constructs, yet optimal channel spacings to recapitulate native cartilage compositional and 
mechanical properties in constructs this large have not been identified. Transient active TGF-β 
treatment consistently reproduces native compressive Young’s modulus (EY) and 
glycosaminoglycan (GAG) content in constructs, but standard dosages of 10 ng/mL exacerbate 
matrix heterogeneity. To ultimately produce articular layer-sized constructs, we must first 
optimize channel spacing and investigate the role of TGF-β in the utility of channels. We 
cultured 10 mm constructs with 0, 12, 19, or 27 nutrient channels (1 mm) for 6-8 weeks with 
0, 1, or 10 ng/mL TGF-β; subsequently we analyzed them mechanically, biochemically, and 
histologically. Constructs with 12 or 19 channels grew the most favorably, reaching EY = 344 ± 
113 kPa and GAG and collagen contents of 10.8% ± 1.2% and 2.2% ± 0.2% of construct wet 
weight, respectively. Constructs with 27 channels had significantly less deposited GAG than 
other groups. Channeled constructs given 1 or 10 ng/mL TGF-β developed similar properties. 
Without TGF-β, constructs with 0 or 12 channels exhibited properties that were 
indistinguishable, and lower than TGF-β-supplemented constructs. Taken together, these results 
                                                 
10
 This study is currently in review as: Cigan, A. D. Nims, R. J. Vunjak‐Novakovic, G. Hung, C. T. Ateshian, G. A., 
2016c. Optimizing nutrient channel spacing and revisiting TGF-beta in large engineered cartilage constructs. J 
Biomech In Review,  
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emphasize that nutrient channels are effective only in the presence of TGF-β, and indicate that 
spacings equivalent to 12 channels in 10 mm constructs can be employed in articular-layer-
sized constructs with reduced dosages of TGF-β. 
 
5.1.2  Introduction 
Cartilage tissue engineering is a promising approach to treat osteoarthritis, a debilitating joint 
disease affecting over 27 million Americans and many more worldwide (Lawrence et al., 2008). 
Current cartilage tissue engineering (CTE) techniques have reproduced native compressive 
Young’s moduli (EY) and glycosaminoglycan (GAG) contents in ~ 4 mm chondrocyte-agarose 
constructs. However, osteoarthritis (OA) is often asymptomatic until cartilage lesions reach ~ 
25 mm (Moisio et al., 2009b), and larger constructs are ultimately necessary for clinical 
relevance of CTE. Previous attempts to culture articular layer-sized constructs exhibited matrix 
heterogeneity due to poor nutrient availability at construct interiors (Hung et al., 2003; Hung et 
al., 2004). 
The incorporation of nutrient channels reduces transport distances within constructs. We 
previously demonstrated beneficial effects of placing 3 (CH3) or 12 (CH12) evenly-spaced  1 
mm channels in 10 mm juvenile bovine chondrocyte-agarose constructs, compared to channel-
free controls (CH0) (Bian et al., 2009a; Cigan et al., 2014b; Nims et al., 2015). Computational 
growth models of constructs with increasing numbers of channels up to CH12 (Nims et al., 2015) 
predicted increased glucose availability, a previously shown marker for construct growth (Cigan 
et al., 2013a; Heywood et al., 2006a; Nims et al., 2014), and concomitant increases in matrix 
synthesis. Later experiments supported these trends, though disparities in tissue growth due to 
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channel spacing were greatly under-predicted by glucose availability alone and had no apparent 
plateaus (Nims et al., 2015). 
For a given hydrogel size and cell seeding density, increasing the number of channels 
reduces the total cell number, and the benefits of heightened nutrient availability become offset. 
Thus an optimum channel density exists, which has yet to be determined. Recently, we 
demonstrated that conventional supplementation of constructs with 10 ng/mL active TGF-β, 
which permits the achievement of native EY and GAG content by constructs in serum-free media 
(Byers et al., 2008), contributes substantially to matrix heterogeneity within constructs (Albro et 
al., 2016), placing new emphasis on the utility of channels in CTE systems requiring TGF-β. 
Ultimately, we aim to employ channels and TGF-β to cultivate articular layer-sized 
constructs that are clinically relevant for treatment of OA. To achieve this aim, our two 
immediate objectives are to more fully elucidate the interplay between channels and TGF-β, and 
to identify optimal channel spacing for this culture system. To these ends, we 1) cultivated CH0 
and CH12 constructs without TGF-β and contrasted the results with TGF-β-supplemented 
constructs, and 2) placed greater numbers of channels (beyond CH12) in 10 mm constructs to 
explore the upper limits of channel effectiveness.  
 
5.1.3 Methods 
5.1.3.1 Custom mold fabrication 
CH0 and CH12 constructs were cast with previously described PTFE/steel/glass molds (Cigan et 
al., 2014b). Closer-set channel configurations were designed such that whole numbers of 
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triangularly-packed 1 mm channels could be symmetrically contained within 10 × 2.3 mm 
cylindrical constructs. The resulting channels were spaced 1.83 mm or 1.54 mm (center-to-
center) to yield 19 or 27 channels (CH19 or CH27), respectively. These molds (Figure 5-1) were 
designed in Solidworks (Dassault Systèmes, Waltham, MA), manufactured from polyacrylate 
material (VeroWhitePlus RGD835) by a 3D printer (Objet24, Stratasys, Eden Prairie, MN), dried 






Figure 5-1: A) CAD diagram of CH27 mold, B) 3D-printed CH19 mold, and 
agarose gels cast for C) CH27 and D) CH19 groups. 
 
 
5.1.3.2 Culture conditions 
Juvenile bovine primary articular chondrocytes were cast in 2% w/v agarose as previously 
described (2.1). Experimental groups are depicted in Figure 5-2. In Study 1, CH0 and CH12 
constructs (n = 5 per group) were cast with 60 × 10
6






media (3.1.3.2) for 42 days without TGF-β. In Study 2, CH0, CH12, CH19, and CH27 constructs 
(Figure 5-1C-D) were cast with 45 × 10
6
 cells/mL and cultured for 56 days (n = 4 per group) 
with 10 ng/mL TGF-β3 for the first 14 days; additional CH12 constructs (n = 2) were 
supplemented instead with 1 ng/mL TGF-β3 (CH12 1ng). 
 
 
Figure 5-2: Experimental groups and their gross morphologies at day 42 or 56. 
 
 
5.1.3.3 Mechanical, biochemical, and histological analyses 
Constructs were tested for EY, bisected, and half of each construct was assessed for GAG and 
collagen contents and cellularity as previously described (Cigan et al., 2014b; Farndale et al., 
1986; Hollander et al., 1994). GAG and collagen were expressed as either percent of final wet 
weight (%/ww, a measure of construct composition) or as percent of initial wet weight 
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(%/D0ww, a measure of total matrix deposition). Swelling ratios (SR) were calculated as the 
ratio of final construct weights to construct day 0 weights. Remaining half-constructs were 
stained with 0.1% Safranin O (for GAG) or 0.1% Picrosirius Red (for collagen) as previously 
described (2.6).  
 
5.1.3.4 Statistics 
Study 1 constructs (CH0 and CH12) were compared by unpaired Student’s t-test for EY, SR, and 
%/ww GAG and collagen. In Study 2, groups receiving 10 ng/mL TGF-β were analyzed by one-
way ANOVA (α = 0.05) with channel configuration as the independent factor, and with EY, SR, 
and GAG and collagen contents (by %/ww and %/D0ww) as dependent variables. Tukey’s HSD 
post hoc tests were instituted upon determination of significance (p < 0.05). In a separate 
analysis, CH12 1ng and CH12 10ng constructs were compared by t-test similarly as above. 
 
5.1.4 Results 
5.1.4.1 Effects of channels without TGF-β 
In Study 1, CH0 and CH12 constructs receiving no TGF-β had similar EY (100 ± 27 kPa, p = 
0.87; Figure 5-3A), GAG (5.0 ± 0.7 %/ww, p = 0.23; Figure 5-3C), and collagen (1.7 ± 0.3 
%/ww, p = 0.42; Figure 5-3D). CH12 constructs had higher SR (1.28 ± 0.07) than CH0 (1.17 ± 
0.04, p < 0.05; Figure 5-3B). Both CH0 and CH12 constructs appeared translucent relative to 






Figure 5-3: A) EY, B) swelling ratios, and C) GAG and D) collagen contents of 



































































Figure 5-4: Histological images of Study 2 constructs, stained for GAG by 
Safranin O (left) or for collagen by Picrosirius Red (right). * filled channels, ▼ 
open channels, † cracks formed in constructs. 
 
5.1.4.2 Effects of channel configuration  
5.1.4.2.1 Morphology and histology 
All Study 2 constructs were opaque and resembled native cartilage (Figure 5-2). Channels tended 
to fill in, in some instances entirely, with dark staining for collagen often present at the margins 
(Figure 5-2, Figure 5-4). CH0 constructs cracked at their centers and formed fluid-filled cavities 
(Figure 5-4A-B), with cracks reaching the surface (Figure 5-2). Distributions of GAG and 
collagen were uniform in channeled constructs (Figure 5-4E-J). Channels influenced SR (p < 
0.0001, Figure 5-5A), with CH27 constructs swelling the least (SR: 1.5 ± 0.4, p < 0.0005) and 
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Figure 5-5: A) Swelling ratio, B) EY, C) %/ww GAG, D) %/D0ww GAG, E) 
%/ww collagen, and F) %/D0ww collagen for Study 2 constructs. † p < 0.05 










































































































































5.1.4.2.2 Functional properties 
Channeled constructs receiving 10 ng/mL TGF-β developed EY ~340 kPa (Figure 5-5B); CH0 
moduli were much lower (66 ± 57 kPa), but because two CH0 constructs could not be reliably 
mechanically tested due to extreme surface irregularities, no statistical effect of channel spacing 
was shown (p = 0.10). All constructs had similar %/ww GAG (10.3 ± 1.2 %/ww, p = 0.26; 
Figure 5-5C) and collagen (2.2 ± 0.2 %/ww, p = 0.51; Figure 5-5E), and %/D0ww collagen (4.7 
± 0.6 %/D0ww, p = 0.08; Figure 5-5F). %/D0ww GAG was influenced by channel spacing (p < 
0.0005, Figure 5-5D), with CH27 having the lowest (15.3 ± 3.9 %/D0ww, p < 0.005) and the 
other constructs being similar (25.8 ± 2.8 %/D0ww, p > 0.46). 
 
5.1.4.3 Reduced TGF-β 
CH12 1ng constructs developed similar morphological and histological features as CH12 10ng 
constructs (Figure 5-2, Figure 5-4C-F), though they swelled less (SR: 2.1 ± 0.1 vs. 2.4 ± 0.1, p < 
0.05; Figure 5-5A). Lower TGF-β dosage yielded EY over twice as high (705 ± 257 kPa) as 
constructs receiving standard 10 ng/mL dosages (347 ± 184 kPa), though this was not 
statistically significant (p = 0.11, Figure 5-5B). CH12 1ng had less %/D0ww GAG (20.1 ± 0.8 
%/D0ww) than CH12 10ng (25.2 ± 2.2 %/D0ww, p < 0.05; Figure 5-5D), but similar %/ww 
GAG (9.8 ± 0.8 vs. 10.4 ± 1.4 %/ww, p = 0.59; Figure 5-5C), %/ww collagen (2.4 ± 0.1 vs. 2.3 ± 
0.2 %/ww, p = 0.33; Figure 5-5E), and %/D0ww collagen (4.9 ± 0.8 vs. 4.7 ± 0.6 %/ww, p = 





A primary objective of CTE studies is to recapitulate cartilage’s native mechanical properties 
and matrix content. In our previous study, CH12 constructs contained over twice as much GAG 
and collagen as CH0 constructs when both were supplemented with 10 ng/mL TGF-β (Nims et 
al., 2015). The present results of Study 1 indicate that when TGF-β is withheld, nutrient channels 
are ineffective, suggesting that TGF-β is critically responsible for the beneficial effects of 
nutrient channels when glucose supplementation is plentiful (Nims et al., 2015). However, 
functional properties of TGF-β-free constructs were low compared to constructs receiving 1 or 
10 ng/mL TGF-β (Figure 5-2, Figure 5-3, Figure 5-5), as demonstrated previously (Byers et al., 
2008; Nims et al., 2014), reinforcing the importance of TGF-β and therefore of nutrient channels 
in chondrocyte-agarose constructs. 
 To investigate denser channel configurations, molds were 3D-printed for CH19 and 
CH27 constructs (Figure 5-1). In contrast to previously-used machined plastic/metal molds, this 
represents a precise, rapid, and economical method of producing various channel configurations. 
CH27 constructs produced substantially less GAG than all other groups (Figure 5-5D), and 
though they still contained similar levels of deposited collagen as other constructs, much of their 
overall growth occurred at the construct peripheries, outside the channel grid, suggesting that an 
upper limit for packing of channels had been reached, since the beneficial effects of shorter 
nutrient transport distances were outweighed by the lower initial cell population. Though CH12 
and CH19 constructs developed similar properties, CH19 constructs were more fragile to handle 
and therefore we will employ the spacing used for CH12 constructs in our future experiments 
growing articular layer-sized constructs. 
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 Constructs without channels performed poorly, albeit for different reasons than observed 
previously (Bian et al., 2009a; Cigan et al., 2014b; Nims et al., 2015). Compared to our prior 
experiment in which CH0 constructs produced less matrix and swelled to lesser extents (Nims et 
al., 2015), the current CH0 constructs swelled extensively at their peripheries, leaving large, 
fluid-filled cracks at their centers which accumulated synthesized GAG. However, we believe 
the inadequacies of CH0 constructs from both studies stem from poor nutrient availability at 
construct interiors, lending credence to channels as a strategy to enhance tissue growth. 
 CH12 constructs cultured with lower dosages of TGF-β (1 ng/mL) had similar GAG and 
collagen contents to those with standard dosages of 10 ng/mL (Figure 5-5C, E). Even though the 
lower dose resulted in less overall GAG synthesis (%/D0ww, Figure 5-5D), the similarly reduced 
swelling may have been responsible for higher EY (Figure 5-5A-B) due to a more uniformly 
cylindrical shape, making more complete contact with testing platens. Furthermore, we recently 
demonstrated that quelling construct swelling can reduce damage to deposited collagen fibrils 
and increase EY (Nims et al., 2016). We deem the properties attained by CH12 1ng constructs 
acceptable, particularly in light of our recent findings that 10 ng/mL TGF-β exacerbates matrix 
heterogeneity (Albro et al., 2016), and considering that reducing TGF-β requirements tenfold 
greatly reduces the cost of cultivating large CTE constructs in sufficient media volumes (Nims et 
al., 2015), and will facilitate the culture of even larger-scale constructs. 
 The cells used in this study were of juvenile bovine origin. Though CTE methods with 
human cells are ultimately necessary to treat OA, juvenile bovine chondrocytes represent a 
highly useful and well-established model system (Freed and Vunjak-Novakovic, 1997; Mauck et 
al., 2000). Further, juvenile chondrocytes have shown promise for clinical applications in 
allogeneic transplantation (Adkisson et al., 2010). Ongoing and future studies by our group seek 
112 
 
to translate results in bovine model systems to human chondrocytes (Cigan et al., 2015; 
O'Connell et al., 2015). 
 Ultimately, we aim to employ nutrient channels to produce high-quality, human articular 
layer-sized CTE constructs with mechanical and biochemical properties reflective of native 
cartilage. The results of the current study expanded on prior results to provide valuable insights 
for cultivating channeled CTE constructs. An optimum channel spacing for enhancing construct 
growth was experimentally determined and a strong relationship was demonstrated between 
TGF-β supplementation and channel effectiveness. Finally, a tenfold reduction of conventional 
TGF-β dosages yielded constructs of similar quality for a fraction of the cost. Together with our 
previous work, these findings will help enable the cultivation of CTE tissues sufficiently large to 
repair entire joints damaged by OA. 
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Award Numbers R01AR060361, R01AR046568, T32AR059038, R01 DE016525 and P41 
EB002520. The content is solely the responsibility of the authors and does not necessarily 
represent the official views of the National Institutes of Health.  
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Chapter 6  
 






6.1 Nutrient channels aid the growth of articular surface-sized 
engineered cartilage constructs11 12 
 
6.1.1 Abstract 
Cartilage tissue engineering is a promising approach to treat osteoarthritis. However, 
symptomatic osteoarthritic lesions span large regions of joint surfaces and current techniques 
typically produce engineered constructs on small scales (~3-6 mm diameter). The ability to scale 
up constructs to clinically relevant sizes is therefore highly desirable. Nutrient transport 
limitations can be mitigated by the introduction of channels in constructs to reduce path lengths 
for diffusion. In this study we built upon prior experiments with 10 mm-diameter bovine 
chondrocyte-agarose constructs with 1 mm-diameter channels. We 3D-printed custom molds and 
scaled up our previous system to cast and cultivate 40 mm-diameter constructs (2.3 mm thick). 
We cultured them alongside 4 mm-diameter and channeled 10 mm-diameter constructs. Further, 
to assess whether prior results using primary bovine cells are applicable for passaged cells – a 
more clinically realistic scenario – we cast constructs of each size with primary or twice-
passaged cells. Constructs were assessed mechanically for equilibrium compressive Young’s 
modulus (EY), dynamic modulus at 0.01 Hz (G*), and friction coefficient (µ); they were also 
assessed biochemically, histologically, and immunohistochemically for glycosaminoglycan 
(GAG) and collagen contents. By ensuring that channels remained open throughout culture, we 
                                                 
11
 These results were published in part as Cigan, A. D. Nims, R. J. Vunjak‐Novakovic, G. Hung, C. T. Ateshian, G. 
A., 2016a. Human-scale engineered cartilage with nutrient channels reaches native mechanical and biochemical 
properties. In Orthopaedic Research Society 2016 Annual Meeting. Orlando, FL, USA. 
12
 These results constitute a manuscript in preparation: Cigan, A. D. Nims, R. J. Vunjak‐Novakovic, G. Hung, C. T. 
Ateshian, G. A., 2016b. Nutrient channels aid the growth of articular surface-sized engineered cartilage constructs. 
In preparation  
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successfully cultured robust constructs the size of entire human articular cartilage layers (final 
sizes ~52 mm diameter, 4 mm thick, 8 g mass), representing a 100-fold increase in scale over our 
4 mm-diameter constructs, without compromising their functional properties. Large constructs 
reached EY of up to 623 kPa and GAG contents up to 8.9 %/ww (% of wet weight), both within 
native cartilage ranges, had G* of over 2 MPa, and up to 3.5 %/ww collagen. Constructs also 
exhibited some of the lowest µ reported for engineered cartilage (0.06-0.11). Passaged cells 
produced tissue of lower quality but still exhibited native EY and GAG content, similar to their 
smaller controls. The constructs produced in this study are, to our knowledge, the largest 
engineered cartilage constructs to date which possess native EY and GAG, and are a testament to 




Cartilage tissue engineering is a promising approach to cultivate cartilage constructs in vitro for 
replacing tissue lost from osteoarthritis, involving the seeding of cells within porous scaffolds 
with the expectation that they will reproduce critical functional properties of native cartilage 
tissue. Cartilage was identified as an early target for tissue engineering due to its thinness, 
avascularity, and population by a single cell type (Cima et al., 1991; Langer and Vacanti, 1993). 
To date, however, obstacles remain which prevent the in vitro cultivation of replacement human 
cartilage, not the least of which being the inability of researchers to produce functional cartilage 
at large enough scales for clinical relevance. The primary objective of this study was to address 
this challenge using channels to enhance nutrient supply in articular surface-sized tissue 
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constructs, mimicking the network of cartilage canals that provide this role during early cartilage 
development (Gruber et al., 1990; Ytrehus et al., 2004). 
The vast majority of current cartilage tissue engineering (CTE) research focuses on small 
(3-6 mm diameter) tissue constructs (Awad et al., 2004; Buckley et al., 2009; Hu and 
Athanasiou, 2006; Mauck et al., 2000; Obradovic et al., 1999; Vunjak-Novakovic et al., 1999). 
Chondrocyte-agarose constructs have proven to be an efficient model system, particularly when 
cultured in ITS media with transient supplementation by 10 ng/mL TGF-β (Benya and Shaffer, 
1982; Buschmann et al., 1992; Byers et al., 2008; Mauck et al., 2000; Mouw et al., 2005; 
O'Conor et al., 2014; Rahfoth et al., 1998). Using this system, our group consistently reproduces 
native cartilage equilibrium compressive Young’s modulus (EY) and glycosaminoglycan (GAG) 
content in 4 mm constructs using either primary or passaged bovine chondrocytes (Bian et al., 
2009b; Cigan et al., 2013a; Kelly et al., 2006; Lima et al., 2007; Ng et al., 2009b; Nims et al., 
2014). However, by the time osteoarthritis (OA) manifests itself symptomatically, articular 
cartilage lesions typically reach ~25 mm in diameter (Curl et al., 1997; Moisio et al., 2009a). 
While studies with small constructs are instrumental to the advancement of the field, they 
ultimately must be scaled up in order to successfully treat OA. 
As scaffold dimensions are increased, constructs experience transport limitations as 
media nutrients necessary for cell survival and/or matrix synthesis are depleted by cells at the 
construct periphery, producing a deficiency at the center (Albro et al., 2016; Cigan et al., 2013a; 
Heywood et al., 2006a; Heywood et al., 2006b; Nims et al., 2014; Obradovic et al., 1999; 
Sengers et al., 2005; Zhou et al., 2008). Even using bovine calf chondrocytes, which readily 
synthesize matrix and represent a “best-case-scenario,” previous attempts to engineer constructs 
at clinically-relevant scales have experienced severe tissue heterogeneity and poor mechanical 
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integrity, and using small constructs to repair large defects would require a mosaicplasty-like 
procedure which may suffer from poor integration (Hung et al., 2003; Hung et al., 2004; Nover 
et al., 2016). The addition of channels reduces transport distances, mitigating nutrient limitations 
and improving construct mechanical properties (Bian et al., 2009a; Buckley et al., 2009). In our 
recent studies, the combination of suspended culture and sufficient glucose supply permitted 
10 mm constructs with 3 or 12 evenly-spaced 1 mm channels (CH3 or CH12, respectively) 
to attain functional properties on par with those of 4 mm constructs, including native EY and 
GAG content (Cigan et al., 2014b; Nims et al., 2015). 
For many tissue engineering studies employing bovine chondrocytes, primary cells are 
harvested and seeded directly into constructs (Cigan et al., 2013a; Eleswarapu and Athanasiou, 
2013; Ng et al., 2005; Svensson et al., 2005). In this approach, numerous calf joints may be 
harvested and pooled together to obtain enough chondrocytes for large-scale studies. While this 
holds benefit for CTE feasibility studies, it does not represent a realistic clinical scenario since 
the isolation of sufficient primary chondrocytes to resurface entire human joints poses an 
extreme logistical hurdle. Thus, many studies have employed passaged bovine, canine, or human 
chondrocytes (Bian et al., 2010; Gan and Kandel, 2007; Ng et al., 2010; Nover et al., 2016; 
Nover et al., 2015; O'Connell et al., 2015; Oswald et al., 2011; Tan et al., 2015; Veilleux et al., 
2004). A direct comparison of passaged versus primary bovine chondrocytes in agarose could 
elucidate whether results derived with primary bovine cells are applicable for constructs seeded 
with passaged cells.  
 The objectives of this study were to overcome transport limitations by incorporating 
channels in the cultivation of articular surface-sized constructs, and to assess whether results 
from large constructs seeded with primary chondrocytes can forecast successes with passaged 
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cells. By scaling up our culture system for 10 mm constructs, we developed techniques for 
casting and cultivating 40 × 2.3 mm chondrocyte-agarose constructs, large enough to resurface 
human joints (e.g., the knee)(Cigan et al., 2014b). The specific hypothesis of this study is that 
these 40 × 2.3 mm constructs can develop functional properties on par with those of channeled 
10 × 2.3 mm and channel-free 4 × 2.3 mm constructs. Additionally, we compared primary 




Two studies were performed on eight casts of constructs (Table 6-1). Study 1 served as a 
preliminary study to identify culture conditions for 40 mm constructs to enhance homogeneous 
growth. By staggering these cultures over several weeks and examining construct growth, 
protocols for manufacturing and culturing large constructs were refined. Upon completion of 
Study 1, the experimental design of Study 2 was established to address our specific aims and 
hypotheses, using conditions optimized in Study 1. The outcomes of Study 1 were valuable, 
warranting their dissemination along with those of Study 2. 
 
6.1.3.2 Mold design 
Custom molds were produced to cast 40 × 2.3 mm cylindrical constructs with nutrient 
channels. The molds, designed in Solidworks (Dassault Systèmes), consisted of three parts: 1) a 
top, featuring a pillar array, 2) a base piece, and 3) a collar (Figure 6-1A). In one set of molds the 
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pillar arrays produced 1 mm nutrient channels that had CH3-equivalent or CH12-equivalent 
spacing (CH3E or CH12E, respectively) based on 10 mm constructs from previous studies 
(Figure 6-2)(Bian et al., 2009a; Cigan et al., 2014b; Nims et al., 2015). A second set of molds 
had 1.4 mm pillars (2× the area of 1 mm), to discourage filling of channels during culture, 
spaced with similar edge-to-edge distances as CH3E and CH12E molds, yielding 2×CH3E and 
2×CH12E constructs, respectively. (Figure 6-2). Detailed mold drawings can be found in 
Appendix 5. 
The Solidworks designs were fabricated from polyacrylate material (VeroWhitePlus 
RGD835) by a 3D printer (Objet24, Stratasys, Eden Prairie, MN), dried overnight under vacuum 
at 50 °C, and sterilized in 70% ethanol for 10 minutes. 
 
 
Figure 6-1: (A) Sample assembled and disassembled 40 mm CH12E casting 







Figure 6-2: Channel arrangements in 40 mm constructs: (A) CH3E, (B) CH12E, 
(C) 2×CH3E, and (D) 2×CH12E. Insets depict channel diameters and c-c spacings 
in mm. 
 
6.1.3.3 Harvest and casting 
Juvenile bovine articular chondrocytes were harvested from calf wrists (n = 16 per cast with 
primary cells, n = 6 total for all casts with passaged cells) and digested in collagenase solution as 
previously described (2.1). The released chondrocytes were either cast immediately as primary 





 in expansion medium (high-glucose DMEM with 10% FBS, 1% Antibiotic-





et al., 2010; O'Connell et al., 2015). After reaching confluence at second passage, P2 cells were 
trypsinized. P0 or P2 cells were cast at nominal cell densities of 60 × 10
6
 cells/mL in 2% agarose 
type VIIA (Sigma-Aldrich), either in one of the 3D-printed molds described above (40 × 2.3 
mm constructs) or as previously described to produce 4 × 2.3 mm and CH12 10 × 2.3 mm 
constructs (Cigan et al., 2013a; Cigan et al., 2014b). 
  
6.1.3.4 3D culture 
To enhance nutrient flow through channels, we modified a previous system optimized for 
culturing 10 mm channeled constructs, in which constructs were suspended in racks and 
subjected to orbital shaking (Cigan et al., 2014b; Nims et al., 2015). The system was scaled up 
such that each 40 mm construct was held by a culture rack housed within a 473 mL 
polypropylene container with a polyethylene lid (detailed drawings may be found in Appendix 5 
and Figure 6-1). Prior to culture, the containers were autoclaved and the lids were sterilized in 
70% ethanol. Constructs were cultured for 56 days in ITS media on an orbital shaker at 0.8 
Hz.(Cigan et al., 2013a) Constructs were supplemented with either 1 or 10 ng/mL TGF-β for the 
first two weeks of culture, after preliminary experiments demonstrated similar or better 
properties of 10 mm constructs with reduced TGF-β dosage (Byers et al., 2008; Cigan et al., 
2013a; Cigan et al., 2016c). Initially each construct was provided 200 mL of media; as cultures 
progressed, constructs swelled substantially, requiring more media to maintain their immersion; 
after day 28, the volume per construct was increased by 25 mL/week, finally receiving 300 mL 






Cast P TGF-ß 
(ng/mL) 
CH3E/ 
CH12E CH open/fill Controls Study 
C1 P0 10 1/1 Filled - 1 
C2 P2 10 0/2 Filled 4 mm 1 
C3 P2 10 2/0 1 Filled 1 Open 4 mm 1 
C4 P2 10 1/0 Open 4 mm 1 
C5 P2 1 1/1 Open 4 mm 1 
C6 P2 1 1/1 (2×CH) Open 4 mm 1 
C7 P2 1 0/4 (2×CH) Open 4 mm, 10 mm 2 
C8 P0 1 0/3 (2×CH) Open 4 mm, 10 mm 2 
Table 6-1: Summary of conditions for each 40 mm constructs by cast. 
 
 
6.1.3.4.1 Study 1 
A series of preliminary studies seeking to fine-tune culture conditions for 40 mm constructs 
was performed, consisting of six casts (C1-C6) generating a total of 11 40 mm constructs, each 
with simultaneously-cast 4 mm constructs serving as controls (n = 4). Culture conditions for 
each cast are summarized in Table 6-1. Constructs were varied by cell passage number (P0 or P2 
chondrocytes), TGF-β dosage (10 or 1 ng/mL), and channel arrangements (CH3E, CH12E, 
2×CH3E, or 2×CH12E). 
 In constructs from C1-C2, channels exhibited a tendency to fill in before day 56. This 
premature filling was suspected to be associated with extreme matrix heterogeneities that were 
observed. Thus, channels in C3-C6 constructs were maintained open throughout culture: during 
weeks 3 and 5, a 1 mm biopsy punch was passed through each individual channel to clear any 
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occluding tissue. From C3, only one of two constructs was re-punched in order to compare the 
resulting construct properties. 
 
6.1.3.4.2 Study 2 
Following Study 1, the most beneficial culture conditions were selected for Study 2: 2×CH12E 
constructs, supplemented with 1 ng/mL TGF-β, with channels re-punched at weeks 3 and 5. In 
two casts, 2×CH12E constructs were cast with either P0 (C7, n = 3) or P2 cells (C8, n = 4). For 
each cast, CH12 10 mm (n = 4) and 4 mm constructs (n = 4) served as controls. 
 
6.1.3.5 Construct processing 
At day 56, each 40 mm construct was bathed in sterile PBS for 45 minutes to elute culture 
media. The diameter, thickness, and mass were recorded. Constructs were photographed before 
being divided for subsequent analyses (Figure 6-3). For histological analysis, narrow strips were 
taken along the diameter of each construct. For mechanical and biochemical analyses, a 6 mm 
biopsy punch was used to harvest cylindrical cores (n = 4) from the constructs, taking care to 
avoid the construct peripheries. For friction testing, two rectangular strips (approximately 20 mm 






Figure 6-3: Subdivision of 40 mm construct (2×CH12E construct pictured) into 
6 mm cores for EY and biochemical analyses, strips for friction testing, and 
diametric slices for histology. 
 
6.1.3.6 Mechanical evaluation 
Constructs (4 mm and 10 mm) and cores (40 mm constructs) were tested under unconfined 
compression as described previously (Cigan et al., 2014b). Briefly, a creep load was applied, 
followed by a ramp to 10% compressive strain which was held for either 6 × 10
3
 s (4 mm), 10
4
 
s (6 mm cores), or 1.1 × 10
4
 s (10 mms). After relaxation, a dynamic test of ±1% sinusoidal 
strain was performed at 0.01 Hz for five cycles. EY was calculated from construct geometry and 
from the equilibrium load and displacement, and dynamic modulus (G*) was extracted by a 
6 mm cores 
For E
Y




~20 × 10 mm strips 
For friction testing 
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custom MATLAB script. Following mechanical testing, 10 mm and 4 mm constructs were 
bisected for biochemical and histological analyses. 
 Rectangular strips from each of five constructs (P0, n = 3; P2, n = 2) were glued onto 
opposing platens of a custom migrating-contact friction testing apparatus outfitted with a 6-
degree-of-freedom 15-lb load cell, linear encoder, stepper motor-driven translating stage, and 
voice coil actuator. Tests were conducted in a PBS bath with protease inhibitors. A 4.5 N load 
was continuously applied with simultaneous reciprocal sliding at 1 mm/s (2.5 mm zero-to-peak 
amplitude) (Movie 1, Supplemental Data, (Cigan et al., 2016b)). The friction coefficient (µ) for 
each cycle was calculated as the ratio of cycle-averaged tangential to normal forces. Tests were 
performed for 30 minutes. For each sample, µ0, µf, and µavg were calculated as the µ for the first 
complete cycle, the final cycle, and the average for all cycles. 
 
6.1.3.7 Biochemical evaluation 
Construct cores (6 mm cores, for 40 mm constructs) and half-constructs (4 mm and 10 
mm constructs) were digested with Proteinase K and assayed as described previously for GAG, 
cellularity, and collagen (2.3). To quantify the deposition of type II collagen, cores from 40 
mm constructs were digested in pepsin and elastase and assayed by a type II collagen ELISA 
(Chondrex, Inc.) alongside samples of juvenile bovine knee cartilage (n = 2). Damage to 
deposited collagen fibrils due to construct swelling was assessed as described previously (Bank 




6.1.3.8  Histological and immunohistochemical evaluation 
Half-constructs (10 mm and 4 mm) and diametric slices of 40 mm constructs (bisected to 
facilitate embedding) were stained either with 0.1% Safranin O (for GAG) or with 0.1% 
Picrosirius Red (for collagen) as previously described (2.6). Immunohistochemistry was 
performed as described by Gadjanski et al. with the following exceptions: antigen retrieval was 
performed by incubating sections in 2 mg/mL bovine testicular hyaluronidase for 1 h at 37 °C, 
and anti-collagen I (ab34710) and anti-collagen II (ab34712, Abcam) primary antibodies were 
used at 1:50 and 1:200 dilutions, respectively (Gadjanski et al., 2013). 
 
6.1.3.9   Statistical analyses 
For Study 1, two-way ANOVAs were performed for C1-C6 constructs combined, with 
independent variables of either 1) channel spacing, open/filled channels, and their interaction; or 
2) channel spacing, TGF-β3 dosage, and their interaction. EY, G*, GAG, collagen, or percent 
collagen damage served as dependent variables (α = 0.05); Tukey’s HSD post hoc testing of the 
means was implemented upon determination of significance (p < 0.05). Though 4 mm controls 
provided points of reference for 40 mm properties, statistical comparisons were not feasible 
due to low n (1-2 40 mm constructs per cast). 
 In Study 2, two-way ANOVAs were performed, with cell passage number (P0 or P2) and 
construct size (4 mm, 10 mm, or 40 mm) as independent factors. Data for both studies are 





6.1.4.1 Study 1 
6.1.4.1.1 Morphology and histology 
After 56 days, constructs bore a cartilage-like opacity and appearance (Figure 6-4A-B). 
Constructs exhibited marked swelling, reaching diameters of 49.3 ± 1.5 mm and thicknesses of 
4.3 ± 0.4 mm. Channels tended to fill in (Figure 6-4A), unless they were re-punched (Figure 
6-4B). Histology revealed large matrix-devoid regions at the centers of constructs with filled-in 
channels; this deficiency was partially mitigated by re-punching channels (Figure 6-4C-H). 
Closer-packed channels (i.e. CH12E), when re-punched, stained richly for GAG and collagen 





Figure 6-4: (A) Day 56 40 mm CH12E construct, with filled-in channels, beside 
an acellular agarose gel; (B) day 56 40 mm CH12E construct with re-punched 
channels. Stains for Safranin O (GAG; C, E, G, I) and Picrosirius Red (collagen; 








































Figure 6-5: (A) EY, (B) GAG and (C) collagen contents of 40 mm constructs in 
Study 1, grouped by culture parameters. CH3E and CH12E contain constructs 
with 2×CH3E and 2×CH12E channel configurations, respectively. * p < 0.05 
between groups. 
 
6.1.4.1.2 Functional properties 
EY
 
were found to be more than twice as high in CH12E constructs compared to CH3E (236 ± 158 
vs. 110 ± 45 kPa), and were markedly improved in 1 ng/mL TGF-β constructs versus 10 ng/mL 
(263 ± 167 vs. 113 ± 44 kPa); EY were similar for constructs with filled or re-punched channels 
(173 ± 128 kPa, Figure 6-5A). GAG content was only significantly improved by 1 ng/mL TGF-β 

































































significantly higher in constructs with CH12E configurations (1.8 ± 0.8 %/ww), re-punched 
channels (1.7 ± 0.3 %/ww), and 1 ng/mL TGF-β (2.1 ± 0.5 %/ww) than they were in constructs 
with CH3E configurations (1.4 ± 0.2 %/ww), filled-in channels (1.2 ± 0.1 %/ww), and 10 ng/mL 
TGF-β-supplemented (1.3 ± 0.1 %/ww, Figure 6-5C). Control constructs (4 mm) from C2-C6 
(n = 16) possessed EY of 449 ± 77 kPa, 6.9 ± 1.1 %/ww GAG, and 2.3 ± 0.4 %/ww collagen. 
Though statistical comparisons were not made between 4 mm and 40 mm constructs due to 
low n, 4 mm constructs generally had far better functional properties, excepting a C6 40 mm 
construct with a 2×CH12E channel arrangement, re-punched channels, and 1 ng/mL TGF-β (EY 
= 490 kPa, 6.8 %/ww GAG, 2.9 %/ww collagen), which had similar properties to its 4 mm 
controls (EY = 464 ± 86 kPa, 6.5 ± 0.7 %/ww GAG, 2.8 ± 0.4 %/ww collagen; p > 0.5) and the 
highest functional properties among all 40 mm constructs. This combination of culture 
parameters was thus implemented for all constructs in Study 2. 
 
6.1.4.2 Study 2 
 
6.1.4.2.1 Morphology, histology, and immunohistochemistry 
All study 2 constructs grew substantially in size; 40 mm constructs had all exceeded 50 mm 
by day 56 (Figure 6-6A-B). At this size, constructs exceeded the dimensions of articular surfaces 
of the human knee (Figure 6-6C-D). Due to manual re-punching most channels remained open, 
except those of P2 10 mm constructs which had nearly all filled in (Figure 6-6B).  
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 Constructs generally showed darker histological staining for GAG and collagen than in 
Study 1 (Figure 6-4C-J, Figure 6-7). Matrix-devoid regions were observed at the centers of 4 
mm constructs, of 10 mm constructs with filled-in channels, and in regions outside the channel 
arrays of 40 mm constructs. Notably, at either end of 40 mm diametrical cross sections, 
regions appeared which were analogous to the centers of 4 mm constructs (Figure 6-7). 
 Immunostaining showed that type II collagen was distributed throughout construct 
centers, with darker staining localized to construct peripheries (Figure 6-8). Type II stained 
darker for P0 cells in larger constructs (10 mm, 40 mm) compared to P2, though in 4 mm 
constructs P0 staining for type II was lighter. Type I collagen staining was generally consistent 
throughout construct centers and peripheries, with the exception of P2 4 mm and P0 10 mm 
constructs wherein construct edges stained more darkly. P2 10 mm constructs possessed the 
darkest type I staining, while 40 mm constructs exhibited less type I staining than other 
construct sizes. Due to disparate binding affinities and concentrations of the collagen I and II 
primary antibodies, we cannot make qualitative assessments of the relative contents of collagen 





Figure 6-6: Day 56 40 mm (2×CH12E), 10 mm, and 4 mm constructs using 
(A) P0 or (B) P2 cells; (C) scale of a P0 40 mm 2×CH12E construct contrasted 
with an adult human knee’s tibial and patellar cartilages, and (D) eclipsing the 












Figure 6-7: Histological stains for collagen by (A-B) Picrosirius Red or (C-D) 
GAG by Safranin O in 4 mm, 10 mm, and 40 mm 2× CH12E constructs. 
Dotted lines indicate cut lines, + regions of little matrix deposition, * filled 





Figure 6-8: Immunohistochemical staining for collagen types 1 and 2 in 
constructs. Due to disparate binding affinities and concentrations of the collagen I 
and II primary antibodies, the relative contents of collagen types may not be 
compared based on stain intensity. 
 
6.1.4.2.2 Functional properties 
On average, 40 mm constructs reached or exceeded native cartilage EY and GAG content (EY = 
450 ± 114 kPa, 8.1 ± 0.7 %/ww GAG), and select constructs reached EY of 623 kPa, G* of 2.48 
MPa, 8.9 %/ww GAG, and 3.5 %/ww collagen (Figure 6-9). Deposited collagen was 51.3 ± 5.9% 
denatured in all samples, with no significant effects of construct size or cell passage number (p > 
0.05). Collagen type as determined by ELISA was predominantly type II, with abundances of 
60.3 ± 6.1% and 62.1 ± 1.6% of total collagen content in P0 and P2 40 mm constructs, 
















































influenced by cell passage number (p < 0.005) and construct size (p < 0.005), but not by their 
interaction (p = 0.7; Figure 6-9A). Primary cells yielded higher EY than passaged cells (P0: 415 ± 
136 kPa, P2: 282 ± 90 kPa; p < 0.005). The largest constructs were significantly stiffer (450 ± 
114 kPa) than 4 mm (289 ± 68 kPa; p = 0.005) and 10 mm (312 ± 145 kPa; p < 0.05) 
controls. G* were significantly affected by construct size (p < 0.05; Figure 6-9B), with 10 mm 
constructs exhibiting higher G* (1.99 ± 1.19 MPa) than 4 mm constructs (1.00 ± 0.35 MPa, p < 
0.05); 40 mm constructs (1.70 ± 0.60 MPa) were not different from 10 mm constructs, (p = 
0.77), and showed a trend towards higher G* than 4 mm constructs (p = 0.067). Passage 
number had a strong effect on G*, (p < 0.005), with primary cells (2.05 ± 1.03 MPa) 
outperforming passaged cells (1.10 ± 0.35 MPa). 
 Primary cells yielded significantly higher matrix contents (9.5 ± 1.3 %/ww GAG, 3.6 ± 
0.7 %/ww collagen) than passaged cells (8.5 ± 0.7 %/ww GAG, p < 0.05; 2.4 ± 0.4 %/ww 
collagen, p < 0.0001; Figure 6-9C-D). Construct size influenced GAG content (4 mm: 9.5 ± 
1.0 %/ww, 10 mm: 9.2 ± 1.2, 40 mm: 8.1 ± 0.7; p < 0.05); 4 mm constructs had more 
GAG than 40 mm constructs (p < 0.05), but construct size did not affect collagen (p = 0.13). 
The interaction of passage number and size was significant for collagen content (p < 0.0005), 
and P0 10 mm constructs had significantly higher collagen than any other group (4.4 ± 0.8 
%/ww, p < 0.05).  
 Swelling ratio (construct final ww/initial ww) depended on passage number (p < 0.0001), 
size (p < 0.0005), and their interaction (p < 0.001, Figure 6-9E). Swelling ratios by construct size 
were statistically distinct (p < 0.05); the most swelling was observed in 40 mm constructs (3.5 
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± 0.2), followed by 4 mm (2.9 ± 1.3) and 10 mm (2.4 ± 1.0). P2 constructs swelled more (3.6 
± 0.5) than P0 constructs (2.1 ± 0.9).  
 Large (40 mm) constructs were robust to manipulation and handling, as illustrated in 
Movie 2 (Supplemental data (Cigan et al., 2016b)). In comparison, 2% agarose gels 
representative of day 0 constructs are fragile and may easily break upon similar manipulation and 
handling, as illustrated in Movie 3 (Supplemental data (Cigan et al., 2016b)). Constructs 
exhibited favorable frictional behavior (Figure 6-10), possessing µ0, µf, and µavg of 0.064 ± 






Figure 6-9: Study 2 construct functional properties. * p < 0.05 for ANOVA effect 
of cell passaging (P), construct size (), or their interaction (P×); + p < 0.05 
between specific groups. n are superimposed on bars. Approximate native 









The primary objective of this study was to engineer articular surface-sized cartilage constructs, 
using channels to enhance nutrient supply, with functional properties and compositions 
comparable to those of much smaller-sized constructs. Results demonstrated that this objective 
was achieved successfully, producing the largest cartilage constructs to date which replicate 
native levels of EY (250-730 kPa) and GAG content (1-5 %/ww), while also producing robust 
levels of collagen (native levels ~10 %/ww), and G* values that are below native levels (12-20 
MPa) but are on par with engineered cartilage from previous studies (Buschmann et al., 1999; 
Fetter et al., 2006; Kelly et al., 2013; Kim et al., 1995; Krishnan et al., 2003; Ng et al., 2009d; 
Treppo et al., 2000). On average by day 56, large constructs had reached sizes of 52 × 4.3 mm, 
weighed 8.1 g, had EY of 450 kPa, and had 8.1 %/ww GAG and 2.6 %/ww collagen. The most 
robust 40 mm construct was cast with P0 cells and reached EY = 623 kPa, 8.9 %/ww GAG, and 
3.5 %/ww collagen. The large size of these constructs afforded us a unique opportunity to test 
entire apposing strips of engineered cartilage in friction. Although the coefficients measured (µ0 











0.025), they are among the lowest recorded by engineered cartilage to date (Bhumiratana et al., 
2014; Bian et al., 2010; Caligaris et al., 2009; Gleghorn et al., 2007; Moutos and Guilak, 2009; 
Peng et al., 2014). 
When comparing 40 mm constructs with smaller constructs, collagen content and G* 
remained comparable, GAG contents decreased slightly but were still within native ranges, and 
EY values were improved (Figure 6-9A-D), supporting our hypothesis that similar functional 
properties could be achieved in scaled-up constructs. This scaling up of conventionally-sized 
(4 mm) cartilage tissue constructs by 100-fold – as large as human knee cartilage layers 
(Figure 6-6) – without compromising their functionalities represents the major contribution by 
this study, and is a testament to the capability of nutrient channels to promote growth in 
constructs of any size. The significantly higher compressive properties of the 40 mm constructs 
may be attributed to the fact that cores taken for mechanical testing were from within the channel 
array and therefore suffered no edge effects that 4 mm and 10 mm constructs likely 
experienced. It is conceivable that in a clinical scenario, constructs could be produced at the 
scale of 40 mm, or even larger, and the desired implant shape could be trimmed from the 
channel array of the construct by the orthopedic surgeon. 
In casts C6-8 of this experiment, the channel diameter was increased from 1 mm to 
1.4 mm, approximately doubling their area, while the edge-to-edge spacing was kept constant. 
This was in an attempt to prevent premature channel filling. Even with these larger channels, the 
re-punching technique was still applied and some tissue was removed from channels. In previous 
experiments, optimizations were carried out with constructs bearing 1 mm channels. A future 
experiment comparing the relative effects of channel spacing and channel diameter would help to 
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further optimize growth in these constructs. Given the exhaustive nature of such an experiment, a 
combined computational and experimental approach would be ideal to narrow down the number 
of experimental groups to be studied. 
Though P0 constructs exhibited better functional properties, those with P2 cells followed 
similar trends based on construct size, and P2 40 mm constructs were within native values of 
EY and GAG content for human knee cartilage (Figure 6-9)(Krishnan et al., 2003). This result is 
encouraging, since it suggests that our past and present results using primary cells are applicable 
to passaged cells, which represent a more realistic clinical scenario. Though adult cells were not 
used in this study, allogeneic implantation of juvenile human chondrocytes has previously shown 
clinical promise and therefore our results hold relevance for the treatment of adults (Adkisson et 
al., 2010). The current study, in tandem with our recent and promising results from constructs 
seeded with young and adult human chondrocytes (ages 17 to 35), suggest that engineering 
articular surface-sized constructs with human cells is a feasible strategy for treating advanced 
OA (Cigan et al., 2016d). 
Study 1 showed that premature channel filling was highly detrimental for construct 
properties (Figure 6-4C-D, Figure 6-5C), whereas Study 2 constructs with re-punched channels 
exhibited the highest functional properties (Figure 6-9). We know from previous experiments 
that punching constructs causes minimal loss of cell viability around the cut region (Bian et al., 
2009a; Tan et al., 2010). While it could be construed that channels compromise construct 
mechanical integrity, our large channeled constructs possess some of the most favorable 
compressive and frictional properties. The degree of matrix heterogeneity observed in constructs 
with filled-in channels (Figure 6-4) typically results in extremely low mechanical integrity, even 
if native bulk levels of GAG are achieved, because bulk compressive testing tends to measure the 
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properties of the softer central region rather than the matrix-rich periphery. Prior studies have 
characterized this spatial mechanical heterogeneity (Bian et al., 2009a; Nover et al., 2015). 
Another advantage of persisting channels is reflected by a feature of at least two commercial 
chondral allografts, Cartiform® (Arthrex Inc., Naples, FL) and Prochondrix® (AlloSource, 
Centennial, CO), which intentionally include similar pores. These pores may aid in surgical 
implantation and host integration, serving as sites for suturing, gluing, and for infiltration by 
stem cells from within the underlying subchondral bone. Therefore, persistent channels in large 
tissue constructs may be advantageous for clinical applications. 
 A common criticism of our cartilage tissue engineering strategy is our reliance on using 
agarose as a scaffold. We have reviewed our many arguments in favor of agarose in our previous 
studies (Hung et al., 2004; Mauck et al., 2003a; Ng et al., 2009b). As a component of 
Cartipatch® (Tissue Bank of France, Lyon, France), agarose has been used in a multi-center 
randomized controlled trial in France, comparing Cartipatch to mosaicplasty; though the long-
term outcome of patients treated with mosaicplasty was superior to those treated with Cartipatch, 
there were no significant adverse events attributed to the agarose-alginate scaffold (Clavé et al., 
2016). Furthermore, a recent investigation has reported that agarose implanted in rats in vivo 
does degrade as a result of phagocytosis, suggesting that biodegradability may not be a 
significant concern (Varoni et al., 2012). 
 This study represents a major milestone in our effort to engineer functional, articular 
surface-sized cartilage constructs for the resurfacing of OA joints. From our perspective the 
remaining major challenges include (a) the need to synthesize collagen to meet native levels, 
which is necessary to enhance interstitial fluid pressurization and produce a dynamic 
compressive modulus and friction coefficient that match native values; and (b) translating our 
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promising results achieved with immature bovine chondrocytes to young adult human 
chondrocytes. With regard to (a), high cell seeding densities, as used in this study, can produce 
native levels of collagen. Indeed, when normalizing final collagen levels to day 0 wet weight, the 
collagen levels achieved in this study reach or exceed 10% (divide collagen w/w by swelling 
ratio in Figure 6-9), and are predominantly the type II collagens (~61% of total collagen) which 
comprise native cartilage. However, the concomitant rapid synthesis of GAG caused swelling 
which diluted this collagen content and resulted in the damage of ~51% of the newly deposited 
collagen matrix, a level consistent with those shown in our recent study for constructs cultured 
56 days (Nims et al., 2016). Therefore, we are currently exploring strategies to delay GAG 
deposition until the elaboration of a strong collagen matrix that can resist swelling and damage. 
With regard to (b), we have recently shown in a manuscript under review that young adult 
human chondrocytes, isolated from expired osteochondral allografts from a tissue bank, exhibit a 
chondrogenic potential nearly comparable to that achieved by immature bovine chondrocytes 
(Cigan et al., 2016d). Therefore, we plan to further investigate this source of human cells in our 
effort to translate our tissue engineering approach to the clinic. 
This study demonstrated the efficacy of nutrient channels in articular layer-sized 
constructs comprised of chondrocyte-seeded agarose. However, all 3D culture strategies for CTE 
at large scales must contend with nutrient transport limitations, and due to the fundamental 
nature of incorporating channels to shorten nutrient diffusion distances, the general techniques 
presented in this study are not system-specific and could be applied for various cell and scaffold 
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7.1 High seeding density of human chondrocytes in agarose 
produces tissue-engineered cartilage approaching native 
mechanical and biochemical properties13 14 
 
7.1.1 Abstract 
Animal cells have served as highly controllable model systems for furthering cartilage tissue 
engineering practices in pursuit of treating osteoarthritis. Although successful strategies for 
animal cells must ultimately be adapted to human cells to be clinically relevant, human 
chondrocytes are rarely employed in such studies. In this study, we evaluated the applicability of 
culture techniques established for juvenile bovine and adult canine chondrocytes to human 
chondrocytes obtained from fresh or expired osteochondral allografts. Human chondrocytes were 
expanded and encapsulated in 2% agarose scaffolds measuring 3 mm × 2.3 mm, with cell 
seeding densities ranging from 15 to 90 × 10
6
 cells/mL. A subset of constructs was subjected to 
transient or sustained TGF-β treatment. Human cartilaginous constructs physically resembled 
native human cartilage, and reached compressive Young’s moduli of up to ~250 kPa 
(corresponding to the low end of ranges reported for native knee cartilage), dynamic moduli of 
~950 kPa (0.01 Hz), and contained 5.7 percent wet weight (%/ww) of glycosaminoglycans (≥ 
native levels) and 1.5 %/ww collagen. We found that the initial seeding density had pronounced 
                                                 
13
 This study was published as: Cigan, A. D. Nims, R. J. Albro, M. B. Jones, B. K. Feingold, H. J. Vunjak‐
Novakovic, G. Hung, C. T. Ateshian, G. A., 2015. Characterization of a Human Chondrocyte-Agarose System for 
Engineering Cartilage: The Importance of Cell Seeding Density. In Orthopaedic Research Society 2015 Annual 
Meeting. Las Vegas, NV. 
14
 This study is part of a manuscript currently in revision: Cigan, A. D. Roach, B. L. Nims, R. J. Tan, A. R. Albro, 
M. B. Stoker, A. M. Cook, J. L. Vunjak‐Novakovic, G. Hung, C. T. Ateshian, G. A., 2016d. High seeding density of 
human chondrocytes in agarose produces tissue-engineered cartilage approaching native mechanical and 
biochemical properties. J Biomech In revision,  
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effects on tissue outcomes, with high cell seeding densities significantly increasing nearly all 
measured properties. Transient TGF-β treatment was ineffective for adult human cells, and tissue 
construct properties plateaued or declined beyond 28 days of culture. These results demonstrate 




Osteoarthritis is a progressive joint disease affecting over 27 million Americans and many more 
worldwide (Lawrence et al., 2008). Articular cartilage is recalcitrant to repair following joint 
injury or osteoarthritis (OA) due to its low cell population and avascular nature. Cartilage tissue 
engineering (CTE) is a promising strategy for treating OA by encouraging cells to produce 
cartilage extracellular matrix in vitro by subjecting them to favorable culture conditions (Langer 
and Vacanti, 1993; Vacanti and Langer, 1999). CTE techniques have improved over the years 
and have shown great promise in animal model systems. However, cells for clinical translation of 
tissue engineering applications must ultimately be of human source and therefore CTE 
techniques that are successful in animal models must next be examined in human model systems. 
 When attempting to grow human cartilage in vitro, human mesenchymal stem cells 
(MSCs) have commonly served as cell sources (Bhumiratana et al., 2014; Bian et al., 2011; de 
Mara et al., 2013; Ghone and Grayson, 2012; Handorf and Li, 2011). While MSCs are readily 
obtained from patients from various tissues, they must be coaxed and maintained along a 
chondrogenic lineage. An alternative is the usage of allogeneic chondrocytes harvested from 
tissue bank cartilage, which are ideal for CTE applications because they already possess 
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chondrocytic phenotype and are not subject to immunological rejection by human joints. Human 
articular chondrocytes (hACs) are already clinically utilized in autologous chondrocyte 
implantation for repairing OA defects (Bentley et al., 2003; Peterson et al., 2000). Further, 
successes in chondrocyte-based CTE studies in animal models will likely translate best for hACs 
over other human cell types. Relatively few studies have utilized hACs in CTE (Adkisson et al., 
2010; Dehne et al., 2009; Dell'Accio et al., 2001; Fernandes et al., 2013; Kafienah et al., 2002; 
Lehmann et al., 2013; Saha et al., 2013; Sittinger et al., 1994; Wang et al., 2006; Wenger et al., 
2006), due perhaps to logistical challenges of obtaining donor cells in sufficient numbers and 
encouraging them to produce sufficient matrix. Even fewer studies have characterized functional 
properties of human cartilage tissue constructs such as mechanical integrity (Murphy et al., 2015; 
O'Connell et al., 2015; Zhao et al., 2012). 
 CTE has benefited from a number of advances made in animal models. Serum-free 
culture media permit reproducible, elevated functional properties over serum-containing media 
when coupled with transient TGF-β supplementation for constructs seeded with immature bovine 
chondrocytes (Byers et al., 2008). Agarose hydrogel scaffolds stabilize the chondrocyte 
phenotype (Benya and Shaffer, 1982; Buschmann et al., 1992; Mauck et al., 2000), and they 
promote deposition of proteoglycans that are most similar to those of native cartilage compared 
to other scaffold types (Mouw et al., 2005). Increasing initial cell seeding densities up to or 
above 60 × 10
6
 cells/mL leads to concomitant increases in matrix synthesis, though this can 
steepen nutrient gradients within the tissue and promote heterogeneity (Albro et al., 2016; Bian 
et al., 2009a; Talukdar et al., 2011; Zhou et al., 2008). Tissue heterogeneity is mitigated by 
nutrient channels, which minimize nutrient diffusion distances and improve functional properties 
(Bian et al., 2009a; Buckley et al., 2009; Cigan et al., 2013b; Nims et al., 2015). In adult canine 
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chondrocytes, monolayer expansion with growth factors prior to 3D culture elevates construct 
properties (Ng et al., 2010).  
 Our group has routinely reproduced native cartilage Young’s moduli (EY) of ~500 kPa  
and glycosaminoglycan (GAG) contents of > 4 percent of wet weight (%/ww) in juvenile bovine 
chondrocyte-seeded agarose constructs (Bian et al., 2009a; Cigan et al., 2013a; Cigan et al., 
2014b; Nims et al., 2014). Other studies have produced high-quality engineered cartilage 
utilizing canine or porcine cell sources (Alegre-Aguaron et al., 2014; Bian et al., 2010; Kelly et 
al., 2013; Ng et al., 2010; O'Conor et al., 2014). Growth factor-aided monolayer expansion of 
hACs is generally necessary to obtain sufficient cell number for CTE studies (Barbero et al., 
2003; Francioli et al., 2007; Jakob et al., 2001). We previously obtained EY of 100 kPa and 2.2 
%/ww GAG in agarose constructs cast with passaged chondrocytes from two osteoarthritic 
donors at 30 × 10
6
 cells/mL for 56 days (O'Connell et al., 2015). While these results are 
promising for viable long-term 3D culture of hACs, functional properties were below native 
levels as well as levels in bovine constructs.  
 The primary objective of this study was to achieve native cartilage properties in a human 
CTE model by translating successful techniques from our bovine and canine systems. Using 
chondrocytes derived from expired human osteochondral allografts, we first assessed the utility 
of transient versus sustained TGF-β supplementation (Figure 7-1). Implementing the more 







Figure 7-1: Experimental design for human constructs. ρ = cell seeding density, 
β3+ = continuous TGF-β treatment, β3- = transient TGF-β treatment. Dotted 
rectangles indicate between which groups statistical comparisons were made. 





7.1.3.1 Harvest & culture 
Five osteochondral allografts (taluses, Figure 7-2) were obtained from the Musculoskeletal 
Transplant Foundation (mtf.org). Donors were male and female and 17-35 years old (Table 7-1). 
Tissue from each donor was cultivated separately. Grafts were expired, having exceeded their 
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shelf lives of approximately one month post-mortem (~14 days in storage). Full-thickness 
articular cartilage was aseptically harvested from grafts, and cartilage pieces were digested in 















1 F 20 17 × 10
6
 12 
2 F 19 
ρ1: 15 × 10
6
 





3 M 17 
ρ1: 23 × 10
6
 





4 F 35 
ρ1: 40 × 10
6
 





5 M 33 
ρ1: 22 × 10
6
 





Table 7-1: Donor demographics for each of the five donors, and seeding densities 
and total numbers of constructs (n) for each respective cast. 
 
 
 Released chondrocytes were plated at 20,000 cells/cm
2
 in expansion medium consisting 
of high-glucose DMEM with 10% FBS, 1% Antibiotic-antimycotic, 10 ng/mL human 
recombinant PDGF-ββ, 5 ng/mL human recombinant FGF-2 (Life Technologies), and 1 ng/mL 
human recombinant TGF-β3 (R&D Systems) (Francioli et al., 2007; Ng et al., 2010; O'Connell 
et al., 2015). P2 cells were trypsinized and resuspended in chemically-defined ITS medium 
(Cigan et al., 2013a).  
 The cell suspensions were mixed 1:1 with molten 4% Type VIIA agarose (Sigma) and 
cast between glass slides to form cellularized 2% agarose gels. A biopsy punch was employed to 
produce 3 × 2.3 mm cylindrical constructs. Constructs were cultured for 14, 28, 42, or 56 days, 
with 2 ≤ n ≤ 5 per time point tested, in ITS media with 0.8 Hz orbital shaking. Media were 
changed thrice weekly and spent media samples were frozen for subsequent analysis. 
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7.1.3.2 Transient TGF-β supplementation 
In the first series of casts, the efficacy of transient versus sustained TGF-β treatment in hACs 
was investigated (Figure 7-1). Samples from Donors 1 and 2 were supplemented with TGF-β for 
either the first 14 days (Byers et al., 2008) (β3-) or for the entire culture duration (β3+). Due to 
the more promising properties of the β3+ group based on these initial cultures (7.1.4.1), 
sustained TGF-β supplementation was used for the second series of casts (Figure 7-1). 
 
7.1.3.3 Cell seeding density 
Nine distinct casts were executed with cells from the five grafts. Cell densities (“ρ”) of 15, 30, 
and 60 × 10
6
 cells/mL were targeted nominally; actual densities were assessed by DNA assay 
(Table 7-1). Media were supplied to constructs at approximately 0.45 mL/(10
6
 cells · day) based 
upon nominal ρ (Nims et al., 2015). 
 
7.1.3.4 Mechanical characterization 
Samples were tested for EY as previously described (2.2), with a creep tare load of 0.5 g, 10% 
strain, 1500 s relaxation time. At equilibrium a 0.01 Hz ± 1% cyclic strain was applied, and a 
custom MATLAB script extracted the dynamic modulus, G*. Following mechanical testing, 




7.1.3.5 Biochemical characterization 
Half of each bisected construct was weighed and digested overnight in Proteinase K solution 
(Hollander et al., 1994; Kelly et al., 2006). Cellularity was assessed by Picogreen dsDNA assay 
(Life Technologies) assuming 7.7 pg DNA/cell (McGowan et al., 2002). A dimethylmethylene 
blue dye-binding assay measured GAG content in Proteinase K digests and spent media samples 
(Farndale et al., 1986). Collagen content was determined by hydrolyzing Proteinase K digests in 
6 N HCl at 110 °C overnight, drying and resuspending the hydrolysates, and measuring 
orthohydroxyproline (OHP) by dimethylaminobenzaldehyde/chloramine T assay (Kelly et al., 
2006). A 7.6:1 collagen:OHP mass ratio was calculated from the molecular weight of 1,000 
residues of the collagen αII chain (98,291 g/mol) and orthohydroxyproline (131.13 g/mol), and 
the frequency of orthohydroxyproline residues in the αII chain (99 in 1,000), and was used to 
infer collagen content (Hollander et al., 1994; Nimni, 1983). To quantify the deposition of type II 
collagen, three day-27 human constructs from a separate casting were digested in pepsin and 
elastase and assayed by a type II collagen ELISA (Chondrex, Inc.). GAG and collagen contents 
were expressed in total mass per sample, percent of day zero wet weight (%/D0ww to assess net 
matrix deposition), percent of final wet weight (%/ww to assess composition by conventional 
measures), or were normalized to DNA content. GAG retention within constructs was computed 
as previously described (Cigan et al., 2013b). 
 
7.1.3.6 Histology 
Histology was performed on half-constructs as previously described (2.6). The wax blocks were 
sectioned to 7 µm slices and stained for GAG by 1% Safranin O or for collagen by 0.1% 
Picrosirius Red (Sigma). Immunohistochemistry was performed similarly as by Gadjanski et al. 
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with the following exceptions: antigen retrieval was performed by incubating sections in 2 
mg/mL bovine testicular hyaluronidase for 1 h at 37 °C, and anti-collagen I (ab34710) and anti-
collagen II (ab34712, Abcam) primary antibodies were used at 1:50 and 1:200 dilutions, 
respectively (Gadjanski et al., 2013). 
 
7.1.3.7 Statistical analysis 
Culture conditions and statistical comparisons are summarized in Figure 7-1. To examine effects 
of TGF-β supplementation, the samples modulated for TGF-β treatment were analyzed for each 
Donor 1 and Donor 2 by unpaired Student’s t-tests (α = 0.05) at day 42. Subsequently, the data 
from Donors 1-5 (omitting β3- constructs) were pooled and analyzed to identify overall trends 
between construct functional properties and culture parameters. Multiple linear regression 
analyses (STATISTICA) were performed to explore first-order relationships of the form: 
                Equation 2 
where Xi are independent factors, Ai are the regression coefficients, and Y is the dependent factor. 
For analyses investigating relationships between construct mechanical properties and matrix 
content, EY or G* was designated as the dependent factor, and %/ww GAG and collagen (COL) 
served as independent variables. To examine effects of ρ and culture duration on functional 
properties, ρ and days cultured (Day) served as independent factors for the dependent variable 
EY, G*, GAG, or COL.  
 After multiple regression analyses indicated positive, pronounced effects of ρ on 
construct functional properties, the data were discretized to permit analysis of variance 
(ANOVA) tests. Pooled data from Donors 1-5 were binned based upon whether their ρ fell 
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below, between or above 30 and 60 × 10
6
 cells/mL, which have served as benchmark ρ in 
previous studies (Bian et al., 2009a; Cigan et al., 2013a; Cigan et al., 2014b; Nims et al., 2014; 
Nims et al., 2015; O'Connell et al., 2015). The resulting low, medium, and high cell seeding 
density bins ranged from 15-23, 33-40, and 70-90 × 10
6
 cells/mL, respectively. These bins were 
compared by two-way ANOVA (α = 0.05) with Bin, Day, and their interaction (Bin×Day) as 
independent factors; Tukey’s HSD corrected post hoc tests of the means were instituted upon 
determination of significance (p < 0.05). To examine whether effects of ρ were consistent when 
controlling for donor variability, pairwise comparisons were made between the lower and higher 
ρ (ρ1 and ρ2) separately for Donors 2-5 by ANOVA as described above. Donor variability was 
assessed by one-way ANOVA with donor as the independent factor and GAG/DNA and 
COL/DNA as dependent variables. Lastly, to analyze the effect of nutrient channels, constructs 
from Donor 6 were compared by ANOVA with CH (presence or absence of channel), Day (28 or 
42), and CH×Day (their interaction) as independent factors. 
 
7.1.4 Results 
7.1.4.1 TGF-β supplementation 
For Donors 1 and 2, β3+ constructs had significantly higher %/ww of GAG (p < 0.0005, Figure 
7-3A) and collagen (p < 0.005) compared to β3+ constructs at day 42. Donor 1 showed 
significantly higher EY in the β3+ group versus β3- (p < 0.005, Figure 7-3B). From day 14 
onward, β3- constructs did not increase appreciably in EY or GAG and collagen contents. 






Figure 7-3: Effects of TGF-β, both transient (treated D0-D14, “β3-”) or sustained 
(treated D0-D42, “β3+”) on tissue composition (A) and mechanical properties (B) 
in a subset of constructs from Donors 1 and 2. “*” denotes p < 0.05 vs. D14 time 
point (when β3- and β3+ diverge), “#” denotes p < 0.05 vs. β3+ group from same 
donor. Numbers of samples per group n are superimposed on bars. 
 
7.1.4.2 Construct functional properties 
Constructs developed a broad spectrum of functional properties. All groups tended to develop 
mechanical and biochemical properties concomitantly, as demonstrated by the approximately 
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higher functional properties. The highest-quality constructs with cells derived from expired graft 
tissue were those with the highest ρ (90 × 10
6
 cells/mL). At D28, they had the highest EY (254 ± 
22 kPa, Figure 7-4C), G* (945 ± 65 kPa), and GAG content (4.8 ± 0.7 %/ww, Figure 7-4D). 





Figure 7-4: Correlation between the tissue composition and mechanical properties 
at all time points (A), retention of GAG over time by combined constructs of 
Donors 1-5 (B), and EY (C) and GAG synthesis (D) of Donor 4 constructs at both 
low ρ (40 × 10
6
 cells/mL) and high ρ (90 × 10
6
 cells/mL). “*” denotes p < 0.05 vs. 
Day 14 time point, “†” denotes p < 0.05 vs. high ρ group, “§” denotes other p < 




 Constructs grew steadily throughout the first four weeks of culture before tending to 
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ANOVA revealed that EY, G*, and collagen increased significantly overall for constructs until 
D28 (p < 0.05), after which no overall increases in properties were observed. GAG levels did not 
significantly depend on culture duration (p = 0.27), indicating that the majority of GAG 
deposition occurred before day 14. Furthermore, analysis of spent culture media revealed that the 
cumulative retention fraction of GAG by constructs decreased from day 28 to day 56 (Figure 
7-4B). Donors exhibited similar GAG contents normalized by DNA (p = 0.11), while a 
significant effect of COL/DNA (p < 0.01) indicated low rates of collagen were synthesized by 







Figure 7-5: EY (A), G* (B), GAG (C), and collagen (D) of constructs from 
Donors 1-5, binned by low (15-23 × 10
6
 cells/mL), medium (33-40 × 10
6
 
cells/mL), or high (70-90 × 10
6
 cells/mL) cell density. “*” denotes p < 0.05 for 
ANOVA factor, “#” denotes all bins are significantly distinct. For panels A, B, 
and D, individual groups not sharing a common letter (a-e) are significantly 
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Figure 7-6: DNA-normalized GAG (A) and collagen (B) contents by donor at 
final time points for each culture group. Groups sharing * or # superscripts are 
significantly different (p < 0.05). D = Donor. 
 
7.1.4.3 Relationships between the culture parameters, construct compositions and 
mechanical properties 
The full results of the regression analyses are listed in Table 7-2. In the relationships between 
construct matrix contents and mechanical properties, both EY and G* were found to have strong 
correlations (R
2
 = 0.78 and 0.83, respectively) with both GAG and COL together (p < 0.0001). 
GAG was highly predictive of both construct mechanical properties measured (p < 0.0001), 
while COL was only a significant factor for G* (p <0.05). Culture duration and cell seeding 
density also shared positive correlations with all dependent factors (EY, G*, GAG, COL; p < 
0.005), though regressions were weaker, especially that of COL (R
2
 = 0.19). The far stronger 
predictor of functional properties was ρ (p < 0.001). Culture duration was found to be less 
strongly correlated with functional properties, being only significantly predictive of G* (p < 
















































 p (total) 
A1 (kPa) 
[X1 = GAG] 
p (X1) 
A2 (kPa) 
[X2 = COL] 
p (X2) 
EY 0.78 <0.0001 41.8±3.2 <0.0001 6.1±10.4 0.56 
G* 0.83 <0.0001 156.2±10.9 <0.0001 82.0±35.5 <0.05 
Y R
2









[X2 = ρ] 
p (X2) 
EY 0.57 <0.0001 0.52±0.30 0.08 1.81±0.17 <0.0001 
G* 0.51 <0.0001 3.3±1.3 <0.05 6.69±0.72 <0.0001 
Y R
2









[X2 = ρ] 
p (X2) 
GAG 0.68 <0.0001 0.014±0.007 0.066 0.04±0.003 <0.0001 
COL 0.19 <0.005 0.0068±0.0036 0.065 0.0061±0.0017 <0.001 
Table 7-2: Results of multiple linear regression analyses. Given are: R
2
 values and 
p-values for overall regressions on dependent factors Y, regression coefficients A1 
and A2 (± 95% confidence intervals) corresponding to dependent factors X1 and X2 
(either GAG & COL or Day and ρ), and p-values for each factor X1 and X2. 
 
 
7.1.4.4 Effects of seeding density 
When the data were binned by ρ (low, medium, high) and examined by ANOVA, the strongest 
predictor of construct functional properties was ρ, as it had significant effects on all properties (p 
< 10
-6
, Figure 7-5). The bins proved to be statistically distinct with respect to both G* and GAG 
content (Figure 7-5B-C), with higher ρ associated with higher functional properties (p < 0.0005). 
Collagen content was lowest in constructs with low ρ (p < 0.0005), and was similar for medium 
and high ρ (p = 0.11, Figure 7-5D). EY was highest for the high ρ constructs (p < 0.0005); at day 
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28, these constructs had the highest EY among groups and time points (p < 0.001, Figure 7-5A). 
Among all ρ at all time points, only high ρ constructs appreciably increased in size at day 28 
(1.4× day 0 wet weight) and at day 42 (1.14× day 0 wet weight). From pairwise comparisons of 
different ρ’s from a common donor (performed on Donors 2-5), higher ρ constructs had 
significantly higher functional properties (Table 7-3). In addition, constructs with high ρ tended 












p < 0.001 
ρ1: 212 
ρ2: 433 
p < 0.0005 
ρ1: 1.30 
ρ2: 2.32 
p < 0.05 
ρ1: 0.38 
ρ2: 0.61 







p < 0.05 
ρ1: 0.42 
ρ2: 3.63 







p < 0.0005 
ρ1: 168 
ρ2: 820 
p < 0.0005 
ρ1: 1.08 
ρ2: 4.39 







p < 0.0005 
ρ1: 97 
ρ2: 482 
p < 0.0005 
ρ1: 0.55 
ρ2: 2.38 
p < 0.0005 
ρ1: 0.50 
ρ2: 1.24 
p < 0.0005 
Table 7-3: Pairwise comparisons between higher (ρ2) and lower (ρ1) cell density 
constructs for each donor, with values averaged across all time points and 







Figure 7-7: Histological stains and construct gross morphology. Stains of select 
samples by Picrosirius Red for collagen (A-B, E-F, I-J) and Safranin O for GAG 
(C, G, K), and photographs of respective constructs. Samples depicted have ρ = 
90 × 10
6
 cells/mL at D28 (A-D) and D56 (E-H), and ρ = 40 × 10
6
 cells/mL at Day 
56 (I-L). 
 
7.1.4.5 Histology & immunohistochemistry 
Safranin O stains revealed GAG distributed throughout the constructs at day 28 of culture 
(Figure 7-7C). In contrast, collagen primarily occupied the pericellular regions whereas 
interterritorial staining was light (Figure 7-7A-B). GAG staining did not improve beyond day 28 
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(Figure 7-7G, K), and collagen staining appeared to fade (Figure 7-7E-F, I-J). The strongest 
stains for both GAG and collagen were found at construct centers. Lower ρ led to lighter staining 
(Figure 7-7I-K). Immunostaining for collagen in constructs showed deposition of types I and II 
collagen localized at construct peripheries (Figure 7-8B, E). Throughout construct interiors, type 
II collagen showed dark staining (Figure 7-8D), while type I collagen was nearly absent when 
compared with negative control (Figure 7-8A, C). ELISA for type II collagen confirmed that 
collagens were predominantly type II (76%) when normalized to total collagen content as 
determined by OHP assay. 
 
 
Figure 7-8: Representative immunohistochemical staining for types I (A-B) and II 
collagen (D-E) in D27 Donor 4 constructs (90 × 10
6
 cells/mL) along with 






















In this study we present some of the most successful engineered human cartilage constructs to 
date. Despite sourcing most constructs’ cells from adult human osteochondral grafts that had 
exceeded their shelf lives, the cells were able to produce high-quality cartilage tissue constructs, 
the best of which rival our previous results in juvenile bovine and adult canine model systems.  
 Seeding density played the largest role in determining construct properties, as was 
revealed by multiple regression analysis and ANOVA of all samples combined (Table 7-2, 
Figure 7-5). Groups with lower ρ experienced less growth, particularly those with ρ similar to 
native human adult cartilage (~10
7
 cells/mL)(Venn and Maroudas, 1977); this effect was most 
directly observed in constructs cast at different ρ from the same donor (Donors 2-5, Table 7-3). 
Impressively, constructs seeded at the highest cell density (ρ = 90 × 10
6
 cells/mL) approached 
properties of human knee cartilage, with GAG levels of 5% (1-5 %/ww for native tissue) and 
Young’s moduli of 250 kPa (250-730 kPa for native tissue) (Fetter et al., 2006; Krishnan et al., 
2003; Treppo et al., 2000). Though their collagen levels were low (1.5 %/ww) relative to native 
cartilage (~10 %/ww), both qualitative and quantitative analyses confirmed that the collagens 
produced are predominantly the type II collagens found in the native tissue (Figure 7-8). To the 
best of our knowledge, the EY and GAG levels we report are the highest for hACs in agarose to 
date, and are similar to those obtained for canine constructs after 28 days in culture (Bian et al., 
2010; Ng et al., 2010). Though cells at high seeding densities may occupy appreciable fractions 
of the construct volume (~10-15%), any structural weaknesses potentially imposed by cells were 
evidently outweighed by increased levels of matrix synthesis. Synthesis rates of GAG by 
constructs with high ρ (80 pg GAG/cell·day) were comparable to those of juvenile bovine 
167 
 
constructs (Nims et al., 2014). These results strongly suggest that seeding densities in CTE 
studies employing hACs must be sufficiently high to reach native cartilage properties. 
Glucose consumption was not measured in the human constructs of this study, since they 
were given excessive volumes of media equivalent to what was provided to juvenile bovine 
constructs with higher seeding densities in previous studies (4.2, 5.1), and it is expected that 
human cells consume glucose at low rates. Therefore, drops in media glucose levels would be 
subtle relative to the sensitivity of the assay. However, it would be informative for modeling 
purposes to run a similar experiment as in 3.3 to extract consumption rates by human cells. For 
practical considerations, 3 × 2.3 mm constructs were studied to permit the casting of a greater 
number of samples; in future studies, 4 mm human tissue constructs may be cultured to make 
more direct comparisons with bovine and canine constructs of similar size.  
 Although cells were sourced from six distinct donors, and some significant differences in 
collagen synthesis were noted in one donor (Figure 7-6B), we are hesitant to draw strong 
conclusions about donor variability. Though it may be expected that younger tissue would 
possess greater growth potential, the constructs exhibiting the most favorable properties had high 
ρ and were cast with cells originating from the oldest donor (Donor 4, Table 7-1), and cells from 
the youngest donor (Donor 3) synthesized the least collagen (Figure 7-6B). These observations, 
taken together with the higher construct properties resulting from higher ρ in pairwise 
comparisons for Donors 2-5 (Table 7-3), suggests that ρ is more impactful than donor-specific 
effects on construct growth. A post hoc power analysis of our results suggests that n in excess of 
100 would be required to detect differences due to donor age and gender with 80% power, 
therefore these effects may be difficult to predict. Therapies seeking to adapt allogeneic human 
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constructs for clinical use would benefit from methods for prescreening and quality control of 
donor graft tissues. 
 Though hAC-laden constructs were similar in gross morphology and matrix content to 
bovine constructs, human constructs experienced plateauing growth. Unlike bovine constructs 
whose growth seemingly continues indefinitely (Nims et al., 2016; O'Connell et al., 2014), or 
canine constructs which have sustained growth for at least 42 days (Bian et al., 2010), human 
constructs generally experienced no significant growth after four weeks in culture. This behavior 
is reflected by the regression analyses’ findings that only G* was positively correlated with 
culture duration after day 14 (Table 7-2). When binned by ρ, the constructs showed no 
significant increases in functional properties beyond day 28 (Figure 7-5). Histology corroborated 
this finding, with the intensity of GAG and collagen stains remaining similar or diminishing after 
day 28 (Figure 7-7). While the underlying causes of this growth plateau were not elucidated by 
this study, it is conceivable that benefits of growth factor priming during monolayer culture 
diminish over time. Transient TGF-β treatment, which has previously shown successes with 
juvenile bovine constructs, was ineffective for hACs (Figure 7-3), similar to our previous 
findings with passaged adult canine chondrocytes (Ng et al., 2008b). However, ongoing research 
suggests that beneficial effects of active TGF-β are limited to constructs’ surfaces and that more 
sophisticated delivery strategies may be necessary for homogeneous tissue growth (Albro et al., 
2013a; Albro et al., 2016). In these early experiments with hACs in 3D culture our knowledge of 
optimal growth factor treatments is not yet complete, and it is evident from our results that 
growth factor supplementation regimens (e.g. 10 ng/mL TGF-β for the first two weeks of 
culture) which have been optimized for juvenile bovine cells are not optimal for adult human 
cells. It is possible that treatment windows for TGF-β should be extended and at different 
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dosages, that transient TGF-β treatment could be repeated throughout culture, or that the 
reintroduction of growth factors PDGF-ββ and FGF could reinvigorate human chondrocytes. In 
any case, we are hopeful that improved delivery of TGF-β and other factors will prove useful in 
encouraging homogeneous and sustained growth of hAC-laden constructs.  
 Unlike our bovine constructs which retain up to ~90% of synthesized GAG (Nims et al., 
2014), hAC-laden constructs retain less GAG (Figure 7-4B, D), and matrix was mostly localized 
at the construct center (Figure 7-7). Initial GAG retention of ~50% significantly decreased to 
~35% at day 56 (Figure 7-4B). This may result from increased diffusivity of smaller GAGs 
typically produced by aged hACs (Buckwalter et al., 1994b; Lee et al., 2013). The 2% agarose 
gels we commonly employ were originally titrated to optimize nutrient transport while retaining 
high levels of synthesized matrix by bovine cells (Ng et al., 2009a; Nims et al., 2014). Our group 
demonstrated that a denser agarose scaffold (3% w/v) results in significantly higher EY of hAC-
laden constructs after four weeks of culture (Estell et al., 2015), suggesting that a more robust 
GAG network was retained by the hydrogel’s smaller pores. A more in-depth characterization of 
GAGs produced by these constructs could provide valuable insight for producing more robust 
human constructs. 
 Limitations of this culture system are similar to those we have observed in prior 
investigations with immature bovine and mature canine chondrocytes in agarose: the collagen 
content remains significantly below native levels, compromising functional mechanical 
properties under dynamic loading, since the dynamic compressive modulus G* correlates 
significantly with collagen content (Table 7-2). This limitation is evident in the values of G*, 
which peak at ~1 MPa (Figure 7-5), whereas native levels in human cartilage are estimated to be 
five to ten times greater (Krishnan et al., 2003). We previously investigated various strategies to 
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alleviate this limitation, by subjecting constructs to dynamic compressive loading to enhance 
functional properties (Bian et al., 2010; Lima et al., 2007; Mauck et al., 2000), temporarily 
digesting GAGs with chondroitinase ABC to delay construct swelling and mitigate steric 
exclusion of synthesized collagen (Bian et al., 2009b; O'Connell et al., 2014), degrading the 
agarose scaffold with agarase to similarly mitigate steric effects (Ng et al., 2009b), or 
supplementing culture media with higher levels of amino acids to enhance collagen synthesis 
(Ng et al., 2008a). Most of these strategies have shown statistically significant improvements, 
though none have raised collagen content or dynamic modulus to native levels. Therefore we 
will continue to investigate alternative strategies to enhance collagen content, using bovine and 
canine chondrocytes as testing systems prior to applying them to hACs. 
 This study provides an in-depth characterization of human chondrocytes in agarose for 
CTE, in which we expanded upon recent results (O'Connell et al., 2015) and adapted techniques 
that have previously proven successful in engineered bovine and canine cartilage. This technique 
of growing human constructs from expired graft tissue has encouraging implications for 
engineering allogeneic cartilage implants for treatment of osteoarthritic joints. Though we have 
identified new obstacles posed by these human cells, such as plateauing growth and low matrix 
retention by constructs, we propose promising strategies for successful growth of human tissue. 
High initial cell seeding density played a key role in construct growth. The grafts used were 
expired, suggesting that expired osteochondral allografts from tissue banks may serve as reliable 
sources of hACs for clinical applications of CTE. Such applications may significantly reduce 
waste of donated tissues since expired allografts are otherwise often discarded. With the insights 
gleaned from these experiments, we expect that future studies will provide further successes for 
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Chapter 8  
 





This dissertation sought to address two longstanding obstacles in cartilage tissue engineering: 1) 
overcoming nutrient transport limitations which have prevented the cultivation of large, 
clinically relevant tissue constructs, and 2) the inability to achieve satisfactory functional 
properties in human tissue constructs relative to in vitro animal models. Through a series of 
systematic experiments designed about five overarching specific aims, strides were made toward 
both of these lofty challenges. It is in our highest hopes that these experiments will help to 
further elucidate the nature of these challenges, and that they will provide valuable information 
and tools to be built upon by current and future CTE studies. The major results of the 
experimental studies performed herein are summarized below, with special attention paid to 
defining their impact on the field of CTE and their implications for future research. 
 
8.1 Conclusions 
8.1.1 Adequate glucose supply is critical for construct growth 
Early tissue engineering experiments with large tissue constructs revealed high levels of matrix 
heterogeneity (Cigan et al., 2014b; Freed et al., 1993; Hung et al., 2003). It is commonly 
believed that the interiors of constructs of increasing dimensions suffer from poor nutrient 
availability due to cellular consumption. The initial studies performed in this dissertation (3.1) 
sought to identify which nutrients among several candidates in serum-free culture media are 
most critical for growth of 4 mm × 2.3 mm chondrocyte-agarose constructs (Cigan et al., 
2013a). We showed that insulin and ascorbate are necessary for construct growth, but that major 
dose dependencies are not apparent. Despite their deliberate inclusion in insulin-transferrin-
selenium supplements to support cell viability and proliferation, transferrin and selenous acid 
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showed virtually no effects on construct properties, even when removed entirely from the media. 
Glucose, on the other hand, played an essential role in ECM elaboration and construct 
mechanical properties, and exhibited a strong dose dependency. A subsequent study (3.2) more 
closely investigated the dose dependence of construct growth on glucose concentration and 
uncovered a threshold concentration below which little matrix deposition occurred (Cigan et al., 
2013c; Nims et al., 2014).  
Having identified glucose as a critical nutrient, we proceeded to quantify its rate of 
consumption. By casting constructs at low cell seeding densities (to lessen potential confounding 
effects of pronounced nutrient gradients within) and monitoring the concentrations of glucose in 
the culture media in the hours and days following media refreshment (3.3), we calculated a 
glucose consumption rate which is characteristic of our culture system (Nims et al., 2014).  
The identification of the critical threshold for glucose and the system-specific glucose 
consumption rate both served to inform computational models of glucose availability within 
constructs (Nims et al., 2014). In turn, these models provided us insights for ensuring adequate 
glucose supply to 10 mm constructs with nutrient channels (Cigan et al., 2014a; Nims et al., 
2015). This strategy of informing system-specific models of glucose transport in CTE constructs 
presents a powerful tool for predicting construct growth that can be adapted for any culture 
system. 
 
8.1.2 A culture system to promote growth in channeled constructs 
The practice of incorporating nutrient channels into CTE constructs to improve nutrient transport 
had previously shown promising results (Bian et al., 2009a; Buckley et al., 2009). In these 
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studies, the presence of nutrient channels improved construct mechanical properties but elicited 
no increases in bulk ECM deposition. Initial attempts to culture 10 mm × 2.3 mm constructs, 
described in Appendix 2, resulted in heterogeneous growth and no benefits of nutrient channels. 
Believing that this limitation was due to media stagnation within channels and the occlusion of a 
large fraction of the construct surface area by the underlying Petri dishes used, in experiment 4.1 
we innovated a system of culture racks set within deep Petri dishes in order to culture 10 mm 
constructs on their sides. All exposed surfaces of the culture racks were comprised of PTFE in 
order to minimize adsorption of TGF-β, which would otherwise deplete media levels and hinder 
construct development. Additionally, we subjected the cultures to multiple stirring modes (static, 
uniaxial rocking, orbital shaking) to encourage media flow through channels. We found that 
orbital shaking constructs in racks had pronounced beneficial effects on constructs, and we were 
able to attain native levels of EY and GAG content (Cigan et al., 2014b). However, channels once 
more only significantly improved EY and not matrix contents. 
In parallel to these experiments, computational models informed by the results of 
experiments in Chapter 3 suggested that glucose supply rates to constructs were too low for 
channels to be fully effective. By increasing volumes of culture media up to triple the levels 
typically supplied to constructs on a per-cell basis (4.2), we observed dramatic increases in 
retained matrix within constructs when nutrient channels were incorporated (Cigan et al., 2014a; 
Nims et al., 2015). Further, it was shown that increasing densities of channels resulted in greater 
levels of matrix production in constructs. This signified the first time that nutrient channels were 
demonstrated to elevate matrix production in CTE constructs. Furthermore, it represents a 
successful instance in which predictions by computational models led to crucial empirical 




8.1.3 Experimental titration of optimum nutrient channel densities 
The addition of nutrient channels to CTE constructs works based on the simple principle of 
reducing nutrient transport distances within the construct center. The greater the number of 
channels, the more access nutrients will have to the entire construct. However, the channel 
density can theoretically become so high that the initial construct volume is insurmountably 
reduced, outweighing the benefits of channel incorporation. Experiment 4.2 showed that by 
packing increasingly dense configurations of 3 or 12 channels into 10 mm constructs, 
concomitant increases in matrix synthesis could be achieved, but no optimum or plateau for the 
beneficial effects of channels was identified. In Chapter 5 we set out to experimentally determine 
an optimum channel density to encourage growth in 10 mm × 2.3 mm constructs. By 
incorporating 0, 12, 19, or 27 channels we demonstrated optimal properties in both 12- and 19-
channel configurations, with 27-channel constructs exhibiting lower matrix content (Cigan et al., 
2016c). All other factors being similar, due to the increased fragility of handling 19-channel 
constructs, we determined that the optimal channel spacing was that of the 12-channel 
arrangement.  
During the time preceding this study, new data that came to light showing that 
heterogeneous matrix growth was attributed to conventional treatment of constructs with 10 
ng/mL TGF-β (Albro et al., 2016). Based on this, we also explored the use of reduced dosages of 
TGF-β (0 or 1 ng/mL), and discovered that channels were entirely ineffective in the absence of 
TGF-β. The low dosage of 1 ng/mL, on the other hand, elicited similar matrix properties as 10 
177 
 
ng/mL while simultaneously improving EY (Cigan et al., 2016c), likely a result of mitigated 
matrix heterogeneity.  
The experiments in this chapter provide results that are useful in optimizing culture 
systems for the cultivation of large, channeled constructs. By titrating an ideal channel spacing, 
we were able to more confidently design later experiments with articular surface-sized 
constructs. Additionally, the relative success of a lower dosage of TGF-β suggests that large 
constructs can be cultured much more economically, considering the cost of the large quantities 
of growth factors needed to supplement such high volumes of media. With these experiments, we 
demonstrate that the spacing of nutrient channels can be tuned to elicit optimal growth by CTE 
constructs. 
 
8.1.4 Nutrient channels aid growth of articular surface-sized constructs  
Having previously designed a culture system able to accommodate 10 mm channeled 
constructs (4.1) and having titrated the optimal spacing for channels (5.1), in Chapter 6 we 
sought to scale up to the cultivation of articular surface-sized constructs. We scaled up the 10 
mm culture system (culture racks + orbital shaking) to accommodate 40 mm × 2.3 mm 
constructs, and rapid-prototyped channel molds with which to cast them. A series of preliminary 
studies (6.1.3.4.1) found that channels had a propensity to fill in prematurely, hindering growth 
at the construct centers. By manually reopening channels throughout culture, using closely-
packed arrangements of 1.4 mm channels, and by reducing TGF-β dosage to 1 ng/mL, we were 




Using these optimal culture parameters, we cultured articular surface-sized constructs 
seeded with either primary or passaged bovine chondrocytes and compared them to 4 mm and 
10 mm controls (6.1.3.4.2). The large constructs reached native levels of EY and GAG, were 
even more mechanically robust than their smaller controls, and showed lower yet acceptable 
functional properties in passaged cells versus primary cells. The final sizes of the constructs are 
comparable with the larger joint surfaces in the human body. To the best of our knowledge, these 
are the largest CTE constructs ever grown, and certainly the only of such size to reach native 
mechanical and biochemical properties (Cigan et al., 2016b). Because these properties could 
only be attained when channels remained open, the results are a testament to the efficacy of 
nutrient channels in producing high-quality, scaled-up cartilage constructs. Remaining channels 
at the end of culture could potentially serve as sites for surgical attachment and for integration 
with the surrounding tissue.  
The incorporation of nutrient channels in CTE scaffolds and the implementation of 
system-specific computational models are both techniques which may be adapted for any CTE 
culture system, regardless of cell type or scaffold. Therefore, these results are broadly applicable 




8.1.5 Human chondrocyte-agarose constructs are promising for cartilage tissue 
engineering 
In the final experiments of this dissertation, a human chondrocyte-agarose system was 
investigated (7.1). By harvesting expired osteochondral allografts, we were able to isolate, 
passage, and encapsulate healthy adult human chondrocytes in agarose. These human tissue 
constructs were subjected to techniques which have proven successful in studies with juvenile 
bovine chondrocytes or adult canine chondrocytes (i.e. transient or continuous TGF-β 
supplementation, modulation of cell seeding density). The constructs exhibited little growth after 
TGF-β cessation, indicating that sustained TGF-β treatment was essential. As initial seeding 
density was increased, construct functional properties increased significantly. Select constructs 
with high seeding densities were as successful as many prior canine and bovine constructs, 
reaching native human levels of GAG content and approaching native EY (Cigan et al., 2015; 
Cigan et al., 2016d). Unlike bovine and canine constructs, human constructs tended to plateau in 
functional properties at and beyond four weeks in culture. Additionally, rates of GAG retention 
were far lower in human constructs than in our animal cell models.  
These results demonstrate that expired osteochondral allografts are a plausible cell source 
for human CTE studies, and provide suggestions for useful techniques with which to culture 
human chondrocytes in agarose. Furthermore, we identified new obstacles in the cultivation of 
these constructs (plateauing properties, low matrix retention). Overall, the results hold promise 




8.2 Future directions 
The experiments in this dissertation greatly advanced our capability to cultivate large bovine 
chondrocyte-agarose CTE constructs by incorporating nutrient channels, supported by predictive 
and highly useful computational models. The recent and promising results with human 
chondrocyte-agarose constructs advance us by several early steps along this same path, to where 
ultimately we may develop clinically-relevant-sized human CTE constructs.  
 
8.2.1 Multifaceted approaches to engineering channeled cartilage constructs 
Throughout the body of literature dedicated to CTE, numerous techniques have been identified 
which hold beneficial effects for the growth of constructs. These techniques range widely in their 
modalities and intended effects on constructs, and include biochemical cues such as growth 
factor treatments (Byers et al., 2008; Francioli et al., 2007; Tan et al., 2015), mechanical cues 
such as hydrostatic pressure or dynamic loading of constructs (Buschmann et al., 1999; Li et al., 
2001; Lima et al., 2007; Mauck et al., 2003b; Mauck et al., 2002), the use of bioreactor 
environments (Freed et al., 1993; Obradovic et al., 1999; Vunjak-Novakovic et al., 1999), and 
innovative scaffold designs (Estell et al., 2015; Hu and Athanasiou, 2006; Hung et al., 2003; 
Moutos and Guilak, 2009; Ng et al., 2009a; Nöth et al., 2007; Nover et al., 2015; Selmi et al., 
2008; Svensson et al., 2005). Thus there are a great number of potential approaches which could 
potentially be combined with channeled scaffolds. 
Some of these techniques (in addition to the vast majority not listed above) encourage 
large increases in construct functional or structural properties, and some have effects that are 
more subtle. Techniques for CTE may also be classified with their ease of application; some 
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involve the mere addition of a supplementation to the media, and some are rather laborious, such 
as subjecting individual samples to daily dynamic loading regimens. Now that we have 
established casting and culture systems for channeled constructs, cultivating them is a relatively 
simple process. Little maintenance for these constructs is required throughout the culture period, 
apart from the re-punching of channels in 40 mm constructs, performed twice over the course 
of eight weeks. The low level of effort involved compared to the highly beneficial results of 
nutrient channels makes them an ideal technique for scaling up construct size in combination 
with other approaches to improve tissue properties. Specific combinations of channels with other 
techniques are left up to the discretion of future researchers, though several such examples are 
described below. 
 
8.2.2 In vivo canine models 
A major consideration for the implantation of CTE constructs is whether or not they will 
withstand the mechanical environment of the synovial joint under loading. For the implantation 
of smaller constructs, they can be slightly recessed relative to the neighboring native cartilage 
surface, partially shielding the implant from stress. In the case of CTE constructs intended to 
resurface entire joint surfaces, the construct alone would be responsible for withstanding loading. 
Therefore, our newfound ability to produce articular surface-sized constructs with native 
compressive strength evokes great interest in in vivo experiments.  
Our group and others have successfully cultivated CTE constructs seeded with canine 
chondrocytes (Bian et al., 2010; Ng et al., 2009c; Ng et al., 2008b; Priddy et al., 2001; Veilleux 
et al., 2004). By combining canine chondrocyte-seeded agarose with porous tantalum bases, we 
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fabricated osteochondral constructs and implanted them into mongrels (Ng et al., 2009c). Later 
work presented beneficial results of the utility of porous titanium as a base material for canine 
osteochondral constructs (Nover et al., 2015). Based on our past successes with producing canine 
constructs, we are optimistic that these techniques may be combined with the strategies detailed 
in this dissertation in order to produce channeled canine constructs suitable for implantation. 
In the experiments detailed above, we took a methodical and two-pronged approach to 
growing large CTE constructs. By performing tissue engineering experiments alongside 
computational models, and by iteratively using the results of one to inform the other, we were 
able to gradually scale up juvenile bovine chondrocyte-agarose constructs from 4 mm × 2.3 
mm all the way up to 100× their size (40 mm × 2.3 mm). A similar approach could be adapted 
for canine chondrocytes, by characterizing nutrient transport limitations of canine chondrocyte-
agarose constructs and by optimizing placement of nutrient channels within them to improve 
tissue growth. Through the use of 3D scanning of canine joint surfaces, we can produce 
constructs exhibiting the same topography as the native tissue, as we have done in early 
experiments with human-patella-shaped constructs (Hung et al., 2003). It may be possible to 
cultivate chondral-only canine constructs large enough to resurface canine patellae through the 
use of channels, which could permit homogenous and mechanically robust tissue growth and 
simultaneously provide sites for surgical attachment and integration. Alternatively, by integrating 
strategies with porous metallic bases we could generate large, channeled osteochondral 
constructs, which could be implanted into mongrels by fixating them directly within the 
subchondral bone. Such studies demonstrating satisfactory results from resurfacing entire joints 
in a preclinical, in vivo canine model would be highly promising for translation into a clinical 




8.2.3 Enhancing growth of human constructs 
The experiments presented in Chapter 7 describe our lab’s first attempts at cultivating healthy 
adult human chondrocytes in agarose. Previously, we isolated osteoarthritic chondrocytes from 
patients receiving total joint replacements and raised them in agarose, demonstrating their 
viability and growth in long-term culture (O'Connell et al., 2015). By harvesting from expired 
osteochondral grafts, donor tissue that would otherwise be discarded, we can upcycle 
chondrocytes into a useful culture system. Due to the effectiveness of allografting osteochondral 
explants (Pritzker et al., 1977), as well as a promising potential therapy of allogeneic 
chondrocyte implantation (Adkisson et al., 2010), this culture system is highly relevant for 
potential cell-based therapies for treating OA.  
We identified successful techniques for cultivating human tissue constructs, as well as 
new obstacles which are not experienced in our animal studies (7.1.4)(Cigan et al., 2015; Cigan 
et al., 2016d). Synthesized GAGs are not as well-retained as they are in bovine constructs, 
perhaps suggesting that they possess smaller molecular weights (Lee et al., 2013) or do not 
readily assemble into large proteoglycans which become more easily entrained within the 
agarose scaffold. By exploring the use of denser scaffolds and/or more closely characterizing 
deficiencies in the synthesized GAGs, we may learn methods to mitigate the poor GAG retention 
exhibited by human constructs. Another major shortcoming of human constructs is their 
tendency to plateau in growth. Since the source tissue spends approximately 6 weeks at 4 °C 
before harvesting, the chondrocytes are initially at low metabolic states and expand slowly in 
monolayer culture. Because supplementation during monolayer with PDGF, FGF, and TGF-β 
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followed by 3D culture with TGF-β is able to overcome this and encourage cell proliferation and 
matrix synthesis (Barbero et al., 2003; Francioli et al., 2007), it may be possible to use strategic 
growth factor treatments in order to achieve sustained growth in human tissue constructs. 
Through further research with human cells, we hope to unlock the ability to elevate construct 
functional properties to native levels. 
 
8.2.4 Cultivating channeled human constructs 
We expect that addressing the obstacles in the culture of human CTE constructs described above 
(8.2.3) will require coordinated efforts and due patience. Fortunately, the future experiments 
proposed in 8.2.1 may be initiated more immediately. The translation of channel culture 
strategies from this dissertation from bovine chondrocytes into canine cells would help bridge 
the gap between the appreciably different bovine and human in vitro model systems. Once the 
canine constructs have been sufficiently characterized to produce accurate, predictive 
computational models of their growth, it will be possible to more fully inform studies with 
larger, channeled canine constructs. By the time in vivo canine studies are realized, we hope that 
sufficient groundwork will have been laid to both computationally and experimentally 
investigate the scaling up of human constructs, given their different behavior and nutrient 
requirements. 
An ultimate culmination of the studies performed herein would be the ability to cultivate 
articular surface-sized, human tissue-engineered cartilage constructs, with sufficient functional 
properties to withstand the mechanical environment of the joint, by incorporating nutrient 
channels and by facilitating experiments with informed computational models. Although this 
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goal is lofty, many potential tools with which to attain it are placed forth by this dissertation, and 
through this body of work it is hoped that these tools are of avail to researchers in the field of 







Adkisson, H. D. t. Martin, J. A. Amendola, R. L. Milliman, C. Mauch, K. A. Katwal, A. B. Seyedin, M. 
Amendola, A. Streeter, P. R. Buckwalter, J. A., 2010. The potential of human allogeneic juvenile 
chondrocytes for restoration of articular cartilage. Am J Sports Med 38, 1324-1333. 
 
Akizuki, S. Mow, V. C. Müller, F. Pita, J. C. Howell, D. S. Manicourt, D. H., 1986. Tensile properties of 
human knee joint cartilage: I. Influence of ionic conditions, weight bearing, and fibrillation on the tensile 
modulus. Journal of Orthopaedic Research 4, 379-392. 
 
Albro, M. B. Chahine, N. O. Li, R. Yeager, K. Hung, C. T. Ateshian, G. A., 2008. Dynamic loading of 
deformable porous media can induce active solute transport. Journal of Biomechanics 41, 3152-3157. 
 
Albro, M. B. Nims, R. J. Cigan, A. D. Yeroushalmi, K. J. Alliston, T. Hung, C. T. Ateshian, G. A., 2013a. 
Accumulation of exogenous activated TGF-beta in the superficial zone of articular cartilage. Biophys J 
104, 1794-1804. 
 
Albro, M. B. Nims, R. J. Cigan, A. D. Yeroushalmi, K. J. Shim, J. J. Chen, Y. B. C. Hung, C. T. Ateshian, G. A., 
2013b. Dynamic mechanical compression of articular cartilage does not activate latent TGF-beta. In 59th 
Annual Meeting of the Orthopaedic Research Society. San Antonio, TX, USA. 
 
Albro, M. B. Nims, R. J. Durney, K. M. Cigan, A. D. Shim, J. J. Vunjak-Novakovic, G. Hung, C. T. Ateshian, G. 
A., 2016. Heterogeneous engineered cartilage growth results from gradients of media-supplemented 
active TGF-beta and is ameliorated by the alternative supplementation of latent TGF-beta. Biomaterials 
77, 173-185. 
 
Alegre-Aguaron, E. Sampat, S. R. Xiong, J. C. Colligan, R. M. Bulinski, J. C. Cook, J. L. Ateshian, G. A. 
Brown, L. M. Hung, C. T., 2014. Growth factor priming differentially modulates components of the 
extracellular matrix proteome in chondrocytes and synovium-derived stem cells. PLoS One 9, e88053. 
 
Alexopoulos, L. G. Williams, G. M. Upton, M. L. Setton, L. A. Guilak, F., 2005. Osteoarthritic changes in 
the biphasic mechanical properties of the chondrocyte pericellular matrix in articular cartilage. Journal 
of Biomechanics 38, 509-517. 
 
Anderson, G. J. Vulpe, C. D., 2009. Mammalian iron transport. Cell Mol Life Sci 66, 3241-3261. 
 
Armstrong, C. G. Lai, W. M. Mow, V. C., 1984. An analysis of the unconfined compression of articular 
cartilage. J Biomech Eng 106, 165-173. 
 
Ateshian, G. A. Nims, R. J. Maas, S. Weiss, J. A., Computational modeling of chemical reactions and 
interstitial growth and remodeling involving charged solutes and solid-bound molecules, Biomechanics 




Ateshian, G. A. Rajan, V. Chahine, N. O. Canal, C. E. Hung, C. T., 2009. Modeling the matrix of articular 
cartilage using a continuous fiber angular distribution predicts many observed phenomena. J Biomech 
Eng 131,  
 
Athanasiou, K. Rosenwasser, M. Buckwalter, J. Malinin, T. Mow, V., 1991. Interspecies comparisons of in 
situ intrinsic mechanical properties of distal femoral cartilage. Journal of Orthopaedic Research 9, 330-
340. 
 
Awad, H. A. Wickham, M. Q. Leddy, H. A. Gimble, J. M. Guilak, F., 2004. Chondrogenic differentiation of 
adipose-derived adult stem cells in agarose, alginate, and gelatin scaffolds. Biomaterials 25, 3211-3222. 
 
Bank, R. A. Krikken, M. Beekman, B. Stoop, R. Maroudas, A. Lafebers, F. P. Te Koppele, J. M., 1997. A 
simplified measurement of degraded collagen in tissues: application in healthy, fibrillated and 
osteoarthritic cartilage. Matrix Biol 16, 233-243. 
 
Barbero, A. Ploegert, S. Heberer, M. Martin, I., 2003. Plasticity of clonal populations of dedifferentiated 
adult human articular chondrocytes. Arthritis & Rheumatism 48, 1315-1325. 
 
Bartel, D. L. Bicknell, V. Wright, T., 1986. The effect of conformity, thickness, and material on stresses in 
ultra-high molecular weight components for total joint replacement. J Bone Joint Surg Am 68, 1041-
1051. 
 
Basalo, I. M. Mauck, R. L. Kelly, T. A. Nicoll, S. B. Chen, F. H. Hung, C. T. Ateshian, G. A., 2004. Cartilage 
interstitial fluid load support in unconfined compression following enzymatic digestion. Journal of 
biomechanical engineering 126, 779-786. 
 
Bentley, G. Biant, L. C. Carrington, R. W. Akmal, M. Goldberg, A. Williams, A. M. Skinner, J. A. Pringle, J., 
2003. A prospective, randomised comparison of autologous chondrocyte implantation versus 
mosaicplasty for osteochondral defects in the knee. J Bone Joint Surg Br 85, 223-230. 
 
Benya, P. D. Shaffer, J. D., 1982. Dedifferentiated chondrocytes reexpress the differentiated collagen 
phenotype when cultured in agarose gels. Cell 30, 215-224. 
 
Bhumiratana, S. Eton, R. E. Oungoulian, S. R. Wan, L. Q. Ateshian, G. A. Vunjak-Novakovic, G., 2014. 
Large, stratified, and mechanically functional human cartilage grown in vitro by mesenchymal 




Bian, L. Angione, S. L. Ng, K. W. Lima, E. G. Williams, D. Y. Mao, D. Q. Ateshian, G. A. Hung, C. T., 2009a. 
Influence of decreasing nutrient path length on the development of engineered cartilage. Osteoarthritis 
Cartilage 17, 677-685. 
 
Bian, L. Crivello, K. M. Ng, K. W. Xu, D. Williams, D. Y. Ateshian, G. A. Hung, C. T., 2009b. Influence of 
temporary chondroitinase ABC-induced glycosaminoglycan suppression on maturation of tissue-
engineered cartilage. Tissue Eng Part A 15, 2065-2072. 
 
Bian, L. Fong, J. V. Lima, E. G. Stoker, A. M. Ateshian, G. A. Cook, J. L. Hung, C. T., 2010. Dynamic 
mechanical loading enhances functional properties of tissue-engineered cartilage using mature canine 
chondrocytes. Tissue Eng Part A 16, 1781-1790. 
 
Bian, L. Zhai, D. Y. Mauck, R. L. Burdick, J. A., 2011. Coculture of human mesenchymal stem cells and 
articular chondrocytes reduces hypertrophy and enhances functional properties of engineered cartilage. 
Tissue Eng Part A 17, 1137-1145. 
 
Bjare, U., 1992. Serum-free cell culture. Pharmacol Ther 53, 355-374. 
 
Bollet, A. J. Nance, J. L., 1966. Biochemical findings in normal and osteoarthritic articular cartilage. II. 
Chondroitin sulfate concentration and chain length, water, and ash content. Journal of Clinical 
Investigation 45, 1170. 
 
Bonet, J. Wood, R. D. (1997). Nonlinear continuum mechanics for finite element analysis. New York, 
Cambridge University Press: 117-143. 
 
Bottenstein, J. E. Sato, G. H., 1979. Growth of a rat neuroblastoma cell line in serum-free supplemented 
medium. Proc Natl Acad Sci USA 76, 514-517. 
 
Bounelis, P. Daniel, J. C., 1983. The effect of ascorbate on embryonic chick sternal chondrocytes cultured 
in agarose. Tissue Cell 15, 683-693. 
 
Brittberg, M. Lindahl, A. Nilsson, A. Ohlsson, C. Isaksson, O. Peterson, L., 1994. Treatment of deep 
cartilage defects in the knee with autologous chondrocyte transplantation. New england journal of 
medicine 331, 889-895. 
 
Brittberg, M. Nilsson, A. Lindahl, A. Ohlsson, C. Peterson, L., 1996. Rabbit articular cartilage defects 





Broom, N., 1988. The collagen framework of articular cartilage: its profound influence on normal and 
abnormal load-bearing function. Collagen: Chemistry, Biology, and Biotechnology 2, 243-265. 
 
Buckley, C. T. Thorpe, S. D. Kelly, D. J., 2009. Engineering of large cartilaginous tissues through the use of 
microchanneled hydrogels and rotational culture. Tissue Eng Part A 15, 3213-3220. 
 
Buckwalter, J. Mankin, H., 1997a. Articular cartilage: degeneration and osteoarthritis, repair, 
regeneration, and transplantation. Instructional course lectures 47, 487-504. 
 
Buckwalter, J. Mankin, H., 1997b. Articular cartilage: tissue design and chondrocyte-matrix interactions. 
Instructional course lectures 47, 477-486. 
 
Buckwalter, J. Rosenberg, L., 1982. Electron microscopic studies of cartilage proteoglycans. Direct 
evidence for the variable length of the chondroitin sulfate-rich region of proteoglycan subunit core 
protein. Journal of Biological Chemistry 257, 9830-9839. 
 
Buckwalter, J. A. Mow, V. C. Ratcliffe, A., 1994a. Restoration of injured or degenerated articular 
cartilage. Journal of the American Academy of Orthopaedic Surgeons 2, 192-201. 
 
Buckwalter, J. A. Roughley, P. J. Rosenberg, L. C., 1994b. Age-Related changes in cartilage proteoglycans: 
Quantitative electron microscopic studies. Microscopy Research and Technique 28, 398-408. 
 
Buschmann, M. D. Gluzband, Y. A. Grodzinsky, A. J. Kimura, J. H. Hunziker, E. B., 1992. Chondrocytes in 
agarose culture synthesize a mechanically functional extracellular matrix. J Orthop Res 10, 745-758. 
 
Buschmann, M. D. Kim, Y.-J. Wong, M. Frank, E. Hunziker, E. B. Grodzinsky, A. J., 1999. Stimulation of 
Aggrecan Synthesis in Cartilage Explants by Cyclic Loading Is Localized to Regions of High Interstitial Fluid 
Flow. Arch Biochem Biophys 366, 1-7. 
 
Butler, D. L. Awad, H. A., 1999. Perspectives on cell and collagen composites for tendon repair. Clin 
Orthop Relat Res S324-332. 
 
Byers, B. A. Mauck, R. L. Chiang, I. E. Tuan, R. S., 2008. Transient exposure to transforming growth factor 
beta 3 under serum-free conditions enhances the biomechanical and biochemical maturation of tissue-
engineered cartilage. Tissue Eng Part A 11, 1821-1834. 
 
Caligaris, M. Canal, C. E. Ahmad, C. S. Gardner, T. R. Ateshian, G. A., 2009. Investigation of the frictional 
response of osteoarthritic human tibiofemoral joints and the potential beneficial tribological effect of 




Cartmell, S. H. Porter, B. D. Garcia, A. J. Guldberg, R. E., 2003. Effects of medium perfusion rate on cell-
seeded three-dimensional bone constructs in vitro. Tissue Eng 9,  
 
Chahine, N. O. Albro, M. B. Lima, E. G. Wei, V. I. Dubois, C. R. Hung, C. T. Ateshian, G. A., 2009. Effect of 
dynamic loading on the transport of solutes into agarose hydrogels. Biophysical Journal 97, 968-975. 
 
Cigan, A. D. Nims, R. J. Albro, M. B. Breves, S. L. Hung, C. T. Ateshian, G. A. (2012). Insulin and ascorbate 
have a much greater influence than transferrin and selenous acid on the growth of engineered cartilage 
in chondrogenic media. ASME 2012 Summer Bioengineering Conference. Fajardo, PR, USA. 
 
Cigan, A. D. Nims, R. J. Albro, M. B. Esau, J. D. Dreyer, M. P. Vunjak-Novakovic, G. Hung, C. T. Ateshian, G. 
A., 2013a. Insulin, ascorbate, and glucose have a much greater influence than transferrin and selenous 
acid on the in vitro growth of engineered cartilage in chondrogenic media. Tissue Eng Part A 19, 1941-
1948. 
 
Cigan, A. D. Nims, R. J. Albro, M. B. Hung, C. T. Ateshian, G. A., 2013b. Effects of media stirring and 
presence of nutrient channels on functional properties of large engineered cartilage constructs. In 
Proceedings of the ASME Summer Bioengineering Conference. Sunriver, OR, USA. 
 
Cigan, A. D. Nims, R. J. Albro, M. B. Jones, B. K. Feingold, H. J. Vunjak‐Novakovic, G. Hung, C. T. Ateshian, 
G. A., 2015. Characterization of a Human Chondrocyte-Agarose System for Engineering Cartilage: The 
Importance of Cell Seeding Density. In Orthopaedic Research Society 2015 Annual Meeting. Las Vegas, 
NV. 
 
Cigan, A. D. Nims, R. J. Albro, M. B. Quien, M. M. Atkatsh, K. Hung, C. T. Ateshian, G. A., 2014a. Elevated 
matrix production in large engineered cartilage constructs significantly facilitated by nutrient channels 
and sufficient media. In 60th Annual Meeting of the Orthopaedic Research Society. New Orleans, LA, 
USA. 
 
Cigan, A. D. Nims, R. J. Albro, M. B. Quien, M. M. Vunjak-Novakovic, G. Hung, C. T. Ateshian, G. A., 2013c. 
Identification of a glucose concentration threshold critical for tissue growth in engineered cartilage. In 
59th Annual Meeting of the Orthopaedic Research Society. San Antonio, TX, USA. 
 
Cigan, A. D. Nims, R. J. Albro, M. B. Vunjak-Novakovic, G. Hung, C. T. Ateshian, G. A., 2014b. Nutrient 
channels and stirring enhanced the composition and stiffness of large cartilage constructs. J Biomech 47, 
3847-3854. 
 
Cigan, A. D. Nims, R. J. Vunjak‐Novakovic, G. Hung, C. T. Ateshian, G. A., 2016a. Human-scale engineered 
cartilage with nutrient channels reaches native mechanical and biochemical properties. In Orthopaedic 




Cigan, A. D. Nims, R. J. Vunjak‐Novakovic, G. Hung, C. T. Ateshian, G. A., 2016b. Nutrient channels aid the 
growth of articular surface-sized engineered cartilage constructs. In preparation  
 
Cigan, A. D. Nims, R. J. Vunjak‐Novakovic, G. Hung, C. T. Ateshian, G. A., 2016c. Optimizing nutrient 
channel spacing and revisiting TGF-beta in large engineered cartilage constructs. J Biomech In Review,  
 
Cigan, A. D. Roach, B. L. Nims, R. J. Tan, A. R. Albro, M. B. Stoker, A. M. Cook, J. L. Vunjak‐Novakovic, G. 
Hung, C. T. Ateshian, G. A., 2016d. High seeding density of human chondrocytes in agarose produces 
tissue-engineered cartilage approaching native mechanical and biochemical properties. J Biomech In 
revision,  
 
Cima, L. G. Vacanti, J. P. Vacanti, C. Ingber, D. Mooney, D. Langer, R., 1991. Tissue engineering by cell 
transplantation using degradable polymer substrates. J Biomech Eng 113, 143-151. 
 
Clarke, I. C., 1971. Articular cartilage: a review and scanning electron microscope study 1. The 
interterritorial fibrillar architecture. Journal of Bone & Joint Surgery, British Volume 53, 732-750. 
 
Clavé, A. Potel, J. F. Servien, E. Neyret, P. Dubrana, F. Stindel, E., 2016. Third‐generation autologous 
chondrocyte implantation versus mosaicplasty for knee cartilage injury: 2‐year randomized trial. J 
Orthop Res 34, 658-665. 
 
ClinicalTrials.Gov (2007). "Comparison of autologous chondrocyte implantation versus mosaicplasty: a 




Cohen, Z. A. Mow, V. C. Henry, J. H. Levine, W. N. Ateshian, G. A., 2003. Templates of the cartilage layers 
of the patellofemoral joint and their use in the assessment of osteoarthritic cartilage damage. 
Osteoarthritis Cartilage 11, 569-579. 
 
Curl, W. W. Krome, J. Gordon, E. S. Rushing, J. Smith, B. P. Poehling, G. G., 1997. Cartilage injuries: a 
review of 31,516 knee arthroscopies. Arthroscopy 13, 456-460. 
 
Davisson, T. Sah, R. L. Ratcliffe, A., 2002. Perfusion increases cell content and matrix synthesis in 
chondrocyte three-dimensional cultures. Tissue Engineering 8, 807-816. 
 
de Mara, C. S. Duarte, A. S. Sartori-Cintra, A. R. Luzo, A. C. Saad, S. T. Coimbra, I. B., 2013. 





Dehne, T. Karlsson, C. Ringe, J. Sittinger, M. Lindahl, A., 2009. Chondrogenic differentiation potential of 
osteoarthritic chondrocytes and their possible use in matrix-associated autologous chondrocyte 
transplantation. Arthritis Res Ther 11, R133. 
 
Dell'Accio, F. De Bari, C. Luyten, F. P., 2001. Molecular markers predictive of the capacity of expanded 
human articular chondrocytes to form stable cartilage in vivo. Arthritis & Rheumatism 44, 1608-1619. 
 
Doege, K. J. Sasaki, M. Kimura, T. Yamada, Y., 1991. Complete coding sequence and deduced primary 
structure of the human cartilage large aggregating proteoglycan, aggrecan. Human-specific repeats, and 
additional alternatively spliced forms. Journal of Biological Chemistry 266, 894-902. 
 
Donnan, F. G., 1924. The theory of membrane equilibria. Chemical Reviews 1, 73-90. 
 
Edwards, J., 1966. Paper 6: Physical Characteristics of Articular Cartilage. In Proceedings of the 
Institution of Mechanical Engineers, Conference Proceedings, SAGE Publications. 
 
Eleswarapu, S. V. Athanasiou, K. A., 2013. TRPV4 channel activation improves the tensile properties of 
self-assembled articular cartilage constructs. Acta Biomater 9, 5554-5561. 
 
Estell, E. G. Tan, A. R. Bansal, S. Ateshian, G. A. Hung, C. T., 2015. Modulation of hydrogel crosslinking 
density to promote development of functional mechanical properties in engineered cartilage. In 
Orthopaedic Research Society 2015 Annual Meeting. Las Vegas, NV, USA. 
 
Farndale, R. W. Buttle, D. J. Barrett, A. J., 1986. Improved quantitation and discrimination of sulphated 
glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 883, 173-177. 
 
Fernandes, A. M. Herlofsen, S. R. Karlsen, T. A. Küchler, A. M. Fløisand, Y. Brinchmann, J. E., 2013. Similar 
properties of chondrocytes from osteoarthritis joints and mesenchymal stem cells from healthy donors 
for tissue engineering of articular cartilage.  
 
Fetter, N. L. Leddy, H. A. Guilak, F. Nunley, J. A., 2006. Composition and transport properties of human 
ankle and knee cartilage. J Orthop Res 24, 211-219. 
 
Francioli, S. E. Martin, I. Sie, C. P. Hagg, R. Tommasini, R. Candrian, C. Heberer, M. Barbero, A., 2007. 
Growth factors for clinical-scale expansion of human articular chondrocytes: relevance for automated 
bioreactor systems. Tissue Eng 13, 1227-1234. 
 
Freed, L. Vunjak‐Novakovic, G. Langer, R., 1993. Cultivation of cell‐polymer cartilage implants in 




Freed, L. E. Marquis, J. C. Langer, R. Vunjak-Novakovic, G., 1994. Kinetics of chondrocyte growth in cell-
polymer implants. Biotechnol Bioeng 43, 597-604. 
 
Freed, L. E. Vunjak-Novakovic, G., 1997. Microgravity tissue engineering. In Vitro Cellular & 
Developmental Biology-Animal 33, 381-385. 
 
Gadjanski, I. Yodmuang, S. Spiller, K. Bhumiratana, S. Vunjak-Novakovic, G., 2013. Supplementation of 
Exogenous Adenosine 5′-Triphosphate Enhances Mechanical Properties of 3D Cell–Agarose Constructs 
for Cartilage Tissue Engineering. Tissue Eng Part A 19, 2188-2200. 
 
Gan, L. Kandel, R. A., 2007. In vitro cartilage tissue formation by co-culture of primary and passaged 
chondrocytes. Tissue Eng 13, 831-842. 
 
Gey, G. O. Thalhimer, W., 1924. Observations on the effects of insulin introduced into the medium of 
tissue cultures. JAMA 82, 1609. 
 
Ghone, N. V. Grayson, W. L., 2012. Recapitulation of mesenchymal condensation enhances in vitro 
chondrogenesis of human mesenchymal stem cells. J Cell Physiol 227, 3701-3708. 
 
Gilmore, R. S. Palfrey, A. J., 1988. Chondrocyte distribution in the articular cartilage of human femoral 
condyles. Journal of anatomy 157, 23-31. 
 
Gleghorn, J. Jones, A. Flannery, C. Bonassar, L., 2007. Boundary mode frictional properties of engineered 
cartilaginous tissues. Eur Cell Mater 14, 20-29. 
 
Gratz, K. R. Wong, V. W. Chen, A. C. Fortier, L. A. Nixon, A. J. Sah, R. L., 2006. Biomechanical assessment 
of tissue retrieved after in vivo cartilage defect repair: tensile modulus of repair tissue and integration 
with host cartilage. J Biomech 39, 138-146. 
 
Grayson, W. L. Bhumiratana, S. Grace Chao, P. H. Hung, C. T. Vunjak-Novakovic, G., 2010. Spatial 
regulation of human mesenchymal stem cell differentiation in engineered osteochondral constructs: 
effects of pre-differentiation, soluble factors and medium perfusion. Osteoarthritis Cartilage 18, 714-
723. 
 
Gruber, H. Lachman, R. Rimoin, D., 1990. Quantitative histology of cartilage vascular canals in the human 
rib. Findings in normal neonates and children and in achondrogenesis II-hypochondrogenesis. J Anat 
173, 69. 
 




Handorf, A. M. Li, W. J., 2011. Fibroblast growth factor-2 primes human mesenchymal stem cells for 
enhanced chondrogenesis. PLoS One 6, e22887. 
 
Hangody, L. Kish, G. Karpati, Z. Szerb, I. Udvarhelyi, I., 1997. Arthroscopic autogenous osteochondral 
mosaicplasty for the treatment of femoral condylar articular defects A preliminary report. Knee Surgery, 
Sports Traumatology, Arthroscopy 5, 262-267. 
 
Hardingham, T., 1981. Proteoglycans: their structure, interactions and molecular organization in 
cartilage. Biochemical Society Transactions 9, 489-497. 
 
Helmy, M. H. Ismail, S. S. Fayed, H. El-Bassiouni, E. A., 2000. Effect of selenium supplementation on the 
activities of glutathione metabolizing enzymes in human hepatoma Hep G2 cell line. Toxicology 144, 57-
61. 
 
Heywood, H. K. Bader, D. L. Lee, D. A., 2006a. Glucose concentration and medium volume influence cell 
viability and glycosaminoglycan synthesis in chondrocyte-seeded alginate constructs. Tissue Eng 12, 
3487-3496. 
 
Heywood, H. K. Bader, D. L. Lee, D. A., 2006b. Rate of oxygen consumption by isolated articular 
chondrocytes is sensitive to medium glucose concentration. J Cell Physiol 206, 402-410. 
 
Hollander, A. P. Heathfield, T. F. Webber, C. Iwata, Y. Bourne, R. Rorabeck, C. Poole, A. R., 1994. 
Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new 
immunoassay. J Clin Invest 93, 1722-1732. 
 
Hu, J. C. Athanasiou, K. A., 2006. A self-assembling process in articular cartilage tissue engineering. 
Tissue Eng 12, 969-979. 
 
Huang, A. H. Baker, B. M. Ateshian, G. A. Mauck, R. L., 2012. Sliding contact loading enhances the tensile 
properties of mesenchymal stem cell-seeded hydrogels. Eur Cell Mater 24,  
 
Huang, C. Y. Gu, W. Y., 2007. Effects of tension-compression nonlinearity on solute transport in charged 
hydrated fibrous tissues under dynamic unconfined compression. J Biomech Eng 129, 423-429. 
 
Huang, C. Y. Stankiewicz, A. Ateshian, G. A. Mow, V. C., 2005. Anisotropy, inhomogeneity, and tension-





Hung, C. T. Lima, E. G. Mauck, R. L. Takai, E. LeRoux, M. A. Lu, H. H. Stark, R. G. Guo, X. E. Ateshian, G. A., 
2003. Anatomically shaped osteochondral constructs for articular cartilage repair. J Biomech 36, 1853-
1864. 
 
Hung, C. T. Mauck, R. L. Wang, C. C. Lima, E. G. Ateshian, G. A., 2004. A paradigm for functional tissue 
engineering of articular cartilage via applied physiologic deformational loading. Ann Biomed Eng 32, 35-
49. 
 
Hutton Jr., J. J. Trappel, A. L. Udenfriend, S., 1966. Requirements for alpha-ketoglutarate, ferrous ion and 
ascorbate by collagen proline hydroxylase. Biochem Biophys Res Commun 24, 179-184. 
 
Ibold, Y. Lubke, C. Pelz, S. Augst, H. Kaps, C. Ringe, J. Sittinger, M., 2009. Effect of different ascorbate 
supplementations on in vitro cartilage formation in porcine high-density pellet cultures. Tissue Cell 41, 
249-256. 
 
Ichinose, S. Yamagata, K. Sekiya, I. Muneta, T. Tagami, M., 2005. Detailed examination of cartilage 
formation and endochondral ossification using human mesenchymal stem cells. Clinical and 
experimental pharmacology and physiology 32, 561-570. 
 
Jadin, K. D. Wong, B. L. Bae, W. C. Li, K. W. Williamson, A. K. Schumacher, B. L. Price, J. H. Sah, R. L., 
2005. Depth-varying density and organization of chondrocytes in immature and mature bovine articular 
cartilage assessed by 3d imaging and analysis. J Histochem Cytochem 53, 1109-1119. 
 
Jakob, M. Demarteau, O. Schafer, D. Hintermann, B. Dick, W. Heberer, M. Martin, I., 2001. Specific 
growth factors during the expansion and redifferentiation of adult human articular chondrocytes 
enhance chondrogenesis and cartilaginous tissue formation in vitro. J Cell Biochem 81, 368-377. 
 
Jeffrey, J. J. Martin, G. R., 1966. The role of ascorbic acid in the biosynthesis of collagen. II. Site and 
nature of ascorbic acid participation. Biochim Biophys Acta 121, 281-291. 
 
Johnstone, B. Alini, M. Cucchiarini, M. Dodge, G. R. Eglin, D. Guilak, F. Madry, H. Mata, A. Mauck, R. L. 
Semino, C. E. Stoddart, M. J., 2013. Tissue engineering for articular cartilage repair--the state of the art. 
Eur Cell Mater 25, 248-267. 
 
Johnstone, B. Hering, T. M. Caplan, A. I. Goldberg, V. M. Yoo, J. U., 1998. In vitrochondrogenesis of bone 
marrow-derived mesenchymal progenitor cells. Experimental cell research 238, 265-272. 
 
Johnstone, B. Yoo, J. U., 1999. Autologous mesenchymal progenitor cells in articular cartilage repair. 




Jones, W. R. Ting-Beall, H. P. Lee, G. M. Kelley, S. S. Hochmuth, R. M. Guilak, F., 1999. Alterations in the 
Young’s modulus and volumetric properties of chondrocytes isolated from normal and osteoarthritic 
human cartilage. Journal of Biomechanics 32, 119-127. 
 
Jungmann, P. M. Mehlhorn, A. T. Schmal, H. Schillers, H. Oberleithner, H. Südkamp, N. P., 2012. 
Nanomechanics of human adipose-derived stem cells: small GTPases impact chondrogenic 
differentiation. Tissue Engineering Part A 18, 1035-1044. 
 
Kafienah, W. e. Jakob, M. Démarteau, O. Frazer, A. Barker, M. D. Martin, I. Hollander, A. P., 2002. Three-
dimensional tissue engineering of hyaline cartilage: comparison of adult nasal and articular 
chondrocytes. Tissue engineering 8, 817-826. 
 
Kelly, T. A. Ng, K. W. Ateshian, G. A. Hung, C. T., 2009. Analysis of radial variations in material properties 
and matrix composition of condrocyte-seeded agarose hydrogel constructs. Osteoarthritis and Cartilage 
17, 73-82. 
 
Kelly, T. A. Ng, K. W. Wang, C. C. Ateshian, G. A. Hung, C. T., 2006. Spatial and temporal development of 
chondrocyte-seeded agarose constructs in free-swelling and dynamically loaded cultures. J Biomech 39, 
1489-1497. 
 
Kelly, T. A. Roach, B. L. Weidner, Z. D. Mackenzie-Smith, C. R. O'Connell, G. D. Lima, E. G. Stoker, A. M. 
Cook, J. L. Ateshian, G. A. Hung, C. T., 2013. Tissue-engineered articular cartilage exhibits tension-
compression nonlinearity reminiscent of the native cartilage. J Biomech 46, 1784-1791. 
 
Kelly, T. N. Fisher, M. B. Oswald, E. S. Tai, T. Mauck, R. L. Ateshian, G. A. Hung, C. T., 2008. Low-serum 
media and dynamic deformational loading in tissue engineering of articular cartilage. Annals of 
Biomedical Engineering 36, 769-779. 
 
Kempson, G. Tuke, M. Dingle, J. Barrett, A. Horsefield, P., 1976. The effects of proteolytic enzymes on 
the mechanical properties of adult human articular cartilage. Biochimica et Biophysica Acta (BBA)-
General Subjects 428, 741-760. 
 
Kim, Y.-J. Bonassar, L. J. Grodzinsky, A. J., 1995. The role of cartilage streaming potential, fluid flow and 
pressure in the stimulation of chondrocyte biosynthesis during dynamic compression. J Biomech 28, 
1055-1066. 
 
Kisiday, J. D. Kurz, B. DiMicco, M. A. Grodzinsky, A. J., 2005. Evaluation of medium supplemented with 
insulin-transferrin-selenium for culture of primary bovine calf chondrocytes in three-dimensional 




Kotlarz, H. Gunnarsson, C. L. Fang, H. Rizzo, J. A., 2009. Insurer and out‐of‐pocket costs of osteoarthritis 
in the US: Evidence from national survey data. Arthritis & Rheumatism 60, 3546-3553. 
 
Krishnan, R. Park, S. Eckstein, F. Ateshian, G. A., 2003. Inhomogeneous cartilage properties enhance 
superficial interstitial fluid support and frictional properties, but do not provide a homogeneous state of 
stress. J Biomech Eng 125, 569-577. 
 
Lai, W. Hou, J. Mow, V., 1991. A triphasic theory for the swelling and deformation behaviors of articular 
cartilage. Journal of biomechanical engineering 113, 245-258. 
 
Langer, R. Vacanti, J. P., 1993. Tissue engineering. Science 260, 920-926. 
 
Latunde-Dada, G. O. Simpson, R. J. (2010). Regulation of Iron Absorption and Distribution. Iron 
Deficiency and Overload. S. Yehuda and D. I. Mostofsky. New York, NY, Humana Press: 31-49. 
 
Lawrence, R. C. Felson, D. T. Helmick, C. G. Arnold, L. M. Choi, H. Deyo, R. A. Gabriel, S. Hirsch, R. 
Hochberg, M. C. Hunder, G. G. Jordan, J. M. Katz, J. N. Kremers, H. M. Wolfe, F., 2008. Estimates of the 
prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 58, 
26-35. 
 
Lee, H. Y. Han, L. Roughley, P. J. Grodzinsky, A. J. Ortiz, C., 2013. Age-related nanostructural and 
nanomechanical changes of individual human cartilage aggrecan monomers and their 
glycosaminoglycan side chains. J Struct Biol 181, 264-273. 
 
Lehmann, M. Martin, F. Mannigel, K. Kaltschmidt, K. Sack, U. Anderer, U., 2013. Three-dimensional 
scaffold-free fusion culture: the way to enhanced chondrogenesis of in vitro propagated human articular 
chondrocytes. European journal of histochemistry: EJH 57,  
 
Levene, C., 1964. THE PATTERNS OF CARTILAGE CANALS. J Anat 98, 515-538. 
 
Li, K. W. Williamson, A. K. Wang, A. S. Sah, R. L., 2001. Growth responses of cartilage to static and 
dynamic compression. Clinical orthopaedics and related research 391, S34-S48. 
 
Lima, E. G. Bian, L. Ng, K. W. Mauck, R. L. Byers, B. A. Tuan, R. S. Ateshian, G. A. Hung, C. T., 2007. The 
beneficial effect of delayed compressive loading on tissue-engineered cartilage constructs cultured with 
TGF-beta3. Osteoarthritis Cartilage 15, 1025-1033. 
 
Linn, F. C. Sokoloff, L., 1965. Movement and composition of interstitial fluid of cartilage. Arthritis & 




Long, M. Rack, H. J., 1998. Titanium alloys in total joint replacement—a materials science perspective. 
Biomaterials 19, 1621-1639. 
 
Maas, S. A. Ellis, B. J. Ateshian, G. A. Weiss, J. A., 2012a. FEBio: finite elements for biomechanics. J 
Biomech Eng 134,  
 
Maas, S. A. Ellis, B. J. Ateshian, G. A. Weiss, J. A., 2012b. FEBio: finite elements for biomechanics. Journal 
of biomechanical engineering 134,  
 
Maidhof, R. Marsano, A. Lee, E. J. Vunjak-Novakovic, G., 2010. Perfusion seeding of channeled 
elastomeric scaffolds with myocytes and endothelial cells for cardiac tissue engineering. Biotechnol Prog 
26,  
 
Mankin, H. J. Thrasher, A., 1975. Water content and binding in normal and osteoarthritic human 
cartilage. J Bone Joint Surg Am 57, 76-80. 
 
Marcus, R. Srivastava, V., 1973. Effect of low oxygen tensions on glucose-metabolizing enzymes in 
cultured articular chondrocytes. Experimental Biology and Medicine 143, 488-491. 
 
Maroudas, A., 1979. Physicochemical properties of articular cartilage. Adult articular cartilage 2, 215-
290. 
 
Marsano, A. Maidhof, R. Tandon, N. Gao, J. Wang, Y. Vunjak-Novakovic, G., 2008. Engineering of 
functional contractile cardiac tissues cultured in a perfusion system. IEEE Eng Med Biol Soc 2008,  
 
Mauck, R. L. Hung, C. T. Ateshian, G. A., 2003a. Modeling of neutral solute transport in a dynamically 
loaded porous permeable gel: implications for articular cartilage biosynthesis and tissue engineering. J 
Biomech Eng 125, 602-614. 
 
Mauck, R. L. Nicoll, S. B. Seyhan, S. L. Ateshian, G. A. Hung, C. T., 2003b. Synergistic action of growth 
factors and dynamic loading for articular cartilage tissue engineering. Tissue Engineering 9, 597-611. 
 
Mauck, R. L. Seyhan, S. L. Ateshian, G. A. Hung, C. T., 2002. Influence of seeding density and dynamic 
deformational loading on the developing structure/function relationships of chondrocyte-seeded 
agarose hydrogels. Ann Biomed Eng 30, 1046-1056. 
 
Mauck, R. L. Soltz, M. A. Wang, C. C. Wong, D. D. Chao, P. H. Valhmu, W. B. Hung, C. T. Ateshian, G. A., 
2000. Functional tissue engineering of articular cartilage through dynamic loading of chondrocyte-




McGowan, K. B. Kurtis, M. S. Lottman, L. M. Watson, D. Sah, R. L., 2002. Biochemical quantification of 
DNA in human articular and septal cartilage using PicoGreen and Hoechst 33258. Osteoarthritis Cartilage 
10, 580-587. 
 
Mesallati, T. Buckley, C. T. Nagel, T. Kelly, D. J., 2011. Introducing microchannels into chondrocyte-
seeded agarose hydrogels influences matrix accumulation in response to dynamic compression and tgf-
B3 stimulation. IFMBE Proc 30, 26-30. 
 
Mesallati, T. Sheehy, E. Vinardell, T. Buckley, C. Kelly, D., 2015. Tissue engineering scaled-up, 
anatomically shaped osteochondral constructs for joint resurfacing. European Cells and Materials 30, 
163-186. 
 
Mobasheri, A. Vannucci, S. J. Bondy, C. A. Carter, S. D. Innes, J. F. Arteaga, M. F. Trujillo, E. Ferraz, I. 
Shakibaei, M. Martin-Vasallo, P., 2002. Glucose transport and metabolism in chondrocytes: a key to 
understanding chondrogenesis, skeletal development and cartilage degradation in osteoarthritis. Histol 
Histopathol 17, 1239-1267. 
 
Moisio, K. Eckstein, F. Chmiel, J. S. Guermazi, A. Prasad, P. Almagor, O. Song, J. Dunlop, D. Hudelmaier, 
M. Kothari, A. Sharma, L., 2009a. Denuded subchondral bone and knee pain in persons with knee 
osteoarthritis. Arthritis Rheum 50, 3703-3710. 
 
Moisio, K. Eckstein, F. Chmiel, J. S. Guermazi, A. Prasad, P. Almagor, O. Song, J. Dunlop, D. Hudelmaier, 
M. Kothari, A. Sharma, L., 2009b. Denuded subchondral bone and knee pain in persons with knee 
osteoarthritis. Arthritis & Rheumatology 50, 3703-3710. 
 
Moutos, F. T. Guilak, F., 2009. Functional properties of cell-seeded three-dimensionally woven poly (ε-
caprolactone) scaffolds for cartilage tissue engineering. Tissue Eng Part A 16, 1291-1301. 
 
Mouw, J. K. Case, N. D. Guldberg, R. E. Plaas, A. H. Levenston, M. E., 2005. Variations in matrix 
composition and GAG fine structure among scaffolds for cartilage tissue engineering. Osteoarthritis 
Cartilage 13, 828-836. 
 
Mow, V. C. Holmes, M. H. Lai, W. M., 1984. Fluid transport and mechanical properties of articular 
cartilage: a review. Journal of Biomechanics 17, 377-394. 
 
Mow, V. C. Kuei, S. C. Lai, W. M. Armstrong, C. G., 1980. Biphasic creep and stress relaxation of articular 




Mow, V. C. Ratcliffe, A. (1997). Structure and Function of Articular Cartilage and Meniscus. Basic 
Orthopaedic Biomechanics. V. C. Mow and W. C. Hayes. Philadelphia, PA, Lippincott-Raven Publishers: 
113-177. 
 
Mow, V. C. Setton, L. Ratcliffe, A. Howell, D. Buckwalter, J., 1990. Structure-function relationships of 
articular cartilage and the effects of joint instability and trauma on cartilage function. Cartilage Changes 
in Osteoarthritis 22-42. 
 
Muir, H. Bullough, P. Maroudas, A., 1970. The distribution of collagen in human articular cartilage with 
some of its physiological implications. Journal of Bone & Joint Surgery, British Volume 52, 554-563. 
 
Murphy, M. K. Huey, D. J. Hu, J. C. Athanasiou, K. A., 2015. TGF-beta1, GDF-5, and BMP-2 stimulation 
induces chondrogenesis in expanded human articular chondrocytes and marrow-derived stromal cells. 
Stem Cells 33, 762-773. 
 
Ng, K. W. Ateshian, G. A. Hung, C. T., 2009a. Zonal chondrocytes seeded in a layered agarose hydrogel 
create engineered cartilage with depth-dependent cellular and mechanical inhomogeneity. Tissue 
Engineering Part A 15, 2315-2324. 
 
Ng, K. W. DeFrancis, J. G. Kugler, L. E. Kelly, T. A. Ho, M. M. O'Conor, C. J. Ateshian, G. A. Hung, C. T., 
2008a. Amino acids supply in culture media is not a limiting factor in the matrix synthesis of engineered 
cartilage tissue. Amino Acids 35, 433-438. 
 
Ng, K. W. Kugler, L. E. Doty, S. B. Ateshian, G. A. Hung, C. T., 2009b. Scaffold degradation elevates the 
collagen content and dynamic compressive modulus in engineered articular cartilage. Osteoarthritis 
Cartilage 17,  
 
Ng, K. W. Lima, E. G. Bian, L. O'Conor, C. J. Jayabalan, P. S. Stoker, A. M. Kuroki, K. Cook, C. R. Ateshian, 
G. A. Cook, J. L., 2009c. Passaged adult chondrocytes can form engineered cartilage with functional 
mechanical properties: a canine model. Tissue Engineering Part A 16, 1041-1051. 
 
Ng, K. W. Lima, E. G. Bian, L. O'Conor, C. J. Jayabalan, P. S. Stoker, A. M. Kuroki, K. Cook, C. R. Ateshian, 
G. A. Cook, J. L. Hung, C. T., 2010. Passaged adult chondrocytes can form engineered cartilage with 
functional mechanical properties: a canine model. Tissue Eng Part A 16, 1041-1051. 
 
Ng, K. W. Mauck, R. L. Wang, C. C. B. Kelly, T.-A. N. Ho, M. M. Y. Chen, F. H. Ateshian, G. A. Hung, C. T., 
2009d. Duty cycle of deformational loading influences the growth of engineered articular cartilage. Cell 




Ng, K. W. O'Conor, C. J. Lima, E. G. Lo, S. B. Ateshian, G. A. Cook, J. L. Hung, C. T., 2008b. Primed mature 
canine chondrocytes can develop an engineered cartilage tissue with physiologic properties. Trans 
Orthop Res Soc 599,  
 
Ng, K. W. Wang, C. C. B. Mauck, R. L. Kelly, T. A. N. Chahine, N. O. Costa, K. D. Ateshian, G. A. Hung, C. T., 
2005. A layered agarose approach to fabricate depth‐dependent inhomogeneity in chondrocyte‐seeded 
constructs. J Orthop Res 23, 134-141. 
 
Nicholson, J. T. Wieder, H. S., Jr., 1956. Total resection of femur with turn-up plasty of tibia and 
prosthetic replacement of hip joint. Ann Surg 144, 271-276. 
 
Nimni, M. E., 1983. Collagen: structure, function, and metabolism in normal and fibrotic tissues. In 
Seminars in arthritis and rheumatism, Elsevier. 
 
Nims, R. J. Cigan, A. D. Albro, M. B. Hung, C. T. Ateshian, G. A., 2014. Synthesis rates and binding kinetics 
of matrix products in engineered cartilage constructs using chondrocyte-seeded agarose gels. J Biomech 
47, 2165-2172. 
 
Nims, R. J. Cigan, A. D. Albro, M. B. Park, D. B. Vunjak-Novakovic, G. Hung, C. T. Ateshian, G. A., 2013. 
Engineered cartilage supplemented with channels increases nutrient availability throughout large 
constructs: a finite element study. In 11th International Symposium, Computer Methods in 
Biomechanics and Biomedical Engineering. Salt Lake City, UT, USA. 
 
Nims, R. J. Cigan, A. D. Albro, M. B. Vunjak-Novakovic, G. Hung, C. T. Ateshian, G. A., 2015. Matrix 
Production in Large Engineered Cartilage Constructs Is Enhanced by Nutrient Channels and Excess Media 
Supply. Tissue Eng Part C 21, 747-757. 
 
Nims, R. J. Durney, K. M. Cigan, A. D. Dusséaux, A. Hung, C. T. Ateshian, G. A., 2016. Continuum theory of 
fibrous tissue damage mechanics using bond kinetics: application to cartilage tissue engineering. 
Interface Focus 6,  
 
Nöth, U. Rackwitz, L. Heymer, A. Weber, M. Baumann, B. Steinert, A. Schütze, N. Jakob, F. Eulert, J., 
2007. Chondrogenic differentiation of human mesenchymal stem cells in collagen type I hydrogels. 
Journal of Biomedical Materials Research Part A 83, 626-635. 
 
Nover, A. B. Jones, B. K. William, T. Y. Donovan, D. S. Podolnick, J. D. Cook, J. L. Ateshian, G. A. Hung, C. 
T., 2016. A Puzzle Assembly Strategy for Fabrication of Large Engineered Cartilage Tissue Constructs. J 




Nover, A. B. Lee, S. L. Georgescu, M. S. Howard, D. R. Saunders, R. A. William, T. Y. Klein, R. W. 
Napolitano, A. P. Ateshian, G. A. Hung, C. T., 2015. Porous titanium bases for osteochondral tissue 
engineering. Acta Biomater 27, 286-293. 
 
O'Connell, G. D. Nims, R. J. Green, J. Cigan, A. D. Ateshian, G. A. Hung, C. T., 2014. Time and dose-
dependent effects of chondroitinase ABC on growth of engineered cartilage. Eur Cell Mater 27, 312-320. 
 
O'Connell, G. D. Tan, A. R. Cui, V. Bulinski, J. C. Cook, J. L. Attur, M. Abramson, S. B. Ateshian, G. A. Hung, 
C. T., 2015. Human chondrocyte migration behaviour to guide the development of engineered cartilage. 
J Tissue Eng Regen Med  
 
O'Conor, C. J. Leddy, H. A. Benefield, H. C. Liedtke, W. B. Guilak, F., 2014. TRPV4-mediated 
mechanotransduction regulates the metabolic response of chondrocytes to dynamic loading. Proc Natl 
Acad Sci USA 111, 1316-1321. 
 
Obradovic, B. Carrier, R. L. Vunjak-Novakovic, G. Freed, L. E., 1999. Gas exchange is essential for 
bioreactor cultivation of tissue engineered cartilage. Biotechnol Bioeng 63, 197-205. 
 
Oswald, E. S. Ahmed, H. S. Kramer, S. P. Bulinski, J. C. Ateshian, G. A. Hung, C. T., 2011. Effects of 
Hypertonic (NaCl) Two-Dimensional and Three-Dimensional Culture Conditions on the Properties of 
Cartilage Tissue Engineered from an Expanded Mature Bovine Chondrocyte Source. Tissue Eng Part C 17, 
1041-1049. 
 
Otte, P., 1991. Basic cell metabolism of articular cartilage. Manometric studies. Z Rheumatol 50, 304-
312. 
 
Oungoulian, S. R. Chang, S. Bortz, O. Hehir, K. E. Zhu, K. Willis, C. E. Hung, C. T. Ateshian, G. A., 2013. 
Articular cartilage wear characterization with a particle sizing and counting analyzer. J Biomech Eng 135, 
024501. 
 
Paige, K. T. Vacanti, C. A., 1995. Engineering new tissue: formation of neo-cartilage. Tissue Engineering 
1, 97-106. 
 
Park, S. Ateshian, G. A., 2006. Dynamic response of immature bovine articular cartilage in tension and 
compression, and nonlinear viscoelastic modeling of the tensile response. J Biomech Eng 128, 623-630. 
 
Peng, G. McNary, S. M. Athanasiou, K. A. Reddi, A. H., 2014. Surface zone articular chondrocytes 
modulate the bulk and surface mechanical properties of the tissue-engineered cartilage. Tissue Eng Part 




Peterson, L. Minas, T. Brittberg, M. Nilsson, A. Sjögren-Jansson, E. Lindahl, A., 2000. Two-to 9-year 
outcome after autologous chondrocyte transplantation of the knee. Clinical orthopaedics and related 
research 374, 212-234. 
 
Priddy, N. H. n. Cook, J. L. Kreeger, J. M. Tomlinson, J. L. Steffen, D. J., 2001. Effect of ascorbate and two 
different media on canine chondrocytes in three-dimensional culture. Vet Ther 2, 70-77. 
 
Pritzker, K. P. Gross, A. E. Langer, F. Luk, S. C. Houpt, J. B., 1977. Articular cartilage transplantation. Hum 
Pathol 8, 635-651. 
 
Rahfoth, B. Weisser, J. Sternkopf, F. Aigner, T. von der Mark, K. Brauer, R., 1998. Transplantation of 
allograft chondrocytes embedded in agarose gel into cartilage defects of rabbits. Osteoarthritis Cartilage 
6, 50-65. 
 
Responte, D. J. Arzi, B. Natoli, R. M. Hu, J. C. Athanasiou, K. A., 2012. Mechanisms underlying the 
synergistic enhancement of self-assembled neocartilage treated with chondroitinase-ABC and TGF-β1. 
Biomaterials 33, 3187-3194. 
 
Rosenthal, O. Bowie, M. A. Wagoner, G., 1941. Studies in the metabolism of articular cartilage. I. 
Respiration and glycolysis of cartilage in relation to its age. Journal of Cellular and Comparative 
Physiology 17, 221-233. 
 
Roth, V. Mow, V., 1980. The intrinsic tensile behavior of the matrix of bovine articular cartilage and its 
variation with age. The Journal of Bone & Joint Surgery 62, 1102-1117. 
 
Sah, R. L. Y. Kim, Y. J. Doong, J. Y. H. Grodzinsky, A. J. Plass, A. H. Sandy, J. D., 1989. Biosynthetic 
response of cartilage explants to dynamic compression. Journal of Orthopaedic Research 7, 619-636. 
 
Saha, S. Kirkham, J. Wood, D. Curran, S. Yang, X. B., 2013. Informing future cartilage repair strategies: a 
comparative study of three different human cell types for cartilage tissue engineering. Cell and tissue 
research 352, 495-507. 
 
Sampat, S. R. O'Connell, G. D. Fong, J. V. Alegre-Aguaron, E. Ateshian, G. A. Hung, C. T., 2011. Growth 
factor priming of synovium-derived stem cells for cartilage tissue engineering. Tissue Eng Part A 17, 
2259-2265. 
 
Selmi, T. A. Verdonk, P. Chambat, P. Dubrana, F. Potel, J. F. Barnouin, L. Neyret, P., 2008. Autologous 
chondrocyte implantation in a novel alginate-agarose hydrogel: outcome at two years. J Bone Joint Surg 




Sengers, B. G. Heywood, H. K. Lee, D. A. Oomens, C. W. J. Bader, D. L., 2005. Nutrient utilization by 
bovine articular chondrocytes: A combined experimental and theoretical approach. J Biomech Eng 127, 
758-766. 
 
Setton, L. A. Mow, V. Müller, F. Pita, J. Howell, D., 1994. Mechanical properties of canine articular 
cartilage are significantly altered following transection of the anterior cruciate ligament. Journal of 
Orthopaedic Research 12, 451-463. 
 
Silver, F. H. Bradica, G. Tria, A., 2002. Elastic energy storage in human articular cartilage: estimation of 
the elastic modulus for type II collagen and changes associated with osteoarthritis. Matrix Biol 21, 129-
137. 
 
Sittinger, M. Bujia, J. Minuth, W. Hammer, C. Burmester, G., 1994. Engineering of cartilage tissue using 
bioresorbable polymer carriers in perfusion culture. Biomaterials 15, 451-456. 
 
Soltz, M. Palma, C. Barsoumian, S. Wang, C. Hung, C. Ateshian, G., 2000. ‘Multi-Axial Loading of Bovine 
Articular Cartilage in Unconfined Compression. Trans. Orthop. Res. Soc 25, 888. 
 
Soltz, M. A. Ateshian, G. A., 1998. Experimental verification and theoretical prediction of cartilage 
interstitial fluid pressurization at an impermeable contact interface in confined compression. J Biomech 
31, 927-934. 
 
Soltz, M. A. Ateshian, G. A., 2000a. A Conewise Linear Elasticity Mixture Model for the Analysis of 
Tension-Compression Nonlinearity in Articular Cartilage. Journal of biomechanical engineering 122, 576-
586. 
 
Soltz, M. A. Ateshian, G. A., 2000b. Interstitial fluid pressurization during confined compression cyclical 
loading of articular cartilage. Annals of Biomedical Engineering 28, 150-159. 
 
Steadman, J. R., 2001. Microfracture: surgical technique and rehabilitation to treat chondral defects. 
Clinical orthopaedics and related research 391, S362. 
 
Steck, E. Bertram, H. Abel, R. Chen, B. Winter, A. Richter, W., 2005. Induction of intervertebral disc–like 
cells from adult mesenchymal stem cells. Stem Cells 23, 403-411. 
 
Stockwell, R., 1971. The ultrastructure of cartilage canals and the surrounding cartilage in the sheep 
fetus. Journal of anatomy 109, 397. 
 




Stockwell, R. A., 1967. The cell density of human articular and costal cartilage. Journal of anatomy 101, 
753-763. 
 
Stockwell, R. A. (1979). Biology of Cartilage Cells. Cambridge, Cambridge University Press. 
 
Svensson, A. Nicklasson, E. Harrah, T. Panilaitis, B. Kaplan, D. Brittberg, M. Gatenholm, P., 2005. Bacterial 
cellulose as a potential scaffold for tissue engineering of cartilage. Biomaterials 26, 419-431. 
 
Talukdar, S. Nguyen, Q. T. Chen, A. C. Sah, R. L. Kundu, S. C., 2011. Effect of initial cell seeding density on 
3D-engineered silk fibroin scaffolds for articular cartilage tissue engineering. Biomaterials 32, 8927-
8937. 
 
Tan, A. R. Dong, E. Y. Ateshian, G. A. Hung, C. T., 2010. Response of engineered cartilage to mechanical 
insult depends on construct maturity. Osteoarthritis Cartilage 18, 1577-1585. 
 
Tan, A. R. VandenBerg, C. D. Attur, M. Abramson, S. B. Knight, M. M. Bulinski, J. C. Ateshian, G. A. Cook, 
J. L. Hung, C. T., 2015. Cytokine preconditioning of engineered cartilage provides protection against 
interleukin-1 insult. Arthritis Res Ther 17, 361. 
 
Treppo, S. Koepp, H. Quan, E. C. Cole, A. A. Kuettner, K. E. Grodzinsky, A. J., 2000. Comparison of 
biomechanical and biochemical properties of cartilage from human knee and ankle pairs. J Orthop Res 
18, 739-748. 
 
Vacanti, J. P. Langer, R., 1999. Tissue engineering: the design and fabrication of living replacement 
devices for surgical reconstruction and transplantation. Lancet 354 Suppl 1, SI32-34. 
 
Varoni, E. Tschon, M. Palazzo, B. Nitti, P. Martini, L. Rimondini, L., 2012. Agarose gel as biomaterial or 
scaffold for implantation surgery: characterization, histological and histomorphometric study on soft 
tissue response. Connect Tissue Res 53, 548-554. 
 
Veilleux, N. Yannas, I. Spector, M., 2004. Effect of passage number and collagen type on the 
proliferative, biosynthetic, and contractile activity of adult canine articular chondrocytes in type I and II 
collagen-glycosaminoglycan matrices in vitro. Tissue Eng 10, 119-127. 
 
Venn, M. Maroudas, A., 1977. Chemical composition and swelling of normal and osteoarthrotic femoral 
head cartilage. I. Chemical composition. Annals of the rheumatic diseases 36, 121-129. 
 
Vunjak-Novakovic, G. Freed, L. E. Biron, R. J. Langer, R., 1996. Effects of mixing on the composition and 




Vunjak-Novakovic, G. Martin, I. Obradovic, B. Treppo, S. Grodzinsky, A. J. Langer, R. Freed, L. E., 1999. 
Bioreactor cultivation conditions modulate the composition and mechanical properties of tissue-
engineered cartilage. J Orthop Res 17, 130-138. 
 
Wakitani, S. Mitsuoka, T. Nakamura, N. Toritsuka, Y. Nakamura, Y. Horibe, S., 2004. Autologous bone 
marrow stromal cell transplantation for repair of full-thickness articular cartilage defects in human 
patellae: two case reports. Cell transplantation 13, 595-600. 
 
Wang, Y. Blasioli, D. J. Kim, H. J. Kim, H. S. Kaplan, D. L., 2006. Cartilage tissue engineering with silk 
scaffolds and human articular chondrocytes. Biomaterials 27, 4434-4442. 
 
Wenger, R. Hans, M. G. Welter, J. F. Solchaga, L. A. Sheu, Y. R. Malemud, C. J., 2006. Hydrostatic pressure 
increases apoptosis in cartilage-constructs produced from human osteoarthritic chondrocytes. Front 
Biosci 11, 1690-1695. 
 
Whitman, W. (1900). Leaves of grass, D. McKay. 
 
Wilsman, N. J. Van Sickle, D. C., 1972. Cartilage canals, their morphology and distribution. The 
Anatomical Record 173, 79-93. 
 
Winter, A. Breit, S. Parsch, D. Benz, K. Steck, E. Hauner, H. Weber, R. M. Ewerbeck, V. Richter, W., 2003. 
Cartilage‐like gene expression in differentiated human stem cell spheroids: A comparison of bone 
marrow–derived and adipose tissue–derived stromal cells. Arthritis & Rheumatism 48, 418-429. 
 
Woo, S.-Y. Akeson, W. Jemmott, G., 1976. Measurements of nonhomogeneous, directional mechanical 
properties of articular cartilage in tension. Journal of Biomechanics 9, 785-791. 
 
Xu, X. Urban, J. P. G. Tirlapur, U. K. Cui, Z., 2010. Osmolarity effects on bovine articular chondrocytes 
during three-dimensional culture in alginate beads. Osteoarthritis Cartilage 18, 433-439. 
 
Yamaguchi, T. Hayashi, K. Tayama, N. Sugioka, Y., 1990. The role of cartilage canals: experimental study 
using rabbits' femoral heads. Nihon Seikeigeka Gakkai zasshi 64, 1105-1110. 
 
Yodmuang, S. Gadjanski, I. Chao, P. H. Vunjak-Novakovic, G., 2013. Transient hypoxia improves matrix 
properties in tissue engineered cartilage. Journal of Orthopaedic Research 31, 544-553. 
 
Yodmuang, S. Marolt, D. Marcos-Campos, I. Gadjanski, I. Vunjak-Novakovic, G., 2015. Synergistic effects 
of hypoxia and morphogenetic factors on early chondrogenic commitment of human embryonic stem 




Ytrehus, B. Carlson, C. S. Lundeheim, N. Mathisen, L. Reinholt, F. P. Teige, J. Ekman, S., 2004. 
Vascularisation and osteochondrosis of the epiphyseal growth cartilage of the distal femur in pigs--
development with age, growth rate, weight and joint shape. Bone 34, 454-465. 
 
Zhao, X. Bichara, D. A. Ballyns, F. P. Yoo, J. J. Ong, W. Randolph, M. A. Bonassar, L. J. Gill, T. J., 2012. 
Properties of Cartilage Engineered from Elderly Human Chondrocytes for Articular Surface Repair. Tissue 
Engineering Part A 18, 1490-1499. 
 
Zhou, S. Cui, Z. Urban, J. P. G., 2008. Nutrient gradients in engineered cartilage: metabolic kinetics 
measurement and mass transfer modeling. Biotechnol Bioeng 101, 408-421. 
 
Zhu, W. Mow, V. C. Koob, T. J. Eyre, D. R., 1993. Viscoelastic shear properties of articular cartilage and 















1. Cigan, A. D., Nims, R. J., Vunjak-Novakovic, G., Hung, C. T., Ateshian, G. A. (2016). 
Nutrient channels aid the growth of articular surface-sized engineered cartilage 
constructs. Manuscript in preparation. 
 
2. Cigan, A. D., Nims, R. J., Vunjak-Novakovic, G., Hung, C. T., Ateshian, G. A. (2016). 
Optimizing nutrient channel spacing and revisiting TGF-beta in large engineered 
cartilage constructs. Journal of biomechanics, In review. 
 
3. Cigan, A. D., Roach, B. L., Nims, R. J., Tan, A. R., Albro, M. B., Stoker, A. M., Cook, J. 
L., Vunjak-Novakovic, G., Hung, C. T., Ateshian, G. A. (2016). High seeding density of 
human chondrocytes in agarose produces tissue-engineered cartilage approaching native 
mechanical and biochemical properties. Journal of biomechanics, In revision. 
 
4. Nims, R. J., Durney, K. M., Cigan, A. D., Dusséaux, A., Hung, C. T., & Ateshian, G. A. 
(2016). Continuum theory of fibrous tissue damage mechanics using bond kinetics: 
application to cartilage tissue engineering. Interface Focus, 6(1), 20150063. 
 
5. Albro, M. B., Nims, R. J., Durney, K. M., Cigan, A. D., Shim, J. J., Vunjak-Novakovic, 
G., ... & Ateshian, G. A. (2016). Heterogeneous engineered cartilage growth results from 
gradients of media-supplemented active TGF-β and is ameliorated by the alternative 
supplementation of latent TGF-β. Biomaterials, 77, 173-185. 
 
6. Nims, R. J., Cigan, A. D., Albro, M. B., Vunjak-Novakovic, G., Hung, C. T., & 
Ateshian, G. A. (2015). Matrix production in large engineered cartilage constructs is 
enhanced by nutrient channels and excess media supply. Tissue Engineering Part C: 
Methods, 21(7), 747-757. 
 
7. Cigan, A. D., Nims, R. J., Albro, M. B., Vunjak-Novakovic, G., Hung, C. T., & 
Ateshian, G. A. (2014). Nutrient channels and stirring enhanced the composition and 




8. Nims, R. J., Cigan, A. D., Albro, M. B., Hung, C. T., & Ateshian, G. A. (2014). 
Synthesis rates and binding kinetics of matrix products in engineered cartilage constructs 
using chondrocyte-seeded agarose gels. Journal of biomechanics, 47(9), 2165-2172. 
 
9. O’Connell, G. D., Nims, R. J., Green, J., Cigan, A. D., Ateshian, G. A., & Hung, C. T. 
(2014). Time and dose-dependent effects of chondroitinase ABC on growth of engineered 
cartilage. European cells & materials, 27, 312.  
 
10. Cigan, A. D., Nims, R. J., Albro, M. B., Esau, J. D., Dreyer, M. P., Vunjak-Novakovic, 
G., ... & Ateshian, G. A. (2013). Insulin, ascorbate, and glucose have a much greater 
influence than transferrin and selenous acid on the in vitro growth of engineered cartilage 
in chondrogenic media. Tissue Engineering Part A, 19(17-18), 1941-1948. 
 
11. Albro, M. B., Nims, R. J., Cigan, A. D., Yeroushalmi, K. J., Shim, J. J., Hung, C. T., & 
Ateshian, G. A. (2013). Dynamic mechanical compression of devitalized articular 
cartilage does not activate latent TGF-β. Journal of biomechanics, 46(8), 1433-1439. 
 
12. Albro, M. B., Nims, R. J., Cigan, A. D., Yeroushalmi, K. J., Alliston, T., Hung, C. T., & 
Ateshian, G. A. (2013). Accumulation of exogenous activated TGF-β in the superficial 
zone of articular cartilage. Biophysical journal,104(8), 1794-1804. 
 
13. Albro, M. B., Cigan, A. D., Nims, R. J., Yeroushalmi, K. J., Oungoulian, S. R., Hung, C. 
T., & Ateshian, G. A. (2012). Shearing of synovial fluid activates latent TGF-
β. Osteoarthritis and Cartilage, 20(11), 1374-1382. 
 
Conference abstracts 
1. Cigan, A. D., Nims, R. J., Vunjak-Novakovic, G., Hung, C. T., Ateshian, G. A., 2016. 
Human-scale engineered cartilage with nutrient channels reaches native mechanical and 
biochemical properties. In: 62
nd
 Annual Meeting of the Orthopaedic Research Society. 
Orlando, FL, USA. 
2. Cigan, A. D., Nims, R. J., Albro, M. B., Jones, B. K., Feingold, H. J., Vunjak-
Novakovic, G., Hung, C. T., Ateshian, G. A., 2015. Characterization of a human 
chondrocyte-agarose system for engineering cartilage: the importance of cell seeding 
density. In: 61
st




3. Albro, M. B., Nims, R. J., Durney, K. M., Cigan, A. D., Shim, J. J., Vunjak-Novakovic, 
G., Hung, C. T., Ateshian, G. A., 2015. Heterogeneous growth of engineered cartilage 
results from gradients of media supplemented active TGF-beta and is ameliorated 
through the alternative supplementation of latent TGF-beta. In: 61
st
 Annual Meeting of 
the Orthopaedic Research Society. Las Vegas, NV, USA. 
4. Nims, R. J., Cigan, A. D., Albro, M. B., Hung, C. T., Ateshian, G. A., 2015. Glucose- 
and TGF-beta-dependent matrix synthesis models explain heterogeneous matrix 
deposition in large engineered tissues. In: 61
st
 Annual Meeting of the Orthopaedic 
Research Society. Las Vegas, NV, USA. 
5. Cigan, A. D., Nims, R. J., Albro, M. B., Quien, M. M., Atkatsh, K., Hung, C. T., 
Ateshian, G. A., 2014. Elevated matrix production in large engineered cartilage 
constructs significantly facilitated by nutrient channels and sufficient media. In: 60
th
 
Annual Meeting of the Orthopaedic Research Society. New Orleans, LA, USA. 
6. Ateshian, G. A., Nims, R. J., Cigan, A. D., and Hung, C. T., 2013. Theoretical and 
computational modeling of tissue growth mechanics with applications to quantitative 
cartilage tissue engineering. In: Biomedical Engineering Society Annual Meeting. Seattle, 
WA, USA. 
7. Cigan, A. D., Nims, R. J., Albro, M. B., Hung, C. T., and Ateshian, G. A., 2013. Effects 
of media stirring and presence of nutrient channels on functional properties of large 
engineered cartilage constructs. In: ASME Summer Bioengineering Conference. Sunriver, 
OR, USA. 
8. Nims, R. J., Cigan, A. D., Albro, M. B., Hung, C. T., and Ateshian, G. A., 2013. Binding 
and release kinetics of glycosaminoglycans and collagen in engineered cartilage under 
TGF-beta supplementation. In: ASME Summer Bioengineering Conference. Sunriver, 
OR, USA. 
9. Nims, R. J., Cigan, A. D., Albro, M. B., Park, D. B., Vunjak-Novakovic, G., Hung, C. T., 
and Ateshian, G. A., 2013. Engineered cartilage supplemented with channels increases 
nutrient availability throughout large constructs: a finite element study. In: 11th 
International Symposium, Computer Methods in Biomechanics and Biomedical 
Engineering. Salt Lake City, UT, USA. 
10. Albro, M. B., Nims, R. J., Cigan, A. D., Yeroushalmi, K. J., Shim, J. J., Chen, Y. B. C., 
Hung, C. T., and Ateshian, G. A., 2013. Dynamic mechanical compression of articular 
cartilage does not activate latent TGF-beta. In: 59th Annual Meeting of the Orthopaedic 
Research Society. San Antonio, TX, USA. 
213 
 
11. Cigan, A. D., Nims, R. J., Albro, M. B., Quien, M. M., Vunjak-Novakovic, G., Hung, C. 
T., and Ateshian, G. A., 2013. Identification of a glucose concentration threshold critical 
for tissue growth in engineered cartilage. In: 59th Annual Meeting of the Orthopaedic 
Research Society. San Antonio, TX, USA. 
12. Nims, R. J., Cigan, A. D., Albro, M. B., O'Connell, G. D., Park, D. B., Hung, C. T., and 
Ateshian, G. A., 2013. Frequent chondroitinase treatment in engineered cartilage with 
native level of cell seeding density does not enhance collagen deposition and is 
detrimental to chondrocytes. In: 59th Annual Meeting of the Orthopaedic Research 
Society. San Antonio, TX, USA. 
13. Cigan, A. D., Nims, R. J., Albro, M. B., Breves, S. L., Hung, C. T., and Ateshian, G. A., 
2012. Insulin and ascorbate have a much greater influence than transferrin and selenous 
acid on the growth of engineered cartilage in chondrogenic media. In: ASME Summer 
Bioengineering Conference. Fajardo, PR, USA. 
14. Ateshian, G. A., Nims, R. J., Cigan, A. D., Albro, M. B., and Hung, C. T., 2012. Finite 
element modeling of matrix synthesis and binding kinetics in a biphasic-solute material. 
In: ASME Summer Bioengineering Conference. Fajardo, PR, USA. 
15. Nims, R. J., Cigan, A. D., Albro, M. B., Wood, K. C., Hung, C. T., and Ateshian, G. A., 
2012. Engineered cartilage constructs retain a much greater fraction of synthesized GAG 
and collagen than COMP. In: 58th Annual Meeting of the Orthopaedic Research Society. 
San Francisco, CA, USA. 
16. Albro, M. B., Cigan, A. D., Nims, R. J., Chen, Y. B. C., Hung, C. T., and Ateshian, G. 
A., 2012. Synthesis and incorporation of latent TGF-beta into the extracellular matrix of 
engineered cartilage constructs. In: 58th Annual Meeting of the Orthopaedic Research 
Society. San Francisco, CA, USA. 
17. Albro, M. B., Nims, R. J., Cigan, A. D., Chen, Y. B. C., Hung, C. T., and Ateshian, G. 
A., 2012. Accumulation of exogenous active TGF-beta in the superficial zone of 
immature bovine articular cartilage. In: 58th Annual Meeting of the Orthopaedic 





Appendix 2: Inhomogeneous growth in centimeter-sized 
constructs cultured flat in Petri dishes 
 
This Appendix details the earliest attempts by our group to culture channeled constructs since the 
preliminary work in (Bian et al., 2009a).  
 
Introduction 
In a previous study, it was found that the incorporation of a single 1 mm channel in a 4 mm 
× 2.3 mm agarose construct could increase construct EY, but not GAG or collagen content; a 
similar result was obtained by placing three channels in triangular configurations in 10 mm × 
2.3 mm constructs (Bian et al., 2009a). As an early thrust toward our greater objective of 
culturing articular layer-sized constructs with optimized channel configurations, we attempted to 
reproduce and build upon these previous results. Custom molds were fabricated for the precise 




Custom mold fabrication 
For the purposes of this study, two new half-molds were fabricated from sheet PTFE and 
stainless steel pins. The design for the mold responsible for casting constructs with 3 or 12 
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channels (CH3 or CH12, respectively) is detailed in 2.4. The second mold was identical, save for 
the fact that the pins were spaced apart by 2.75 mm rather than 2.165 mm. The resulting mold 




Primary juvenile bovine chondrocytes were harvested and resuspended in 2% w/v agarose as 
described above (2.1). The molten agarose-chondrocyte suspension was cast into both custom 
molds, with pin deployed to produce equal numbers of CH0, CH3, CH7, and CH12 constructs. 
The constructs were cultured flat in Petri dishes, as is conventional for 4 mm constructs. After 
a recent observation in which 4 mm constructs benefited from orbital shaking during culture 
(Roach, unpublished observations), the dishes were subjected to 0.8 Hz orbital shaking 
throughout culture. Each construct was provided 6 mL of ITS media (3.1.3.2), and media were 
changed 3× weekly. TGF-β3 was provided to constructs at concentrations of 10 ng/mL for the 
first 14 days (Byers et al., 2008). Constructs were removed from culture after 28 or 50 days for 
mechanical and biochemical characterization (5 ≤ N ≤ 8 per channel group per time point) (2.2, 
2.3).  
 
Spatial biochemical analysis 
Due to visibly high levels of heterogeneous construct opacity and swelling, with greater swelling 
and opacity preferentially localized to construct peripheries, constructs were subdivided for 
biochemical assessments (Figure A-1). The intact half of each construct was analyzed for GAG 
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and collagen contents, representing the spatially averaged contents of the constructs. The other 
half was further divided into three sections, a half-core and two half-annuli, by 4 mm and 6 




Figure A-1: Subdivision of a 10 mm construct into a half-construct, half-core, 
















Constructs developed heterogeneously, with extreme swelling noted at the outer (radial) edges 
(Figure 4-1B-C). The peripheries of constructs had thicknesses up to twice as high as the 
construct centers. Furthermore, the centers tended to be translucent compared to the peripheries. 
 
Functional properties 
After four weeks in culture, constructs had not developed substantially in stiffness (Figure A-2). 
By day 50, however, constructs had EY ~ 386 kPa, with no differences attributable to channel 
configuration.  
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Average contents of cartilage ECM reached ~ 4.5 %/ww GAG and ~1.2 %/ww collagen at 
day 50 for all channel groups. From the spatial analysis of constructs, the peripheral annuli had 
markedly higher contents of both matrix constituents, especially GAG (Figure A-3, Figure A-4). 
The core regions had the least collagen compared to annuli (Figure A-4). For both GAG and 




Figure A-3: Spatially varying GAG contents of channeled constructs at day 50. 
 













































The 10 mm constructs cultured in this study attained values of EY, and spatially-averaged GAG 
and collagen contents that rivaled those of previous studies with 10 mm and 4 mm constructs 
(Figure A-2, Figure A-3, Figure A-4)(Bian et al., 2009a; Cigan et al., 2013a). However, matrix 
was preferentially deposited at the construct peripheries, resulting in large levels of heterogeneity 
(Figure A-3, Figure A-4). What’s more, no beneficial effects of channels were discernible, unlike 
in the previous study (Bian et al., 2009a). 
 The introduction of orbital shaking during culture had previously been successful in 
enhancing growth in 4 mm constructs, presumably due to the stirring of the media and 
prevention of stagnation around constructs. It is our belief that this stirring may have encouraged 
mixing around the construct periphery but not within the nutrient channels, since the direction of 
stirring (horizontal) was perpendicular to the channel axes. It was also observed that constructs 
would swell unevenly, in some cases warping visibly (Figure 4-1). This may be attributable to 
poor nutrient exchange across the bottom face of the constructs, which is occluded by the Petri 
dish. In constructs as small as 4 mm, this effect may also be observed, though to a lesser extent 
(Bian et al., 2009a). Future studies will seek to overcome these limitations in the culture of 10 




Appendix 3: Cartilage Advanced Growth Environments (CAGEs) 
 
Introduction 
As engineered cartilage constructs grow, extracellular matrix macromolecules are synthesized by 
cells, many of which become entrained within the construct’s network of agarose and previously 
deposited matrix. A relatively recent observation was made during experiments contained in this 
dissertation: chondrocyte-agarose constructs, when supplied with sufficient nutrients and media 
stirring, exhibit large levels of swelling. Above, it was demonstrated that 10 mm × 2.3 mm 
channeled cylindrical constructs could swell by up to nearly 3× their initial wet weight (4.1, 4.2) 
(Nims et al., 2015). In a more recent study, 3 mm × 2.3 mm constructs seeded with 120 × 10
6
 
cells/mL saw ninefold increases in their initial wet weights over an extended culture period 
(Nims et al., 2016). In the latter study, it was predicted by theoretical models and demonstrated 
experimentally that collagen deposited early in culture is damaged by subsequent swelling. 
Though new collagen is consistently being produced, the structural integrity of previous 
generations is likely compromised due to this swelling effect. By curbing construct swelling, it 
may be possible to prevent collagen damage and yield more mechanically robust tissue. 
Furthermore, an undamaged collagen matrix could buttress the construct against swelling, 
potentially increasing the apparent wet weight fraction of collagen closer to native levels. 
The swelling of constructs is most notably attributed to the deposition of a large quantity of 
negatively-charged GAGs which generate a strong Donnan osmotic effect (Donnan, 1924). Cells 
in CTE constructs generally produce GAG more readily than collagen, which runs counter to the 
relative proportions of the two matrix constituents in native tissue, in which collagen dominates. 
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Previous attempts to increase concentrations of collagen relative to GAG include the enzymatic 
destruction of either the agarose scaffold with agarase (Ng et al., 2009b) or the existing GAG 
network with chondroitinase ABC (Nims et al., 2016; O'Connell et al., 2014). While both have 
been shown to result in increases to the final construct wet weight fraction of collagen, agarase 
treatment represents only a one-shot opportunity for boosting construct functional properties, and 
chondroitinase ABC has had detrimental effects on cell viability even at low dosages (Nims et 
al., 2016). A reliable technique for mitigating construct swelling that is safe for long-term cell 
viability would therefore be highly desirable.  
 In this experiment, a novel culture device is to be designed and fabricated in order to 
mechanically constrain 10 mm × 2.3 mm constructs and prevent their swelling. The device 
must satisfy several criteria: it must be rigid enough to resist construct swelling pressure, it must 
exhibit no or low cytotoxicity,  it must be able to be sterilized and handled aseptically, it must 
not deplete media TGF-β levels via binding (Albro et al., 2016), and it must permit nutrient 
exchange to constructs. The device will be evaluated by assessing cell viability and construct 
functional properties.  
 
 Methods 
Device design and fabrication 
The form for the culture device was selected to consist of an assembly of three primary rigid 
parts: two perforated 316 stainless steel sheets (0.9 mm thick, 1.4 mm holes, 2.47 mm hole 
spacing) to prevent construct axial expansion while still permitting nutrient supply to the axial 
faces of the construct, and a central polysulfone spacer (2.5 mm thick, 2 10.5 mm holes) 
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machined to prevent construct radial expansion (Figure A-5A-B). The three layers would be 
fastened with steel screws and nuts. Stainless steel was selected for its strength and its resistance 
to oxidation, and polysulfone for its rigidity, heat tolerance, and biocompatibility; both stainless 
steel and polysulfone can be sterilized by autoclaving. The device was termed as the Cartilage 
Advanced Growth Environment (CAGE). 
The design must allow for the aseptic loading and unloading of 10 mm × 2.3 mm CTE 
constructs. Due to the fragility of freshly-cast agarose constructs, and the propensity of TGF-β to 
bind to a variety of materials (Albro et al., 2016), the device was designed such that constructs 
could be loaded on day 14, following transient TGF-β supplementation. For this reason, the slots 
for constructs were prescribed to be 10.5 mm to account for swelling transpiring prior to day 
14. Each CAGE was designed to hold two constructs and to be accommodated by an existing 




Figure A-5: (A) Solidworks model of device prototype, with top perforated steel 
layer exploded to reveal polysulfone spacer containing 10 mm × 2.3 mm 
constructs; (B) Machine drawing for polysulfone spacer, all dimensions in mm. 
 
 
 Experimental design 
In this preliminary experiment to test the functionality of CAGES, sixteen CH12 constructs were 
cast with twice-passaged juvenile bovine chondrocytes and cultured as described above (2.4, 
4.2.2.1) until day 17 (following the conclusion of TGF-β supplementation of 1 ng/mL, based on 





using aseptic technique (Figure A-6) and returned to culture. To ensure CH12 channels were 
aligned with perforated sheets, a 1 mm biopsy punch was passed through perforations in both 
sheets and the construct within. From this point on, two different culture media were used: 
standard ITS media or 3× glucose media (3.1.3.2). The 3× glucose media was utilized as an 
attempt to alleviate what was anticipated to be diminished nutrient transport to CAGE constructs 





Figure A-6: Day 17 CH12 constructs being loaded into a CAGE device (top), and 
the CAGE with constructs placed within a culture rack (bottom). 
 
 
 Construct assessment 
At day 42, constructs were removed from culture and subjected to mechanical, biochemical, and 
histological assessments as described above (2.2, 2.3, 2.6, 4.1.3.4, 4.1.3.5, 4.1.3.6), using 0.1% 
Safranin O to stain for GAG and 0.1% Picrosirius Red to stain for collagen. Additionally, to 
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examine any potential cytotoxic effects of the CAGEs, a LIVE/DEAD viability assay was 
performed by incubating bisected samples 30 minutes in a calcein AM/ethidium homodimer 
solution and imaging by fluorescent microscopy. 
 
 Results 
 Cell viability 
After 42 days in culture and either zero or 25 days in CAGEs, constructs displayed similarly high 
cell viabilities with few dead cells (Figure A-7). Due to swelling of samples between bisection 
and imaging, not all regions of each sample appeared in-plane simultaneously; peripheral regions 
have been highlighted in Figure A-7. Interior regions of all constructs were highly viable. 
 
 
Figure A-7: LIVE/DEAD images of CG and FS constructs given standard (1×) or 
high (3×) GLU. CG = CAGE, FS = free-swelling, GLU = glucose. 
 













 Morphology and histology 
Constructs assumed a white, opaque, cartilage-like appearance after 42 days in culture (Figure 
A-8). Many of the channels that had been re-punched in CAGE constructs remained open, while 
the original channels in free-swelling constructs had almost entirely filled in (Figure A-8). Free-
swelling constructs receiving 3× glucose were visibly larger in diameter and thicker (Figure 
A-8). 
Histological analysis revealed fairly homogeneous staining for both collagen and GAG 
within the construct interior, though collagen also accumulated at the margins of filling channels 
(Figure A-9). In free-swelling constructs, all channels were at least partially occluded with GAG 
at one surface of the construct, and collagen filled channels to a larger extent. Some channels in 





Figure A-8: Photographs of CAGE and FS constructs given standard (1×) or high 
(3×) GLU. FS = free-swelling, GLU = glucose. 
 
 
Figure A-9: Histological images of CG and FS constructs given standard (1×) 
glucose, stained either for GAG (0.1% Safranin O) or for collagen (0.1% 
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 Construct functional properties 
The CAGEs significantly increased EY (391 ± 132 kPa vs. 144 ± 62 kPa, p < 0.005), reduced 
swelling ratio (1.3 ± 0.1 vs. 1.9 ± 0.2, p < 0.0005), and elevated GAG content (7.7 ± 0.7 %/ww 
vs. 6.9 ± 0.7 %/ww, p < 0.05), but did not influence collagen content (p = 0.08). Increasing the 
media glucose concentration to 3× resulted in greater swelling (1.7 ± 0.4 vs. 1.5 ± 0.3, p < 0.005) 
and reduced collagen content (2.3 ± 0.1 vs. 2.7 ± 0.3, p < 0.005), but did not influence EY (p = 
0.3) or GAG content (p = 0.07). Only for swelling ratio was the effect of the interaction between 
CAGEs and glucose significant (p < 0.05), with all groups being significantly distinct (p < 0.005) 
with the exception of the two CAGE groups from each other (p = 0.7). The group in CAGEs 
with 1× glucose possessed the highest EY (471 ± 141 kPa), GAG content (8.0 ± 0.7 %/ww) and 





Figure A-10: (A) EY, (B) swelling ratio, and (C) GAG and (D) collagen contents 
of CG and FS constructs. CG = CAGE, FS = free-swelling, CG × GLU = 
interaction between CG and GLU, GLU = glucose. * p < 0.05 for ANOVA effect. 




In this study, we provided proof-of-principle that our chondrocyte-agarose constructs can be 
successfully cultured in rigid enclosures (Figure A-5, Figure A-6) to curb large amounts of 
swelling. By using readily available and machined materials (stainless steel and polysulfone), we 
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constructs. All constructs maintained good viability throughout culture (Figure A-7), and CAGE 
constructs swelled significantly less than their free-swelling controls while simultaneously 
developing higher EY and GAG content (Figure A-10). By restraining the constructs from 
excessive swelling, deposited matrix became more concentrated and construct surfaces were 
smoother. We speculate that the reduced swelling by constructs potentially results in less damage 
to deposited collagen (Nims et al., 2016); ongoing studies are investigating this with greater 
scrutiny. With continued success of the CAGEs, we believe that they have the potential to be 
effective in increasing collagen contents and tensile properties of constructs of increasing scale.  
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Upon performing initial cartilage tissue engineering experiments using human chondrocytes 
sourced from expired osteochondral allografts, it was observed that the human chondrocytes 
exhibited distinct characteristics from bovine or canine cells. Whereas during monolayer 




 could be raised at 





During casting procedures with human chondrocytes, high cell seeding densities were difficult to 
achieve; human chondrocytes were of such size that resuspending them in media at densities as 
low as 120 × 10
6
, for casting constructs with 60 × 10
6
 cells/mL, once mixed 1:1 with agarose), 
yielded what was essentially a cell pellet rather than a suspension. Based on our findings that 
high cell seeding densities are extremely beneficial for improving construct properties (7.1), we 
sought to determine whether human chondrocyte size was influenced by time spent during 





Cell harvest and culture 
Similarly as above, human chondrocytes were isolated from expired osteochondral allografts 
(7.1.3.1). Cells were passaged either zero (primary cells), one, two, or three passages in 
monolayer (7.1.3.1) before sizing experiments. 
 
Cell size measurements 
A Coulter counter (Beckman Coulter #Multisizer 4, Brea, CA) was used for cell sizing. Sizing 
was performed similarly as a previous study in which cartilage wear particles were measured 
(Oungoulian et al., 2013). A 70 µm aperture tube was employed to measure particles over a size 
threshold of 5 µm diameter. For each sample, 5 × 10
6
 cells were resuspended in 25 mL of culture 
media and tested immediately. Four sequential tests were performed per sample, with each test 
measuring 3 × 10
4




Cell sizing measurements were similar for healthy osteochondral allografts, ranging from 10.0-
17.9 µm with a mean of 14.8 ± 2.3 µm. The single measurement performed on OA cells 
registered higher at 19.1 µm, though not enough samples were taken in order to form a reliable 
size comparison. For each donor there was no distinct trend to suggest increasing or decreasing 





Figure A-11: Cell diameters of human chondrocytes. D1-5 are distinct healthy 




Though there appeared to be slight variations in the cell diameters of chondrocytes from different 
human donors, and of the lone arthritic donor, not enough samples were measured to be able to 
make reliable and confident comparisons between the donors. There were no apparent changes in 
cell size as a result of passaging up to three times; indeed, the cells began approximately as large 
when first harvested from the tissue as they did after up to three passages. The sizes of cells from 
healthy donors are towards the high end of human chondrocyte diameters reported in the 
literature, which range broadly from 11-16 um (Alexopoulos et al., 2005; Jones et al., 1999; 

























This large size of human chondrocytes may present logistical challenges in the casting of 
hydrogel constructs with human chondrocytes. While with bovine cells we have previously cast 
by combining cell suspensions of up to 240 × 10
6
 cells/mL (Nims et al., 2016) with equal parts 
agarose with relative ease, the relatively large human chondrocytes were difficult to resuspend as 
cell solutions with as little as 120 × 10
6
 cells/mL. With spherical cells of diameters between 11-
16 µm, such a suspension is comprised of 8-25% cells by volume. Even with gentle pipetting, it 
is possible that cell death occurs when aspirating and/or mixing such a dense suspension. A 
potential method to mitigate this would be to combine a more dilute cell suspension with more 
concentrated agarose, e.g. 80 × 10
6
 cells/mL combined 3:1 parts with 8% v/v molten agarose to 
yield final concentrations of 60 × 10
6
 cells/mL in 2% v/v agarose in constructs. Another 
possibility could be to manipulate growth factor treatments post-encapsulation by supplementing 
constructs with mitogenic factors such as PDGF and FGF to encourage cell proliferation, and 
subsequently treat with chondrogenic factors such as TGF-β. Both of these techniques would 




Appendix 5: Culture racks and mold drawings 
 
Culture racks for 10 mm constructs 
 
 
Figure A-12: PTFE stands used to hold PTFE-coated steel wires. All dimensions 
are in mm.  
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 Culture racks for 40 mm constructs 
 
 
Figure A-13: PTFE culture racks to hold PTFE-coated steel wires for culturing 





 Casting molds for 40 mm constructs 
The below design was implemented for casting 40 mm constructs. For different channel 
diameters and arrangements, the diameter and/or the spacing of the pegs and holes in the top and 
bottom parts were altered. These diameters and spacings may be inferred from specifications 






Figure A-14: Sample top (upper left), collar (upper right), and bottom (lower) of 
casting mold for 40 mm constructs. All dimensions are in mm. 
